Articles of Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences | Volume , Issue suppl.1 / 2010

Search by Journal

HOME
> Search by Journal
> Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences

Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences

Volume , Issue suppl.1 / 2010

English Article

Japanese Article

Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.

	Clinical pharmacy to return from a clinic to a learning clinic Koichi Kitada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2010.

	A way of thinking and common practice of life-style related diseases Yasushi Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2010.

	Mental disorder and weak gene DISC1 Toshitaka Nabeshima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2010.

	For practice - East-West medical fusion of Japanese and Chinese practice studies - 寺澤捷年 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 169-169, 2010.

	As a leading figure of the regional medicine of prospective pharmacist image ... super aged society of the near future ... Ken Hazama solstice Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2010.

	We think about pharmacist duties from a physicochemical viewpoint Hideko Kanazawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2010.

	The ethical procedure that is demanded from the clinical studies of the pharmacist Hiroyuki Furukawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2010.

	Message to diabetes reserve army of people: Encouragement of human experimentation 鎌滝哲也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2010.

	Laughter and an impression draw likelihood Kazuo Murakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2010.

	A design and evaluation: of "the preparation which is kind to the patients" -Polyethylene oxide (PEO) -Iota (ι) -Applied - to the hospital preparation basis of the carrageenan mixture 花輪剛久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2010.

	The expression mechanism of the side effect with the cancer medical treatment and study on factor analysis Takuya Iwamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2010.

	Construction of the evidence for the medical treatment management that assumed the TDM of the immunosuppressive drug a base Takafumi Naito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2010.

	To a study to change the settings from the study for studies to Shunichi Fukuhara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2010.

	Way of thinking, how to build studies for the medical supplies proper use Nobuyuki Goto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2010.

	Matters that require attention in an ethic and the article writing of clinical studies Yasushi Yamamoto Jiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2010.

	It is an outline at the S1-PL beginning Junichi Kawakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2010.

	With the evaluation of the fur Matthew tical care judging from S1-1 fee-for-service Hiroshi Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2010.

	To visualize result of the S1-2 medical supplies management Mitsuko Onda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2010.

	The impact that S1-3 pharmaceutical intervention gives to the financing index of the hospital 赤瀬朋秀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2010.

	The economic effect that S1-4 pharmacotherapy protocol making and the collaboration by the ward pharmacist result in Masahiro Hayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2010.

	The S1-5 fur Matthew tical care for what for whom? Makiko Kusama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2010.

	Of the ward activity of the pharmacist in the S2-1 children special hospital, actually Hidemi Tokunaga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2010.

	Thing to hope for as a fact and a pharmacist of the S2-2 child care Mari Saikai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2010.

	Of the pediatric care settings of the S2-3 area pharmacist, actually Hiroyuki Sugiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2010.

	About a pharmacist found in S2-4 NICU ward with "a childhood authorized pharmacist system" 河田興 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2010.

	As for anyone, it is ... by illness medicine cooperation everywhere in illness medicine cooperation ... using S3-1 "medication reporting book" Chie Yoshimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2010.

	Because ... psychological care pharmacotherapy is provided about the cooperation system in the S3-2 Tokyo Women's Medical Coll. hospital; cooperation system ... with the community pharmacy Shun Ito is elegant Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2010.

	The present conditions and problem of the mild fur Matthew tical care in the S3-3 drugstore Harikae eyes Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2010.

	As the thing ... patients family who saw through S3-4 at-home mild medical care as health insurance pharmacy pharmacist ... Mayumi Oe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2010.

	Importance and specialty of the medical treatment in the S4-1 pressure sore practice Isogai good storehouse Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2010.

	Utility of the pressure sore measures team participation in planning of the S4-2 pharmacist Sulcular Fumihiro God Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2010.

	Practice of a relation and the team approach in medical care of the pharmacist to pressure sore treatment in the S4-3 Hospital Taku Morikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2010.

	Role of the pharmacist to patients with S4-4 at-home pressure sore Masako Mizuno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2010.

	Battle front - of S5-PL basic tone lecture - diabetes treatment Ryuzo Kawamori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2010.

	Trial - of the study - insulin non-injection preparation development of the diabetes remedy in the S5-1 basics pharmacy Mariko Morishita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2010.

	Practice of the diabetes medical treatment instruction in the S5-2 hospital pharmacy Junichi Shimizu 1, Tsuyoshi Horii 2, Takeshi Minami husband 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2010.

	Practice of the diabetes medical treatment instruction in the S5-3 health insurance pharmacy Masako Satake Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2010.

	Trial - for induction - side effect evasion of the physical assessment to S6-1 psychiatry acute phase Koji Kase Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2010.

	For consciousness reform of - medical staff recording the wind of the prescription that is simple for S6-2 psychiatry chronic stage - Hiroko Baba Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2010.

	S6-3 Latest findings for the drug therapy of refractory cases : Pharmacist can do for proper use 高橋結花 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2010.

	Thing - that support results after - discharge that S6-4 patients association, family society demands it Yoko Hashimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2010.

	The mission of the pharmacist specialized in S7-1 cancer and authorized trend Yusuke Tanigawara 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2010.

	Of S7-2 lung cancer standard medical treatment and the pharmaceutical intervention, actually Hiroki Miyata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2010.

	Of S7-3 gastric cancer standard medical treatment and the pharmaceutical intervention, actually 橋本浩伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2010.

	Of S7-4 colorectal cancer standard medical treatment and the pharmaceutical intervention, actually Hisashi Shimizu example Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2010.

	Of S7-5 breast cancer standard pharmacotherapy and the pharmaceutical intervention, actually Masato Yonemura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2010.

	Of S7-6 hematologic cancer standard medical treatment and the pharmaceutical intervention, actually The Mishima one up, Uchida まやこ, Pond end Hiroaki, Ryozo Oishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2010.

	About the purpose of the S8-PL symposium Tadashi Shiraishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2010.

	Pharmacist as the S8-1 infection management representative Naoto Onodera Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2010.

	Resistant bacteria measures and TDM duties to become the part of the S8-2 team approach in medical care Masahiro Igarashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2010.

	Infection management as the S8-3 team approach in medical care Yoshiko Takahashi, Yoshio Takesue Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2010.

	Way as the pharmacist specialized in S8-4 infection in the future Tadao Kimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2010.

	The S9-1 physician hopes that a pharmacist shows the true value in NST Eiji Yamanaka 1, Yasuhide Yasuda 2, Kazuki Sugimoto 2, Ueda exhibition charges 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2010.

	To show the true value of the pharmacist in S9-2 NST; from the situation of - nurse - Ito seven Nako, Thistle Noriyo, Hunting Noe Rika, Tadatoshi Machida, Yayoi Sudo, 原澤健, Kazutoshi Maejima, Tetsushi Ogawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2010.

	To show the true value of the pharmacist in S9-3 NST; from the situation of - pharmacist - Akira Ogino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2010.

	The place that - NST pharmacist aims at from the situation of - pharmacist to show the true value of the pharmacist in S9-4 NST Nobuyuki Muroi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2010.

	So that a pharmacist shows the true value in S9-5 NST Hiroyuki Hayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2010.

	S10-1 Pre-licensure Pharmacy Education in the University of Tokyo Makiko Kusama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2010.

	S10-2 Clinical Practice Experience in KOREAN Hospital for Pharmacy Education KIM JAE-YOUN Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2010.

	S10-3 Clinical Training for Pharmacy Students in the Six-year Course Newly Started in Japan： An example in Gunma University Hospital Tomonori Nakamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2010.

	S10-4 Overview and Prospects of Academic Education for Clinical Pharmacy in China XiaoHui XIE Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2010.

	S10-5 Education of Pharmacists to improve Japanese Healthcare System Kiyohito Nakai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2010.

	S10-6 The status of clinical trial in Korea from hospital pharmacists' perspective Sun Choi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2010.

	S10-7 Current clinical pharmacy mode and practice in China Health Care System Zhangqin Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2010.

	S10-8 Evaluation of Adverse Drug Reactions in the Medical Intensive Care Unit and Preliminary Development of Signals for Early Detection of ADR Park Sojin1, Kim Eunyoung1, In Yongwon1, Sohn Kieho1, Suh Jiyoung2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2010.

	S10-9 Overview of Pharmacy Intravenous Admixture Service Practice of China Rongsheng Zhao Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2010.

	S10-10 Molecular mechanism for neuropathic pain induced by anti-cancer drug paclitaxel Yasuo Takeda, Kentaro Nishida, Katsushi Yamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2010.

	Result of the S11-1 ICT utilization and the evaluation 杉原多公通 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2010.

	Inflection - of humanism education - learning support system of the S11-2 pharmacy student Shiro Iijima, Satoko Ishikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2010.

	The evaluation that utilized S11-3 portfolio Miho Utsumi 1, Hiroshi Onishi High School 2, Yumiko Yamaoka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2010.

	Examination of the education effect using the S11-4 text mining Itsuko Ishii Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2010.

	Why S12-1 is CKD now; is definition and problems ... of ... CKD Makoto Ogawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2010.

	Strategies for treatment of S12-2 CKD Shiro Ueda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2010.

	Drug administration design of the S12-3 CKD patients Yoshiyuki Ono 1, Taketo Yamamoto 1, Gutter slope Akihiro 2, Hiroshi Suzuki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2010.

	Change of the extrarenal clearance in patients with S12-4 renal failure Masayuki Tsujimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2010.

	Relation of practice and the pharmacist of the drug proper use of the S12-5 CKD patients Old Taku Kubo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2010.

	The medication support that S13-1 ethical pharmacy works on Hideki Kanai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2010.

	Collaboration - of a medication support - medication history list prescription and the medicine calendar in the S13-2 ward activity Katsuaki Arai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2010.

	Psychological support to an at-home outpatient demanded from S13-3 pharmacist Naoko Takeuchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2010.

	Expectation - to team approach in medical care - pharmacist whom S13-4 physician thinks about Kazuhiro Akiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2010.

	Proposal - from a pharmacist with medication support - hearing impairment that the S13-5 patients demand Kumi Hayase Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2010.

	We think about S13-6 "patients center" some other time Is Kurata; see it Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2010.

	S14-1 Based on the Medicine to grow of the hypercholesterol plasma therapeutic drug 花輪正明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2010.

	When society talks with S14-2 medical supplies Toshiko Kikkawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2010.

	After the marketing of S14-3 medical supplies about the importance of safety measures Straw bag tree Tomiko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2010.

	"The scientific power of observation" that thing, it which are demanded from S14-4 pharmacist do not miss the signal from the patients Hiroyuki Furukawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2010.

	Relief, - to think from the present conditions of the team approach in medical care in - this hospital for a safe medical offer to patients with S15-1 diabetes Michiko Aoki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2010.

	All medical persons cross a team and will examine S15-2 diabetes Masaki Shinomiya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2010.

	Medication support for adherence improvement in the S15-3 health insurance pharmacy and pharmaceutical management Sanno Naoko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2010.

	S15-4 regional medicine cooperation pass and pharmacist Yoshiko Miyazaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2010.

	Side effect and pharmacogenomics of the S16-1 anticancer drug Yoshiro Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2010.

	Gene marker of the S16-2 serious case drug eruption Kaniwa Nahoko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2010.

	The kidney transition mechanism of S16-3 aminoglycoside system antibiotics and nephrotoxic defense based on it Junya Nagai, Mikihisa Takano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2010.

	It is the approach using the nano beads technology teratogenic molecular mechanism with the S16-4 thalidomide Taku Ito water 1, Hideki Ando 2, 山口雄輝 2, Hiroshi Handa 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2010.

	We think about the role of the pharmacist from the viewpoint that S17-1 is global Atsumi Nishikiori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2010.

	It is ... for practice of reclamation - protocol of S17-2 clinic duties Makiko Iwasawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2010.

	Way of thinking necessary for S17-3 medical treatment monitoring and clinical skill - case study - Upper mound Tomoko 1, Atsumi Nishikiori 2, Aya Ueda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2010.

	The impact that S17-4 ICU pharmacist gives for medical treatment 前田幹広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2010.

	Pharmacotherapy of the S18-1 epilepsy complications pregnant woman Keiko Minato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2010.

	Medical treatment of the S18-2 hyperthyroidism pregnant woman We cannot look at Tada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2010.

	Pharmacotherapy of the S18-3 diabetes merger pregnant woman Yoko Maeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2010.

	Pharmacotherapy of the S18-4 ulcerative colitis merger pregnant woman Seiichi Maruyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2010.

	S19-1 through relation - cooperation with patients with cancer in being at home - Masahiko Kimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2010.

	Examine S19-2 cancer regional alliances network - illness; cooperation and other types of job cooperation - Yasushi Nomoto 1, Hiroyuki Hirakawa 2, Haruko Ishikawa 2, Sakiko Nagae 3, Mitsuru Otake Expo 4, Katsuya Sugawara 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2010.

	- to think about the role of the nurse from activity of cooperation - last year from the situation of the S19-3 nurse Satoko Yamagishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2010.

	One or - that a pharmacist can do it in patients with S19-4 at-home cancer - cooperation to where Hideki Yamaguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2010.

	Clinical significance of the SLCO1B1 genetic polymorphism in the S20-1 irinotecan individualization treatment Hiroshi Takane Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2010.

	Utility of the genetic polymorphism diagnosis in the treatment with S20-2 warfarin individualization The amount of Ariyoshi example Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2010.

	Application to the azathioprine pharmacotherapy in patients with SLE of the S20-3 ITPA genetic polymorphism analysis Tomonori Nakamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2010.

	Individualization therapy to S20-4 renal-transplant recipients and patients with chronic myelogenous leukemia 三浦昌朋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2010.

	Trial of the thalidomide proper use in consideration of S20-5 genetic polymorphism Katsunori Nakamura, Naoki Matsuzawa, Sakae Omori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2010.

	CYP2D6 and SCN5A genetic polymorphism analysis in the TDM of S20-6 flecainide Masato Honma 1, 2, Kosuke Toki 1, Kazutaka Aonuma 2, Koda good luck direct 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2010.

	The role that a businessman teacher should achieve in the pharmacy education that S21-1 is new Junko Kitsu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2010.

	The role that a prior learning businessman teacher for the business training that S21-2 is smooth achieves Akira Takayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2010.

	Practice and businessman teacher of the S21-3 team approach in medical care Mari Kogo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2010.

	Practice and businessman teacher of the S21-4 regional medicine Eight folds of Tetsuji 1, Hiroshi Araki positive 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2010.

	Practice of clinical studies patients-oriented by the cooperation with the S21-5 healthcare setting Strong marsh Masami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2010.

	- to regard health service study - pharmacist usability test as S22-PL pharmacist Hiroyuki Sakamaki 1, Nobuo Yamamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2010.

	The need and problem of the S22-1 pharmacist health service study Hiroyuki Sakamaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2010.

	Summary and results - of health service study - asthmatic outcome study based on S22-2 regional alliances Miwako Kamei Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2010.

	Standardization - asthma inhalational instruction of the pharmacist duties in the S22-3 health service study for a case - Masaya Hasegawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2010.

	The need of the S22-4 health service study and the utilization policy Soichiro Isobe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2010.

	The future way of S22-5 health service study and the pharmacist Nobuo Yamamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2010.

5-FU-related elevated blood pressure mainly on the O1-01 FOLFOX/FOLFIRI therapy and investigation examination about the factor
Toyoji Otani 1, Eiji Hata 1, 涌嶋伴之助 1, Kuniaki Moriki 1, Chisato Iwai 1, Sasaki Nanase 1, Hasegawa general 1, Kainoki Keisuke 1, Yoshikazu Shiiki 1, Masakazu Hayashibara 1, Kenji Otsubo 1, 堅野国幸 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2010.

	Tolerability of the docetaxel / cyclophosphamide therapy in the O1-02 breast cancer postoperative chemotherapy Hiroto Tanaka 1, Sonoko Furubayashi 1, Yoshizo Watanabe 1, Ichiji Endo 2, Junko Kitsu 3, Satoshi Izumi Shiro 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2010.

	Fact-finding of the olfactory function disorder with the O1-03 cancer chemotherapy Kan Yukio 1, 北出紘規 2, Atsushi Kawagishi 3, Kazuki Takeda 3, Yuri Sakaguchi field 1, Junko Ishizaki 1, 崔吉道 3, Kenichi Miyamoto 3, Arai country three 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2010.

	Relations of a neutrophil count and the febrile neutropenia of the day of O1-04 chemotherapy 宮本康敬, Kyoko Sumiya, Toru Watanabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2010.

Comparison of primary therapy in Bevacizumab, Carboplatin, the Paclitaxel combination chemotherapy for the O1-05 progress-related non-small cell lung cancer and the non-primary therapy
Makoto Nakajima 1, 2, Takahiro Kumagai 1, Takuya Goto 1, Yoshie Nomura 1, Yumi Suzuki 1, Yukiko Shibata 1, Shuichi Matsumoto 1, Tatsuo Kato 3, Tadashi Sugiyama 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2010.

	The effect that blood pressure just before the initial administration in patients receiving O1-06 bevacizumab gives to subsequent blood pressure control Takahiro Sakai 1, Genei Shinya 1, Yoshihiro Aoyagi 1, Naoki Kondo 2, Yoshizo Watanabe 1, Satoshi Izumi Shiro 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2010.

Examination about the effect prediction of patients with bevacizumab administration colon that assumed O1-07 elevated blood pressure an index, rectal cancer
Horinouchi Hironari 1, 2, Takumi Sakurada 1, Toshi Nakamura oneself 1, 2, Tsuyoshi Mori 1, 2, 小中健 1, 2, Yukiyo Miki 2, Soichiro Tajima 1, 西迫寛隆 1, Shinji Abe 1, Kazuyoshi Kawazoe 1, Kazuo Mizuguchi 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2010.

	Examination about the protective efficacy of the antihistamine for the hypersensitivity symptom at the O1-08 paclitaxel administration Mio Koike, Kenta Tanaka, Sect Ayako, Atsushi Wada, Manabu Kume, Makimoto Hiroo, Tsuyoshi Hirano, Hirai green Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2010.

An antinausea effect with 3mg/body administration and the 1mg/body administration of granisetron injection in patients with O1-09 hematopoietic organ malignant tumor and adverse event
Shinya Motohashi 1, History of moat male 1, 2, Takaaki Ono 2, 3, Kazunori Onishi 2, 3, Junichi Kawakami 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2010.

	Comparison of nausea, vomiting before and after delayed emesis measures by the cisplatin component regimen in O1-10 lung cancer Hiroyuki Watanabe 1, Star Ikuko 1, Yuka Nakai 1, Beam Hisashi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2010.

	Examination about the effect of aprepitant on O1-11 cisplatin divided doses Misato, Kariya, Kenta Tanaka, Kumiko Matsumoto, Manabu Kume, Makimoto Hiroo, Tsuyoshi Hirano, Hirai green Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2010.

	Efficacy of aprepitant in the O1-12 outpatient department chemotherapy and safe examination Corner Shintaro 1, Child 1 too rare Mochinaga, Egoe Masayoshi 1, 中野行孝 1, Every bear Keiko 2, Arrow ヶ part Tomomi 3, 4, Naoko Arakane 4, Shinya Kimura 4, Fujito Expo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2010.

	Evaluation of the utility of aprepitant for the lung cancer chemotherapy with the O1-13 caloric intake situation as an index Hayasaka state straight 1, Hiroko Yamamoto 1, Kimiyoshi Takeuchi 1, Osamu Ogino 1, Shigeo Yamazaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2010.

Standardization of the NK1 receptor antagonism type antiemetics aprepitant combination regimen in the antinausea management after the administration such as O1-14 altitude emetic risk anticancer drugs
Chiyoko Yamada, Miwa Yonezawa, South Kenichi, Yukiyo Kinoshita, Country book Sae, Katsuichiro Kamei
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2010.

Examination about the stratification of the antinausea therapy with aprepitant at the O1-15 colorectal cancer chemotherapy enforcement
Kazuaki Fukazawa 1, Ayano Nakazawa 1, Masato Matsuura 1, Riyusuke Aihara 2, Yasushi Mochida 2, Hirayama success 3, Isono Junichi 1, Yasuo Hosonai 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2010.

	Nausea, vomiting with the O2-01 cancer chemotherapy and examination of the utility of aprepitant for anorexia Koji Okada, Yuji Koyanagi, Hidekazu Takahashi, 小笠原信敬, Katsuhiko Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2010.

	Utility evaluation for cancer chemotherapy-induced nausea and vomiting of O2-02 new antiemetics aprepitant Toshiaki Teratani 1, Takehiro Yamada 2, Toru Kawagishi 2, 斎藤佳敬 2, Takayuki Nagata 2, Yasuo Kubota 2, Kumiko Kasashi 2, Takeshi Iseki 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2010.

	Clinical response after the O2-03 aprepitant induction Kazuaki Kojima 1, Miwa Takayuki 1, Relation Tadashi 1, Akira Maruyama 1, Kan law of nature fine weather 2, Hideo Kita 3, Shinobu Araya 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2010.

	Examination about the O2-04 childhood cancer treatment vomiting expression investigation and effect of NK1 receptor blocker aprepitant to be able to put It is Naho in a circle, Kumiko Matsumoto, Atsushi Wada, Manabu Kume, Makimoto Hiroo, Tsuyoshi Hirano, Hirai green Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2010.

	About an effect when we extended Aprepitant dosing period in O2-05 same patient from 3rd to 5th Atsushi Shirai, Yuko Kudo, Kenichi Suzuki, Michihiro Shino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2010.

	Derivation and evaluation of the physiology, child dose estimate method that considered a biochemical development of O2-06 children Shinya Suzuki 1, 2, Yu Murayama Kei 1, Eri Sugiyama flower 1, Masao Sekiyama 2, Hitoshi Sato 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2010.

From the viewpoint of carboplatin doses difference by risk factor - calculating formula of the myelosuppression expression in the O2-07 carboplatin / paclitaxel therapy
Aiko Hashimoto 1, Small Ido Keiichi 1, Ryuuto Yasuaki 1, Noriyuki Katsumata 2, Koji Murakoshi 1, Nobuaki Yokote 1, Yasuhiro Fujiwara 2, Hiroshi Yamamoto 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2010.

	The effect that O2-08 circadian rhythm disorder gives in PK-PD of the diabetes therapeutic drug The autumn Yamahana world, Makoto Miyazaki, Kazunori Iwanaga, Masao Kakemi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2010.

Examination about the circadian rhythm of the Everolimus in O2-09 heart-transplant recipients
和田恭一1, 野島香織1, 中野一也1, 越智裕之1, 岡田博1, 小原延章1, 堀由美子2, 藤田知之3, 戸田宏一3, 村田欣洋4, 瀬口理4, 簗瀬正伸4, 中谷武嗣4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2010.

	Prediction based on the fur Mako kinetics transitional from head to foot of the O2-10 ketoprofen tape forerunner, the generic medicine Awa Keisuke 1, Hiroki Sato 1, Moat foster child 1, 2, Yasufumi Sawada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2010.

	The factor which affects the AUC of the O2-11 vancomycin hydrochloride Keiko Ikeda 1, Chie Ikeda 2, Katsuhiro Kato 3, Naoki Tomiyama 4, Sumio Matsuno 5, Kenji Matsuyama 5, Noboru Okamura 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2010.

	Examination about the administration plan of vancomycin hydrochloride in patients with O2-12 blood system cancer Umaki Kato 1, Tadao Kimura 1, 2, Nozomi Nishida 1, Kushiro, Kiyo Kawazumi 1, 2, Hiroko Saito 1, Takaaki Hasegawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2010.

	The polymethyl methacrylate membrane to use in O2-13 persistent hemofiltration dialysis adsorbs teicoplanin Toshiyuki Irie 1, 道越淳一 2, Kazuhisa Masuda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2010.

	Examination about the absorption delay of mitiglinide by the rise in O2-14 intragastric pH 浦嶋庸子, 有本諭司, Eiji Kayano, Takashi Kato children, Yoshio Ijiri, Kazuhiko Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2010.

	Examination of the anti-inflammatory action of Capsaicin for O2-15 Lipopolysaccharide-induced inflammation Yu Yamamoto, 楠川侑吾, Takashi Kato children, Yoshio Ijiri, Kazuhiko Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2010.

The effect that combination of clopidogrel and proton pump inhibitor in the O3-01 coronary-artery stenting patients gives to a clinical outcome
Masayuki Tanaka, Yukiko Inui, Haruna Kita, Aya Nakano, Hiromi Utsumi, Ryohei Fujii, Atsuko Utsunomiya, Yuko Adachi, Yuko Kuhara, Yumi Nakano, Mayumi Inoue, Nishiyama rich person, Furunaga Ikumi, Hisayo Kadoi, 打谷和記, Yasuhiko Hirota
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2010.

	The effect that antacids give for antitumor effect of the Gefitinib in O3-02 patients with nonsmall cell lung cancer Kohei Tanaka 1, Shigeru Hishinuma 1, Mitsuo Mita 1, Yutaka Fukaya 2, Kanemura Toshinori 3, Shoji A 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2010.

	Effect of the Loxoprofen Sodium which gives it to antiplatelet action of O3-03 aspirin and the workaround Your Yu Akagi 1, Kenta Shibata 1, Shuji Shimada 1, Akinori Yanaka 1, Kaichi Hikami 1, Takashi Tsuchiya period 1, 2, Yoshiro Kubota 3, Takao Aoyama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2010.

	The effect that CYP2D6 antagonism by O3-04 China Cal Seto gives to the metabolism of the cardiovascular disease therapeutic drug Takeki Narita 1, Daisuke Kadowaki 1, Satoshi Shibata intellect 2, Lower stone Kazuki 3, 飛野幸子 2, Eiko Fukunaga 3, Sumio Hirata 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2010.

	Examination about the valproic acid blood level that induction of O3-05 hyponatremia costs Tetsuro Koide 1, 2, Takuya Iwamoto 2, 3, Katsuhiro Tanaka 4, Kaoru Kuroki line 4, Masatoshi Muramatsu 4, Shinko Okuda 2, 3, Keiko Watanabe 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2010.

	Examination about the nephrotoxicity of calcineurin inhibitor (CNI) in the renal biopsy periodical after O3-06 kidney transplantation 桑原達朗1, 酒井謙2, 河村毅2, 宍戸清一郎3, 水入苑生2, 長谷川昭4, 相川厚2, 定本清美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2010.

	Examination of the constipation mechanism induced by O3-07 hydrochloric acid Seve Lamar Misato Nagashima, Ayaka Sota, Daisuke Kadowaki, Sumio Hirata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2010.

	The case that thrombocytopenia was prolonged by O3-08 adalimumab administration for a long term Sone book Emi 1, 2, Yasuhiro Tsuji 1, Nozomi Iwanaga 3, Yukitaka Ueki 3, Kenichiro Nakajima 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2010.

	An example of the haemolytic uraemic syndrome (HUS) that occurred in patients who received renal transplant from living donors during O3-09 immunosuppressive drug cyclosporin administration Kentaro Tani 1, 2, Koichi Kozaki 1, 3, Sei Yajima 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2010.

	2 cases that was able to prevent side effect becoming severe of the warfarin potassium by the cooperation with the O3-10 test department early Kazutaka Hiraga 1, Hiroshi Yamamoto 1, Masaharu Kakegawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2010.

	Association with the actual situation and the side effect expression of the prophylaxis of the O3-11 sulfamethoxazole trimethoprim combination Hiromi Yokoo, Akiko Emoto, 中野行孝, Fujito Expo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2010.

A side effect simultaneous investigation of the O3-12 antiinfluenza medicine and the statistical analysis
Tsuyoshi Nakanishi light 1, Shinnya Muto 2, Tomoko Matsukawa 3, Nakamura joy Ichiro 4, Shoji Takei 5, Depths corner Takahisa beauty 6, Ikuko Asano 7, Ainoki Kenji 8, Koichi Tabata 9, East Takashi Kubo 10, Ken Hirota authority 11, Hattori truth 12
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2010.

	Does the O3-13 lanthanum carbonate improve the digestive symptom of the hemodialysis patient for a long term? Daisuke Suzuki 1, Shogo Uchida 1, Nakamura lawn intellect 1, Kazumasa Yasui 1, 市江敏和 1, Akira Goto 1, Satoshi Suzuki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2010.

	Pharmaceutical intervention for O3-14 heparin induced thrombocytopenia type II (HIT) Junko Kai 1, 大橋経昭 2, 京嶌和光 2, Shiro Nagasawa 2, Ei Tsuda light 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2010.

	Comparison between the preparation of the chemical burn incidence in the O3-15 10% povidone iodine solution Gentaro Nagae 1, Hiroyuki Naito 1, Michiko Komori 2, Akira Nakamaru 1, Yasushi Kawatsu kernel 1, Mitsu Tamura 3, Satoru Shiraishi 4, Masao Kojima 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2010.

	Evaluation of the hand rough weather protective efficacy of the barrier type hand cream using the O4-01 original hand rough weather evaluation scale 波能満理惠 1, Masayuki Wakita 1, Tomomi Hoshino 1, Tsutomu Kato 2, Risa Imamura 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2010.

	The use situation of the antimicrobial agent in the O4-02 west Sendai Hospital (chronic stage) and the susceptibility situation Koji Sato 1, Kikuyo Sakuma 1, Norio Kato 1, Mari Yamada 2, Yumiko Abe 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2010.

	Relation of the pharmacist for patients with infection in the O4-03 ICU Kato Takahiro 1, Masanari Hagiwara 1, Umaki Kato 1, Yukio Toyama 1, Tatsuya Muto 1, Hiroko Saito 1, Takaaki Hasegawa 1, Hiroko Ishibashi 2, Takashi Nakagawa 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2010.

	Practice of preventive measures against infection by the O4-04 pharmaceutical intervention Jun Taniguchi, Minato book Yasunori, Takanori Kobayakawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2010.

	Participation in planning of the pharmacist to O4-05 meningoencephalitis treatment Hiroshi Hara person Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2010.

	O4-06 For further promote the use of generic : District 5 Pharmaceutical Association survey results and future issues 井上茂一1, 田中大介1, 西村友男2, 坂口眞弓3, 土屋千雅子3, 一瀬信介4, 新井悟4, 中村清治5, 長井彰子6, 福澄重泰6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2010.

	For further reliable use promotion of the O4-07 generic medicine Prince Taniguchi chapter, 後藤志央, Shrine Akihiro Ichiro, Mimata Sayaka, Maruyama Akina, Tatsuya Sasaki, 末安由拓, Kaifu Masayo, Akihiro Kai, The Ishikawa immensity, Keiko Kitajima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2010.

	O4-08 pharmacist is the actual situation of intelligence, the transmission and the problem after the marketing of the generic drug which we looked at Moat foster child 1, 2, Hiroki Sato 2, Akiko Miki 2, Yasufumi Sawada 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2010.

	Effect of the injection inventory control using O4-09 electronic chart data 東禎二 1, Takeshi Yasuda 1, Koji Yamada 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2010.

	The construction of the appropriate inventory control system of the O4-10 cancer chemotherapeutic agent and stock amount of money depression effect Takeshi Abe, Kenichiro Kawana, Kazumi Goto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2010.

	Is there the preference of the patients to the device of the O4-11 DPI inhalant? Masashi Sakano 1, Izumi Shimada 2, Mariko Aota 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2010.

	Improvement of the asthmatic control by the O4-12 pharmacist outpatient department Inoue Seicho, Hisashi Ono, Kawamorita early period, Katsuhisa Tahara, Yuichi Itagaki, Ikuyo Kanzaki, Naoya Kamiyama, Kazuo Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2010.

	For the improvement of O4-13 drug control instruction electromagnetic record Hiromi Sekimoto, Minoru Kawai, 吉野宗宏, Naoki Hayakawa, Hiroyuki Ueno, Yasukazu Sakamoto, Makoto Saito, 山内一恭, Yoshihisa Honda, Katsuya Komori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2010.

	Examination ... by study on action and evaluation ... patients questionnaire of the O4-14 "telephone medication communication" Hisano Kitayama 1, Fumio Nakajima 1, Hisashi Nakajima 1, Hidehiko Sakurai 2, Shimamori beauty light 2, 早瀬幸俊 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2010.

	Case report (ward activity report second report) which contributed to discovery of the serious disease by O4-15 ward working full time pharmacist placement History of Yasushi Iwabuchi 1, Eiichiro Ikeno 2, 岩山忠輝 2, Hiroyuki Abe 1, Jin Wagatsuma 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2010.

	Relative examination with the application of counseling by a critical mind and the drugstore pharmacist of the health literacy of the O4-16 patients Island ノ江千里 1, Kazuhiro Hirano 2, 中野行孝 2, Megumi Tanaka Taro 3, Fujito Expo 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2010.

	About drug control instruction in the O4-17 breast surgery outpatient department Hiroko Yabumoto, Keiko Fujita, Yuka Shibata, 櫻下弘志, Kazuko Yamanaka, Yuki Sekino, Yasuyuki Saeki, Furrow well Hiroko, Tree flat Kenji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2010.

	Pharmacist duties in the O4-18 neonates treatment room Saori Kato 1, Kato Takahiro 1, Yukio Toyama 1, Tatsuya Muto 1, Hiroko Saito 1, Takaaki Hasegawa 1, Harue Sato 2, Daisuke Muto 3, Riding ground etiquette three 3, Masahide Nimura 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2010.

	The present conditions and problem of the drug duties in the O4-19 ICU Wataru Goto, Mountain Rieko Sawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2010.

	The present conditions of drug control instruction duties in the emergency care judging from O4-20 DPC data Even study 1, Soma law of nature person 1, Yukiko Watanabe 1, Aki よしかわ 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2010.

	Change of the pharmacokinetics of digoxin at diuresis with O5-01 diabetes Masako Satake 1, 2, Igarashi sincerity intellect 1, 鏡真依 1, Yudai Toda 1, Yasushi Kobayashi 1, Ochiai sum 1, Kiyoshi Sugiyama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2010.

	An adverse event of the linezolid in patients with O5-02 impaired renal function and pharmacokinetic correlation 辻泰弘1, 平木洋一2, 松元加奈3, 溝口晶子1, 小林奨4, 曽根本恵美1, 佐道紳一1, 神村英利5, 森田邦彦3, 加留部善晴6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2010.

	Effect of aprindine which gives it to pharmacokinetics of the O5-03 bepridil Satoru Aida, Kyoko Fukumoto, Kazuyuki Ueno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2010.

It is the development of the quickness assay of human plasma and urinary gabapentin level an evaluation of the pharmacokinetics of the O5-04 neuropathic pain therapeutic drug gabapentin
Yagi Tatsuya 1, Takafumi Naito 1, Takashina Yoshiaki 1, 見野靖晃 1, Kazuo Umemura 2, Junichi Kawakami 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2010.

	O5-05 Development of the simultaneous measurement of human plasma voriconazole and its N-oxide thereof by isocratic elution method 山田尚広, 見野靖晃, 八木達也, 田中紀章, 内藤隆文, 川上純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2010.

	Study on excretory system transporter expression change in the O5-06 Type II diabetes mellitus model rat Megumi Watanabe cloth 1, Masanori Kobayashi 2, Jiro Ogura 2, Hiroaki Yamaguchi 2, Takeshi Iseki 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2010.

The CYP3A5 genetic polymorphism of the O5-07 live donor liver transplant patients is the comparison of the CLIA method and the ACMIA method effect to give to tacrolimus levels out of the whole blood
Yuichi Muraki 1, Takuya Iwamoto 1, Enoki shop Tomoyuki 1, Masanobu Usui 2, It is 3 of Nakatani, Tsutomu Nobori 3, Isa place Hideji 2, Shinko Okuda 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2010.

	Construction of the predictive model of the O5-08 triptan drugs reactiveness Yuki Sakairi 1, Masakazu Ishii 1, Yuika Naito 1, Ayumu Nagamine 1, Atsuko Imagawa 2, Joji Takahashi 2, Shunichi Shimizu 1, Yutaka Masuda 3, 4, Original one 2, Shino Usami 5, Yuji Kiuchi 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2010.

Individualization of the administration of irinotecan based on the O5-09 UGT1A1 genetic analysis
Masaru Yamazaki British 1, Mika Hiraoka 1, Hideto Yahagi 1, Fumiko Sugaya 2, Yoshiaki Narita 3, Noburu Kashimura one 4, Hiroyuki Moriya 5, 齊藤嘉津彦 5, Naoko Kurosawa 5, Seiji Sato 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2010.

	Effect of the CYP3A mutation in the gene to give to the tacrolimus in O5-10 renal-transplant recipients and blood kinetics of the main metabolite Kimiyoshi Hirano 1, Takafumi Naito 1, 見野靖晃 1, Shuji Maruyama 1, Tatsuya Takayama 2, Seiichiro Osono 2, Junichi Kawakami 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2010.

By the hearing investigation in the O5-11 ethical pharmacy come out; comparison and patient compliance instruction - of drug evaluation - adverse event incidence of meat phosphorus
Nukui celebration of longevity male, Tree wearing for the first time, Satoshi Taniguchi, Asako Ohata, Otani Teppei
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2010.

	About examination - remedy feeling about the effective evaluation of 500 mg of O5-12 precipitated calcium carbonate tablets "Miwa" and a clinical response - Ikue Terao, Ayumu Ichimura, Masayuki Hirose, Yoichi Sakakibara, Shigeru Yamada tree, Shinji Takahashi, Yuichi Takemoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2010.

	Induction therapy in patients with O5-13 Crohn's disease Kana Umeda 1, Hideki Atsumi 1, Mikio Nishikawa 1, Hiroyuki Hanai 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2010.

	- with fact-finding - cholesterol level of patients who underwent percutaneous transluminal coronary angioplasty in the O5-14 this hospital concerned Adachi Naoya, Masaru Nakano, Yoshinobu Kawamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2010.

	Action of the inhalational instruction for patients with O5-15 infantile asthma Fumie Shimazu, Usui Naoko, Rie Tamura, Yuya Fukuchi, Stone gutter Yasuhiro, Court Security Office Mika, Gilt bronze Yoko, Nobuhisa Fukushima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2010.

Effect with the single dose of promethazine, fexofenadine and the olopatadine on histamine-induced cutaneous symptom of the O5-16 healthy subject and psychokinesia function
亀井浩行1, 伊佐治亜美1, 野田幸裕1, 石川和宏2, 千崎康司2, 山田清文2, 杉浦一充3, 富田靖3, 鍋島俊隆1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2010.

	Pharmacist-led type clinical trials about the O5-17 health drink continual medication Minae Izawa 1, Hiroyuki Ito 1, Noriko Kose 1, Tomohiro Nishimura 1, 登美斉俊 1, Mayumi Mochizuki 2, Emi Nakajima 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2010.

	Safety of medicine evaluation - antineoplastic - that we saw it from O5-18 clinic dose, an exposure level and a nothing toxic level, an exposure level Arumi Hideto 1, Takaaki Yaginuma 2, Miyuki Fujita 2, Kazuyuki Saito 3, Shunsuke Ono 4, Tsuneo Kodama 2, Tomoji Yoshiyama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2010.

Exploratory controlled trial (the first report) of the delayed-action diarrhea protective efficacy with the oral alkalinization agent and Hangeshashinto for patients who received O5-19 FOLFIRI-3 therapy
Kaori Yamazaki 1, 宮内英聡 2, Noriko Kanetani 1, Akira Yamamoto flat 1, Manabu Ohira 2, Yasuo Yoneyama 2, Yasutaka Nakamura 1, 3, Amount of Ariyoshi example 1, 仲佐啓詳 1, Hiroshi Nakamura justice 1, 松原久裕 2, Koichi Kitada 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2010.

	Exploratory study ... which aimed at the factor - individualization treatment to have an influence on the dose intensity decrease of the O5-20 gemcitabine hydrochloride Katsuya Makihara, Miki Ota, 中山実智惠, Hirokazu Ueno, Ichiro Hama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2010.

Evaluation of the utility of the fondaparinux proper use check sheet for O6-01 physician, nurses
Yoshihisa Ishihara 1, Taku Ando 1, Persimmon former Ikuyo 1, Kaori Fukushima 2, 廣津匡隆 2, Tomomi Hamada 3, Tadahisa Wada 1, Karasaki Yumi 1, Toru Tanabe 1, Aya Horikiri 1, Sayaka Tanaka 1, Ryuichi Fukuoka 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2010.

A digital camera is useful in the O6-02 "the number of medicine is different!" patients objection measures "whom medicine is not!" in
Masakazu Kinoshita 1, Sachiko Tanaka 1, Michiko Kano 1, Sawai one 1, Ritsuko Matsuo 1, Yukiko Akamine 1, Akiko Miki 2, Hiroki Sato 2, Moat foster child 2, 3, Yasufumi Sawada 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2010.

	Evaluation of the exposure to O6-03 antitumor agents prevention device that considered administration, the disposal from a mixed preparation Ryoji Yanagihara 1, Takashi Tomabechi 1, Yasuko Kataoka 2, Chieko Komiyama 2, Katsuyoshi Nakajima 1, Hiroshi Suzuki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2010.

About relations of O6-04 pharmacist and the number of incidents about contribution of the safety management in the number of - ward pharmacists and ward duties -
Mariko Nagao, Shigeru Yamada tree, Kana Kato, Nomura connection, Yuichiro Wada, Hiromi Sakai, Hiroshi Hozumi, Mika Shinoda
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2010.

	It is ... through the process that led to package insert revision of ... September, 2009 about crack occurrence of intralipid infusion R by the O6-05 infusion set needle insertion 久保嘉靖1, 奥野昌宏1, 梅谷義晴1, 坂本弘子2, 柴田佑子2, 藤井一雄3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2010.

Patients who received cancer chemotherapy support and contribution to team approach in medical care that utilized O6-06 bringing medicine management
Otsu good luck, Shigeru Morimoto sentence, Yuko Horikawa, Field road Akihiro, Ayako Nakanishi, Hirase friendship, Kayoko Fujii, Yumiko Itani, Akiko Kamiya, Mai Murata, Masayuki Ishizuka, Yoshio Kitamura
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2010.

	Economic effect by the bringing medicine management use in the O6-07 ward permanent residence pharmacist Yasushi Yamamoto University, West love, Yukio Toyama, Tatsuya Muto, Hiroko Saito, Takaaki Hasegawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2010.

	Construction of the bringing medicine system of administration by the O6-08 electronic chart Yuka Tsutsui 1, Yuki Meishin 1, Nobuo Nagayama 2, Satomi Kubota 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2010.

	Incidence of the pre-Abo id associated with the O6-09 bringing medicine Aya Ido Keiko, Fumio Yoshimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2010.

About the use of the department in drug "bringing medicine team" aiming at shortening of the O6-10 bringing medicine administrative work
山本清司1, 上野朋子1, 小島基嗣1, 松尾一典1, 松本晴年1, 浅野知子1, 近藤勝弘1, 黒田純子1, 江崎哲夫1, 小池香代1, 木村和哲1, 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2010.

	Example that supported the psychological care of O7-01 outpatient department chemotherapy patients by medicine medicine cooperation Eri Ito Kei, Shigeru Yamada tree, Shinji Takahashi, Yuichi Takemoto, 吉田雅彩, Ayumu Ichimura, Masayuki Hirose, Yoichi Sakakibara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2010.

	From an example of pharmaceutical support - psychological care based on the O7-02 EBM - Yuko Kanbayashi 1, 2, Keisuke Yomo 1, Yoko Konishi 1, 2, Fujimoto early Kazuko 2, 3, Koji Okada 1, Hideyuki Konishi 4, Toyoshi Hosokawa 2, 5, Toshiichi Yoshikawa 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2010.

	Likelihood of the occupational exposure in the calculation compounding of medicines to O7-03 cyclophosphamide vial preparation 濱宏仁, Flat field Masaki, Koichi Fukushima, Toru Hashida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2010.

	Comparison of the preparation quality between between the standards that assumed quantity of vial surface contamination of the O7-04 anticancer drug an index and the preparation Takashi Osawa, Takafumi Naito, Naoya Suzuki, Tadashi Kadoguchi kernel, Junichi Kawakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2010.

	Pollution investigation to come from other than O7-05 anticancer drug preparation work Reina Nishigaki 1, Totsuka ゆ K 2, Mitsue Hirano 1, 軍司剛宏 1, Satoru Otsuka sincerity 1, Nobuaki Yokote 1, Hiroshi Yamamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2010.

Examination before and after the O7-06 closed system anticancer drug preparation aid beginning to use
Junko Kuroda 1, Katsuhiro Kondo 1, Shiota history on record 1, Kazunori Yoshikawa 1, Ichihara greens one a month, Shoko Ueda 1, Yu Maeda ankle 1, Kaori Tsuji 2, Hirokazu Komatsu 3, 木村和哲 1, 4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2010.

	It is ... through action ... closed ring system induction as the pharmacist for becoming it reduction of the anticancer drug exposure to whole O7-07 inside the hospital Hama name Noriko, Fujishima Wakana, Yuzo Kajita child, Yukiko Yamashiro, Reed Chitose, Kawai order meter Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2010.

	Action for the improvement of the O7-08 anticancer drug preparation Kabayama Tomoichi, 眞原達男, Emi Horiguchi, Hiroshi Morita, Michiko Matsumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2010.

	The practice results and evaluation of the pharmacist outpatient department "support outpatient department" for patients with O7-09 cancer Imamura pasture employee, 武本千惠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2010.

	About the role of the pharmacist in O7-10 cancer pharmacotherapy Committee Hiroyuki Ueno, Naoki Hayakawa, Minoru Kawai, 吉野宗宏, Yasukazu Sakamoto, Makoto Saito, Hiromi Sekimoto, 山内一恭, Yoshihisa Honda, Katsuya Komori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2010.

The effect that a wearing method of the O7-11 portable chronofuser gives to flow
Hisashi Ono 1, Kaori Koshiro 1, Hitomi Tsuzuki 1, Inoue Seicho 1, Hemp lower Tomoka 1, Yasushi Yamashita example 1, Twig Masayoshi 1, Yuichi Itagaki 1, Kuniko Yamamoto 1, Satoshi Ogawa 1, Shu Kimura old 1, Ikuyo Kanzaki 1, Kawamorita early period 1, 安達知輝 1, Seven field Tomomi 1, Katsuhisa Tahara 1, Yuzuru Yamamoto 1, Shinya Iida 1, Suno study 1, Chieko Hara 1, Koichi Otaki 1, 2, Toshio Awaya 1, Yoshikazu Tazaki 1, Kazuo Matsubara 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2010.

	About pump explosion for the carrying at use of O7-12 4% morphine hydrochloride injection New branch Maiko 1, Hiroki Iwane 2, Yuka Kobayashi 2, Toshiko Aramiya 2, Tomori Nishina 1, Hirokazu Nakanishi 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2010.

	Likelihood - of the interaction with examination -Alb about the protein binding of the O7-13 platinum Takashi Kato children 1, Takushi Sato 2, Misa Tsuchiya 2, 1, Asuka, Iwamoto, Yamasaki swamp 1, Yoshio Ijiri 1, Kazuhiko Tanaka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2010.

	Additional analysis for the constipation in the granisetron intravenous administration of the O7-14 2 dose 秋田賢宏 1, Masato Yonemura 1, Noriyuki Katsumata 2, Satoshi Izumi Shiro 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2010.

	Examination about a drug control procedure in the treatment with O7-15 lenalidomide and the safe security Hana Arima one a month, Yukako Morita 1, Up Kazuko 1, Kitada Noriaki 1, 田中詳二 1, Takayuki Takahashi 2, Toru Hashida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2010.

	Examination about the neutrophilic decrease at O8-01 pemetrexed alone and the carboplatin combined medication Kenichi Manabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2010.

	About correspondence to neutropenia in the O8-02 FEC100 therapy Kazuyo Matsuyama 1, Hiroyuki Ueno 1, Shigeru Morimoto sentence 2, Kinuyo Kajiwara 3, 山内一恭 1, Yoshihisa Honda 1, Yoshio Kitamura 2, Shin Masuda three 4, Katsuya Komori 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2010.

	The side effect expression situation in the Gemcitabine/Cisplatin combination chemotherapy for the O8-03 urothelial carcinoma Noriko Komura, Hiroki Tamaki, Naoyuki Komura, Nobuhiro Nishimura, 直良浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2010.

	Examination of the factor associated with the side effect expression of the O8-04 paclitaxel carboplatin combination therapy Yasushi Habu 1, Yoshihiko Kimura 1, 2, Ikuko Yano 1, Toshiya Katsura 1, Kenichi Inui 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2010.

	Effect on premature diarrhea with the scopolamine butylbromide prophylaxis at the O8-05 hydrochloric acid irinotecan administration Shin Taguchi 1, Fukidani Kazuko 1, 向井想一 1, Muto law of nature 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2010.

	Three cases of the depressive disorders that became the stopping dosage by a side effect after beginning of dosage of O8-06 mirtazapine early Akira Yoshikawa 1, Akiko Yasunaga 1, Miwa Watanabe 1, Open Koichi 1, Takeshi Wada 2, Yonezawa sing; 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2010.

	Action of the pharmacy where there was the potential side effect extraction of the schizophrenia patient with O8-07 serum prolactin level measurement Takako Suzuki, 成田妃重, Tomomi Matsumoto, Kimiko Yamamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2010.

1 case - of schizophrenia that improvement of the medication situation was seen in through report - patient compliance instruction and the prescription suggestion about the utility of the home care patient visit drug control instruction in the O8-08 psychiatry region
Hidenori Kuwahara 1, Seiko Ikemoto 2, Kyohei Konuma 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2010.

	"The antipsychotics weight loss, single agent of the ward wrestles to becoming it by the treatment adequacy committee O8-09 for a psychiatry chronic stage" Shunsuke Sato 1, 1 which is related to Fukuo, Kimiko Matsuda 1, Kunihiko Asai 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2010.

	It is ... from proper use and role - agreement explanation assistance of the O8-10 clozapine of the pharmacist to side effect monitoring Tomoki Baba, Mika Iwamoto, Kenji Sasaoka, Hasegawa Azusa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2010.

	Examination toward the medication self-care of the prolonged hospitalization patients in the O8-11 mind regular hospital Masazumi Ando 1, 2, Shigeru Ishiwatari elegant 2, Hisahiro Yoshida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2010.

	The use situation of mirtazapine in the O8-12 this hospital Michiko Uchiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2010.

	The prescription actual situation with the cf. attached document system in O8-13 psychiatric hospitals of a check Junji Uno, Miho Nakata, Shinichi Tojo, Saeko Yamahata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2010.

It is ... through a use evaluation of psychiatric pharmacotherapy support - risperidone sustained release injection by the cooperation with the O8-14 physician
Yuko Inoue 1, Noriko Kudo 1, Ken Matsuno product 1, Miwako Yokoyama 1, Atsuko Funakoshi 1, Kimiko Shigematsu 1, Tsuyoshi Onoe 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2010.

Activity report of the pharmacist in the many types of job team approach in medical care in the family psychoeducation of the O8-15 schizophrenia patient
赤羽理也 1, Takahiko Inagaki 2, Mitsuko Ando 3, Autumn Dasein lawn 2, Mizuho Konishi 4, Upper Etsuyo Yamazaki 5, Koji Uenishi 1, 蓑内徳蔵 1, Naoto Yamada 2, 寺田智祐 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2010.

	Attitude survey for the anaphylatic shock of the O9-01 drug Keiko Kitajima 1, 丸山明莱 1, Tatsuya Sasaki 1, Kaifu Masayo 1, Ishikawa immensity 1, Prince Taniguchi chapter 1, Kaifu Michiyo 2, Ken Takakura 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2010.

	Questionary survey about the acquisition of a packing, the preparation change information in the O9-02 drugstore Tamaki Hirofumi 1, Moat foster child 1, 2, Hiroki Sato 1, Akiko Miki 1, Doi reason Yuko 3, Yasufumi Sawada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2010.

Do the O9-03 remote island inhabitants require the online sale of medical supplies?
Masahiko Hirayama 1, Hidekazu Tanaka 1, Hitoshi Omura own 1, Masayoshi Nagase 1, Product former Seiji 1, Masanori Sugawara 2, Toshihiro Kitahara 1, Choichiro Miyazaki 1, Noboru Yamashita 3, Kiyomitsu Yoshitani 3, Hiroki Sato 4, Akiko Miki 4, Moat foster child 4, 5, 6, Yasufumi Sawada 4, 6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2010.

	Investigation about the criteria for selection of eye drops judging from O9-04 questionnaire Yuko Hiraki 1, Masakazu Miyachi 1, Haru Sato or 2, Noriko Tsuchiya 1, Naoyuki Yakura 1, Ishiwatari beach 1, Junko Matsuoka 1, Well beauty relationship 1, Tetsuro Yumoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2010.

Examination of the effect of the action to control about the oseltamivir proper use based on the compounding of medicines information in the O9-05 ethical pharmacy
漆原尚巳 1, Doi reason Yuko 2, Masaru Arai 3, Toshiyuki Matsunaga 3, Yosuke Fujii 2, Naoko Iino 4, Takashi Kawamura 5, Koji Kawakami 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2010.

	Action ... of medication support - drugstore DOTS for patients with O9-06 tuberculosis Yoshiyuki Akimoto 1, Noriko Tamai 2, Hideko Ozaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2010.

	A role and practice of the pharmacist in the O9-07 Onomichi method (regional medicine cooperation) Mitsue Mukai, 本嶋世紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2010.

	The present conditions and problem of the communication attitude toward foreign patients at the O9-08 patient compliance instruction Hama well Taeko 1, Fumiko Nagata 2, Takayo Yamada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2010.

	For the spread to out of the hospital of O9-09 simple suspension methods Makiko Miyatani, Taeko Kitano, Nobuko Mori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2010.

	Approach of "the pharmacist salon" toward the university where O9-10 was borderless 平田純生, 門脇大介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2010.

Action for the pharmacy six years system hospital business training leader text making in O9-11 Kumamoto
Shigeyuki Miyamura 1, Satoshi Shibata intellect 2, Masayasu Kino 3, 宮本晋治 4, Naoyuki Suematsu 5, Kondo New Year's Day 6, Yasushi Fujii 7, Quantity of Seo 8, Toru Irie beauty 9, 濱田哲暢 4, Hideyuki Saito 4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2010.

Trial of the "list of essential drugs" utilization in the O9-12 six years system business training
Keiko Hirano 1, Midori Kimura 1, Nabeta Izumi 1, 高橋鉄治 1, Satoru Minami 1, Tashiro Kei straight 1, Hiroaki Utsuki 1, Nakata season furrow 1, Tatsu Sakamoto Ichiro 1, Tomoki Tsuji 2, Kazuhito Kosuge 2, 宮嵜靖則 2, Yoshiyuki Kagawa 2, 河原崎貴伯 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2010.

It is the trial to the effective cooperation construction with a member of ... pharmacy and the businessman teacher for a lot of O9-13 six years system business training acceptance
Midori Kimura, Keiko Hirano, Nabeta Izumi, Satoru Minami, 高橋鉄治, Miwa Saegusa, Kimiko Asakura, Yoko Ikoma, Tatsu Sakamoto Ichiro, 河原崎貴伯
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2010.

	Action of the long-term student training in the cottage-hospital out of O9-14 Makoto Tanaka, Shina Sogabe, Kenichi Manabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2010.

	Activity of the businessman teacher in the O9-15 North Carolina University pharmacy school Maiko Machida 1, Yamashita beauty princess 1, Williams Dennis2, Eckel Stephen3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2010.

	Examination about the efficacy of the skin warming for alopecia by O10-01 Cyclophosphamide Sanae Shino 1, Fumio Itagaki 1, Shigeto Suzuki 2, Junichi Kurihara 2, Hideaki Niwata 1, Hiroyuki Hosono 1, Machiko Watanabe 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2010.

	Examination of the predictor of the hypersensitivity reaction expression in O10-02 carboplatin Toshiya Goto, Takayashiki Nana, Kazuaki Hirose, Tomomi Matsushita, Akira Takada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2010.

Investigation about the actual situation and the prognosis of hepatitis B virus reactivation measures in the cancer chemotherapy using O10-03 rituximab
Sanae Imamura 1, Kitada Noriaki 1, Yoshi Suginoshita tree 2, Flat field Masaki 1, 田中詳二 1, Tetsuro Iguma 2, Takayuki Takahashi 3, Toru Hashida 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2010.

	About a utility of the oral pyrimidine drugs supplementation after the O10-04 colorectal cancer postoperative adjuvant chemotherapy fluoride Kenji Taniguchi, Rika Nakajima, Noriyuki Shimoi, Hiroya Fukunaga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2010.

	Effect of Growth Factor to give metabolism of O10-05 CPT-11 Akira Takagi period, Manabu Okumura, Tomomi Iwakiri, Masashi Nagata, Yohei Kawano, Hiroyuki Yamaguchi, Yasushi Hirahara Kotobuki, Yasushi Sekiya, Kazuhiko Arimori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2010.

Comparison of the adverse event of sorafenib in O10-06 hepatocellular carcinoma, renal cell carcinoma
The description of Hama field existence beauty, Misato, Kariya, Hiromi flat for a period, Utsubo Yuko, Kumiko Matsumoto, Manabu Kume, Makimoto Hiroo, Tsuyoshi Hirano, Hirai green
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2010.

Importance - of the side effect of hypertensive - team treatment with O10-07 sorafenib management
Grow of Oda; 1, Shinya Suzuki 1, Yoshiko Nishimura 1, Kayo Onoda 2, Funasaki Hideki 1, Relation place Kohei 3, Shuichi Mitsunaga 3, Satoshi Shimizu 3, Izumi Ono 3, Hideaki Takahashi 3, Yoshizo Watanabe 1, History of Prince Ikeda 3, Ichiji Endo 2, Satoshi Izumi Shiro 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2010.

HFSR risk factor of sorafenib in the O10-08 hepatoma patients
Shinya Suzuki 1, Grow of Oda; 1, Hideaki Takahashi 2, Yoshiko Nishimura 1, Funasaki Hideki 1, Kayo Onoda 3, Satoshi Shimizu 2, Izumi Ono 2, Shuichi Mitsunaga 2, Relation place Kohei 2, Yoshizo Watanabe 1, History of Prince Ikeda 2, Ichiji Endo 3, Satoshi Izumi Shiro 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2010.

Study on aggregate contained in O10-09 marketing antibody preparation
Satoshi Uchino sincerity 1, Yutaka Okawa charges 1, 宮嵜靖則 1, Hidehiro Honda 2, Ryoji Yanagihara 2, Masahiro Takahashi 3, Takayuki Yoshimori 4, Tomohiro Sakurai 5, Katsuyoshi Nakajima 2, Hiroshi Suzuki 2, Yoshiyuki Kagawa 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2010.

	Role of the pharmacist in the chemoradiotherapy of O10-10 lung cancer Misaki Takase tree 1, Way field Momoyo 1, Maruoka eyes 1, 飴谷太 1, Hiromi Hara 2, Miyuki Takahashi 2, Hiroshi Kotani 2, Kazuhiko Shibata 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2010.

Structure-activity relationship - in the photobleaching response of mechanism elucidation (the fourth report) - coloration pigment carminic acid of the photobleaching response in O11-01 five mini-(R)
Tadashi Okubo 1, 2, Mariko Tanaka 2, 7, Okubo branch 1, Setsuko Okubo 3, Miho Okubo 4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2010.

	The information that is necessary at fact-finding and the dosage form change of the change to the dosage form for O11-02 children Makoto Komura 1, Yoichi Ishikawa 1, Kenji Kushida 2, Kenichi Odaka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2010.

	Examination of the continuation medication of the bisphosphonate preparation at fracture by the O11-03 document retrieval 守内匡, Satomi Asano, Osamu Tanaka, Hiromi Matsui, Yoshimi Matsuda, 高田加壽代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2010.

It is ... about the education effect on study on understanding degree investigation method (I) - investigator of the attached document of the O11-04 non-prescription drug
Hosaka indigo plant 1, Risa Kaneko 1, Masayuki Hashiguchi 1, Keiko Ueda 2, Mayumi Nakamura 2, Mikio Sakakibara 2, Mayumi Mochizuki 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2010.

O11-05 Research on the understanding of survey method of attachment of OTC drugs (II) : Comparison of two types of attachments with different formats of the same effect drugs
金子梨沙1, 保坂藍1, 橋口正行1, 小寺典子2, 植田恵子2, 中村眞弓2, 榊原幹夫1, 2, 望月眞弓1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2010.

	Action of the prescription adequacy of the renal function degeneracy patients who utilized O11-06 electronic chart system Tsuneo Kuwamura, Megumi Matsumoto, Takashi Akamatsu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2010.

	Action to patients waiting time shortening by the O11-07 prescription mini-medication history utilization Kaoru Miki daylight, Shinya Iwakawa, Tanaka Riyoko, Kazuyo Takayanagi, Takako Aoyama, Nitta Kei Satoko, Yasuhide Okumura, Mulberry well Yukio Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2010.

	Taste bitter prediction of the amlodipine OD lock 10 preparation using the O11-08 taste sensor Takahiro Uchida, Haji River dance, Miyako Yoshida, Tamami Haraguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2010.

	Effect of pH of the carbocysteine preparation which gives it to taste bitter of the O11-09 clarithromycin preparation or the ambroxol preparation Haji River dance, Tamami Haraguchi, Miyako Yoshida, Takahiro Uchida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2010.

	About contribution of effect - elution quantity and the taste bitter threshold of the temperature to give it to the taste bitter intensity of the O11-10 ambroxol tablets 10 preparation - Yuka Sugino, Haji River dance, Tamami Haraguchi, Miyako Yoshida, Takahiro Uchida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2010.

	The effect that the insulin self-administration procedure in the O12-01 outpatient gives for a glycemic control Tomoko Kawaguchi 1, Liujiang Masatsugu 1, Naomi Iwasaki 1, Tomomi Oda 1, Small thicket Kayoko 1, Yuji Hirose 1, Tetsuya Morita 1, 大野恭裕 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2010.

	Examination of the efficacy of the insulin intensive therapy using O12-02 CGMS Tomoyuki Saito 1, Kyoko Nomura 2, 金光宇 3, Satoru Yamada 4, Kaori Chiba 3, Kaoru Ichiyanagi 5, Small Hiroshi Sano 6, Kazuhiro Sase 1, Shunichi Yamauchi 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2010.

	Three cases of diabetes that lifestyle improvement was effective in addition to O12-03 medical treatment Miki Nakai, 大西稚香, Mika Yamada, Well fence Toshiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2010.

Examination of vanity and the instruction method in the visually impaired having difficulty in O12-04 insulin self-administration
Hiroyuki Nishimura 1, Yoichi Ishizuka 2, Chiho Maeda 2, Yoshida positive 1, Asako Eguchi 1, Kumiko Tsuruta 1, Mitsuru Irikura 2, Toru Irie beauty 2, Fumio Miyamoto 3, Keizo Kajiwara 4, Tomio Jinnai 4, Hideaki Jinnai 4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2010.

	The patients background factor which affects the glycemic control after the O12-05 diabetes education hospitalization Sekiguchi Machi child 1, Kaoru Wakabayashi 2, Takeshi Minami husband 2, Emi Nakajima 3, 登美斉俊 3, Tomohiro Nishimura 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2010.

	Comparison between the preparation of the O12-06 insulin crystal Setsuko Tomioka 1, 小佐野磨子 1, Takayuki Nagata 1, Shinichi Yoshikawa 1, Susumu Yoshida 1, Yuji Fukuchi 1, Shigenari Shinoda 3, Yukio Nohara 1, Hiroaki Kubo 1, Ryo Murata 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2010.

	Precision study of the O12-07 pre-filled type insulin device Main room three picture 1, Yuko Kanezaki 1, Osamu Egawa 1, Hideaki Kondo 2, Kiyoshi Ashizawa person 2, Motomori Izumi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2010.

	Fact-finding II (analysis according to the drawing blood site) of the explanation method about O12-08 self blood glucose measuring instrument and the puncture device of the whole country Tatsuya Muto 1, Reiko Nakano 2, Toshinari Asakura 3, Tiger stone Kenichi 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2010.

	The participation type training using the O12-09 drama, satisfaction of the diabetes theater Hiroshi Okada 1, Toshinari Asakura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2010.

	About usefulness of the O12-10 new antidiabetic drug DPP-4 inhibitor sitagliptin 岡本朋子1, 上田浩貴1, 塚本康彦1, 矢部大介2, 黒瀬健2, 濱口良彦1, 清野裕2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2010.

	Intervention to the lifesaving treatment in O13-01 emergency visit, the ward Satoshi Kataoka 1, Kyoko Kataoka 1, Tomoko Hirayama 1, Matsuda law of nature beauty 1, Makoto Tanaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2010.

	Role of the pharmacist in the O13-02 bone marrow transplantation team Kunihiro Saegusa, High Yoshihide Kubo, Reiko Hamamoto, Yasukazu Odaka, Koji Akasaka, Hiroko Mine that it is the way it goes Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2010.

	The actual situation and utility evaluation of the prescription brushing up by the O13-03 pharmacist Satoshi Shibata intellect 1, Toru Maruyama 2, 3, One field Hitomi 1, Yukiko Horikawa 1, Harumi Tanoe 1, Koichi Nakao 4, Hirayama unification 5, 飛野幸子 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2010.

	Contribution of the positive pharmacist in the O13-04 outpatient department hemodialysis patient Junko Onishi 1, 2, Plum Miyoshi 3, Yuka Onoe 4, Hoe mound Keiko 4, Akiyo Miyake 4, Yoshihisa Kitamura 4, Hiromi Kawasaki 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2010.

It is ... through the setup of mutual understanding between the types of job for the O13-05 team approach in medical care reinforcement and pursuit - team approach in medical care promotion special committee of the specialty
Saito wish 1, Koji Kase 1, Kimiko Matsuda 1, Kunihiko Asai 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2010.

	Design of the new oral sustained release liquid drug using the O13-06 methyl cellulose / alginic acid mixture system Descent from a mountain Tetsuya, Kunihiko Ito, Asa Kimura group, Shozo Miyazaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2010.

	Development and skin transitivity evaluation of the emulsified lotion which combined O13-07 prednisolone Keiko Miura, Makiko Fujii, Shiori Aiuchi, Naoya Koizumi, 渡辺善照 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2010.

	AntiTNF - alpha action of capsaicin in the O13-08 CCI4-induced liver damage Mina Takano, Daisuke Sasaki, Takashi Kato children, Yoshio Ijiri, Kazuhiko Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2010.

	For the Residual medicine in the instillator at the O13-09 transluminal administration become calm; examination - lansoprazole orally disintegrating tablet ... of the effectiveness of the use of adjustment food 青木悠, 杉山昌秀, 依田一美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2010.

	Examination - of utility - pollen automatic measurement device (KH-3000) of Ministry of the Environment pollen observation system "Hanako" in patients with O13-10 sugi pollinosis Hiroyuki Nanba 1, 2, Reiko Kishikawa 3, 4, Yoshimitsu Higaki 2, Norio Sahashi 4, 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2010.

	Analysis of the doubt inquiry example in the P1-001 prescription order Hoshino Yugo, Kiyotaka Kawazumi, Yoshiharu Kato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2010.

	The present conditions and utility of the checking prescription with the double check system in the P1-002 Osaka Saiseikai Ibaraki Hospital Naoko Ueda, Masaaki Sano, 眞継賢一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2010.

	Examination about the present conditions of the checking prescription system in the P1-003 this hospital and the utility 河内山佳英, 永田浩泰, Mika Miyazaki, It is Sachiko in a camp, Eiko Fukunaga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2010.

	Action to the patients with P1-004 compounding of medicines medicine certification Hiromi Otomo, Sum chestnut Yuko, Mikio Uesugi, Yosuke Sudo, Miki Ito, Masae Samejima, Jiro Tsuruta Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2010.

Construction of the high-risk medicine (medicine for external application) compounding of medicines system which utilized P1-005 bar code
Takeshi Kaneko 1, Hiroshi Muramatsu 1, Osamu Ikeya 1, Soichiro Tsuda 1, Yamakichi Yasuko 1, Tomohisa Hayakawa 1, Hiroshi Shiina good luck 1, Masaya Yamaguchi 1, Shunichi Kawamura 1, Shinichiro Okamoto 1, 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2010.

	Improvement of the prescription checking precision by the introduction of the creatinine clearance guess level printing system to the prescription which linked P1-006 electronic chart 鈴木成実, 後藤千寿, 小森善文, 丹羽隆, 安田浩二, 松浦克彦, 伊藤善規 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2010.

	Questionary survey about collection of of the patients information in the P1-007 health insurance pharmacy and the computerization of the medicine notebook Hidetoshi Honda, Yoshiyuki Ono, Toshiichi Seino, Katsuyoshi Nakajima, 伊藤晃成, Hiroshi Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2010.

	Problem of the communication between the patients, a pharmacist, physicians seeing from P1-008 doubt inquiry example Takuya Nonaka 1, Yoshikawa Keiji 2, Akiko Miki 3, Moat foster child 3, 4, Hiroki Sato 3, Doi reason Yuko 2, Yasufumi Sawada 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2010.

Relation of the medical office pharmacist to the medical supplies safety management in the P1-009 outpatient clinic
1, Kyoshi, Shimizu, Noriko Kuramochi 1, Castle tail Mariko 1, 岩冨由江 1, Tomoko Fukuda 1, Kyoko Inoue 1, Koichi Nakamura 1, Kazuyuki Hara 2, Kenichi Tomomatsu 2, Kazuo Nosaka 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2010.

	Importance of the checking prescription in the P1-010 compounding of medicines process 本加典子, Noriko Hirano, Kenichi Yumura, Hidemi Hamada, Satoshi Yamazaki, Mitsuru Kaneta Expo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2010.

	Combination of P1-011 ceftriaxone and calcium component preparation Yoshiharu Mitsunaga, Well ノ口岳洋, Yukiko Omura, Suguru Kasahara Castle, Jun Hamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2010.

	Development of the prescription prescription to adapt to P1-012 order ring and an electronic chart Kazuko Kawai, Seiichi Ito, Takamitsu Akita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2010.

	About the effect that P1-013 system environment and mean hospitalization give to inpatient dispensing Tamiko Kimura, Yasuko Saito, Masahiro Iwasa, Masayuki Watanabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2010.

	About the present conditions of induction and the use of the P1-014 drug management support system 天野二愉香, Yukie Okada, Naoteru Fujie, Mika Matoba, Yoshiko Shimomura, Kazuko Shimura, Yoshihiro Sakagami, Emiko Tanaka, 脇條康哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2010.

	Action to the new administration cart development about the P1-015 internal use set Yukio Toyama, Tatsuya Muto, Hiroko Saito, Takaaki Hasegawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2010.

	Induction of the simple suspension method using P1-016 prescription data Toshiko Furukawa, Hideko Noto, Onishi rises, 東禎二, Takeshi Yasuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2010.

	Construction of the P1-017 simple suspension method compounding of medicines inspection system Chiharu Onoda 1, Keiko Makita 2, Misuzu Yamanashi 2, Keiko Okabe 2, Ikenotani deferred bunch 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2010.

	Construction of the database about suspension pH of the simple suspension method in the P1-018 Yokohama Asahi center general hospital Takekawa seven rebirths, Miyuki Ozawa, Takeshi Yamamoto, 牧村吏恵, 大澤眞希子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2010.

	Action to the simple suspension method in the P1-019 "oral medicine intubation administration handbook" non-publication medicine Kazuaki Sugio, Aya Komine, Mountain ノ Kawakatsu, Ishii Toshihiro, Masaka Wataru Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2010.

	Examination of the tablet crushing appliance in the P1-020 simple suspension method Yuko Kasuya 1, Kimiyoshi Kimura 2, Mayumi Mitsuhashi 2, Kazuko Shirosawa 1, Hideya Kokubun 1, Mariko Arai 1, Hajime Matsubara 1, Kazuo Yago 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2010.

	Comparison of the crush method and the simple suspension method about the incompatibility of P1-021 olmesartan prospect Kiso mil preparation and the metformin preparation 矢吹優1, 杉山恵理花1, 秋山滋男2, 倉田なおみ3, 斉藤清美1, 中村明弘3, 佐藤均1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2010.

	Effect - at basic study - other agents simultaneous suspension in the simple suspension of the P1-022 Valixa (R) lock 小川敦, 河崎陽一, 正岡康幸, 山路和彦, 名和秀紀, 佐藤智昭, 松永尚, 千堂年昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2010.

	About an effect of the P1-023 simple suspension method induction 右川浩, Junko Hiroi, Kaori Ito, Kanichi Kawasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2010.

	Nasal transluminal tube passage characteristics of the oiliness oral medicine at the P1-024 simple suspension sermon line Shiro Ishida 1, 賀勢泰子 2, Yoshiro Okano 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2010.

	Advisability of a stability evaluation after the P1-025 aspirin tablet folding and the simple suspension parcel application 木奈崎昭男, Shiro Ishida, Katsuaki Arai, Yoshiro Okano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2010.

	Role of the pharmacist in the P1-026 ICU ward Hiroshi Matsuzawa, Mariko Negishi, Mari Hosaka, Noriko Ishii, Funatsu Kumi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2010.

	Relation of the pharmacist to P1-027 ICU team approach in medical care Harada University 1, Eiko Kato 1, Nami Suda 1, Junichiro Kato 1, Masato Murayama 1, Shigehiko Uchino 2, Masaru Takinami celebration 2, Takashi Kawakubo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2010.

	Effect - of role - drug information offer of the ICU permanent residence pharmacist in the P1-028 team approach in medical care Hiromi Yanamoto, Fumihiko Kitta, Ai Endo tree, Keiji Kawata, Masahiko Suzuki, 花輪剛久, Toshio Oguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2010.

	From relation - intervention of the pharmacist judging from the pre-Abo id report in the P1-029 ICU after one year - Nobue Uetake, Toshiharu Matsumoto, Shinichi Miyamori, Open Koichi, Yonezawa sing Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2010.

It is ... about discussion - pharmacy central dispatching about the pharmaceutical management for P1-030 intensive care unit and the lifesaving ward admission patients and patients-specific management
Kazumasa Ueda 1, Tatsuya Otsubo 1, Mitsuru Otsuka 1, Yoshiji Junko 1, Kyuutoku Emi 1, Naomi Iio 1, Yoshitaka Kato 1, Yasuyuki Nishikawa 2, 野田能成 1, Kazumasa Oda 3, Yumi Kito 3, Suzuki dies out; 3, Takeshi Shinozuka 3, Satoshi Higaki 3, Ryoji Iizuka 3, 小西偉雄 1, Tadashi Mikami 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2010.

	Of drug control instruction and the patients intervention in the P1-031 CCU ward, actually Jun Kawazoe 1, Yuika Naito 1, Miyamoto beach 2, Yuka Kashiwabara 1, Junko Minemura 1, Tetsuro Sakai 3, Yoichi Kobayashi 3, Junichiro Murayama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2010.

	The new duties development of the pharmacist in the P1-032 NICU and the evaluation Hiromi Tanoe 1, Ikemi Yasuaki 1, 深津祥央 1, Ikuko Yano 1, Masahiko Kawai 2, Toshiya Katsura 1, Kenichi Inui 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2010.

	Team approach of the pharmacist in the P1-033 NICU Ayako Fujita 1, Mayu Tomita 1, Miyuki Miyaguchi 1, Mikio Chiba 1, 寺田智祐 1, Shigeki Koshida 2, Yoshihiro Takeuchi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2010.

	The evaluation of drug control instruction duties in the P1-034 NICU and the future prospects Shinya Yoshida, 宇佐美英績, Michio Kimura, Tadashi Yasuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2010.

Analysis of drug control instruction duties - drug information offer contents in the P1-035 altitude critical care center and evaluation -
Yoshiro Sakai 1, Maruta tree light 1, Yuko Yoshimaru 1, Kyoko Higuchi 1, Chiyoko Arima 1, Mieko Tsuruta 1, Shuhei Niiyama 2, Norio Yamashita 2, Teruo Sakamoto 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2010.

	Drug control instruction duties necessary for P1-036 critical care center Eiichi Maruta, Hiroko Shimada, Makiko Yamazaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2010.

	Action (the second report) of the resident pharmacist in the P1-037 regular hospital Shina Sogabe, Makoto Tanaka, Kenichi Manabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2010.

	Action of the fur Matthew tical care in the P1-038 this hospital Tsubotani Ayako 1, Shigeo Hatta 1, Shibuya Tomoyo 1, Haji day Kaori 1, 浅見妥江 1, Yuko Sakashita 1, Keiso Masuhara 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2010.

Through pharmacist duties - ward permanent residence pharmacist duties carrying it in P1-039 team approach in medical care -
Makoto Nakamura Tsu child, Ayumi Kondo, Masayo Tanahashi, Maki Arakawa, Nozomi Nishida Kushiro, Iku Kawamura person, Yukio Toyama, Tatsuya Muto, Hiroko Saito, Takaaki Hasegawa
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2010.

	Activity report of the ward exclusive duty pharmacist in the P1-040 this hospital Bell mountain Naoto, Hiroshi Tsujimura, Tatsuo Kai, Masatoshi Tadokoro, Kazuhiko Kawakita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2010.

	Examination about the management of the pharmacist duties in the P1-041 ward Akira Kitaoka, Junichi Iida, Yasuyuki Matsumura, Akihiko Yoshikawa, Hajime Kagaya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2010.

	The present conditions and problems of the drug control instruction in the P1-042 center of gravity institution Tsuyoshi Ebihara 1, Fumihiko Aida 2, Kazuki Kushida 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2010.

	About the development of emergency department duties mainly on the P1-043 bringing medicine confirmation Masahiro Someya, Setsuko Gamo, 千葉圭恵, Masako Nunokawa, Masaki Kitamura, Takashi Kawakubo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2010.

Action ... for the calculation of relation ... discharge drug information management instruction charges of the pharmacist until a discharge to be carried out using P1-044 medicine file
酒井孝征, Millet rice Miwa Hara, Ito graciousness, Tadaaki Okada, Sae Takii incense, Sayuri Tanaka, Tamae Ono, Kumi Kawano, Yuko Takada, Shiho Tanaka, Tomomi Matsumoto, Yono tree Katsuya, Nakagawa saturation, Yoshihiro Matsumoto, Junko Kai
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2010.

	For the inflection of the medicine notebook at the P1-045 discharge guidance Akira Tsujimoto, 原知斉, Yoko Imamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2010.

About the way of the drug control instruction calculation to make we consider it and patient compliance instruction of the high risk medicine activated about the job evaluation of the P1-046 patient compliance instruction
Masako Ieda, Morihiro Nomura, Naoko Matsuura, 角野雄亮, Koji Yoshida, Kitai Miwa, Hajime Asano, Yasuyuki Tsukioka, Yuzuru Yamazoe, Kenzo Moriyama
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2010.

	Action to the use of P1-047 high risk medicine situation and drug control instruction standardization We go to Saito, Yutaka Ito law of nature, Hiroto Ito, Katsuyuki Yoshioka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2010.

	Improvement of pharmaceutical management, discharge instruction of the high-risk medicine in the P1-048 circulatory organ ward Naoto Hirata, Shigeru Yamasaki, Nakazawa one purely Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2010.

	Actions of this hospital in the regime such as P1-049 medical supplies safety information Hiroaki Mizuno, Miki Segawa, Kimi Sakata, Masae Tsuji, Morihiro Okada, Haba Hisae, Origin of Takeda, It is moisture in the west Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2010.

Examination about the efficiency of the drug control instruction of the antitumor agents that P1-050 was based on "duties guidelines about the drug control instruction on high-risk medicine"
Takahiro Arai, Taeko Saito, Eriko Hiruta, Fumi Mukoda, Kawashima greens Yasuko, Aki Kuwahara, Toshiaki Kogure, Yaeko Mishima, Yukiko Kashima
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2010.

Relative - with the increase and decrease and drug duties of the calculation in effect on P1-051 drug control instruction charges calculation score - institution of the 2008 fee-for-service revision
Tetsuro Yumoto 1, 2, Body marsh Masami 2, 3, Yukino Ayabe 2, Junichi Iida 2, Hideko Kojima 2, Left side of the stage Mariko 2, Akitoku Kojima 2, Shinji Soeda 2, Jun Takimoto 2, Tamura harmony, reverence, purity and tranquility 2, Masatoshi Nakamura 2, Hisashi Fujiwara up 2, Takuya Maeda 2, Hajime Matsubara 2, Yoshiko Miyazaki 2, Masahisa Saito 2, Hajime Kagaya 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2010.

	P1-052 The introduction of audit in drug management guidance business 坂本愛, 寺沢匡史, 山下朋子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2010.

	A consciousness change by Audit of the P1-053 drug control instruction record and examination of problems 原知斉, Akira Tsujimoto, 廣末毅, Yoko Imamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2010.

	The super support system afferent use situation in P1-054 drug control instruction duties Kazuhiro Nakata 1, Hidekazu Kishida 1, Kenji Saegusa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2010.

	About a utility of the simulated patient (SP) participation type role playing training for P1-055 Shinnyu job pharmacists Toshiaki Miyazaki 1, Hiromi Okazaki 1, Kazuko Kubo 1, Junko Maeda 2, Sendo Toshiaki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2010.

	The evaluation of the medication self-care criteria that we made jointly with P1-056 nurse and future problem Kana Akahori, Otake A tree, Shizuka Takaoka, 須山奈見子, Saori Okamoto, Yoko Nakano, Ikuko Fukumoto, Takushi Morimoto, Maki Ushijima, Takeshi Miyake sentence Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2010.

Making of the patient compliance instruction tool of the antipsychotics in the P1-057 health insurance pharmacy
Yosuke Kawano 1, Hiroshi Sato rare 2, Iwao Yamamoto 1, Tokuko Ito 1, Fumiko Koga 1, Miwa Takaichi 3, Emiko Mimura 3, Sachiko Omori 3, Tomoko Ikeda 3, Yoshiro Okayama 2, Toru Maruyama 4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2010.

	About an action of this hospital in the P1-058 outpatient department medicine consultation window Fukushima sheath, Gain book Shuji, Yuriko Ishibe, Taketo Kamei, Kazunobu Takayanagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2010.

For improvement of action - outpatient department patient compliance instruction of the P1-059 "pharmacist outpatient department" -
Terukazu Nakajima 1, Kyoko Iwata 1, Hill-climbing 1,000 Saint 1, Kumaoka Maiko 1, Rie Shibue 1, Title prefecture reason officer 1, Hiroki Tajima 1, Tadao Inoue 1, 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2010.

	Patient compliance instruction to the outpatient using the P1-060 medication support program Masaaki Shibata 1, 熊田顕浩 1, Eri Kinoshita 1, Jun Hirano 1, Masaaki Takahashi 1, Yokomaku ability line 1, 2, Sugiura Wataru 1, 2, Toshiharu Nomura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2010.

Action of the pharmacist outpatient department for patients with P1-061 HIV infection
吉野宗宏 1, 矢倉裕輝 1, Hiroyuki Kushida 1, Minoru Kawai 1, Naoki Hayakawa 1, Hiroyuki Ueno 1, Yasukazu Sakamoto 1, Makoto Saito 1, Hiromi Sekimoto 1, 山内一恭 1, Yoshihisa Honda 1, Katsuya Komori 1, Takuma Shirasaka 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2010.

	Role of the pharmacist by the P1-062 CKD education hospitalization Shinichiro Ando Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2010.

	Relation of an introduction and the pharmacist of the renal disease classroom in the P1-063 Fujinomiya Municipal Hospital Yutaka Kobayashi, Kazuo Katsumata, Hiroshi Kawaguchi fruit, Yoshinori Kobayashi, Osamu Kitamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2010.

	Action ... as education hospitalization program - team for patients with P1-064 serious case atopic dermatitis Court Security Office Mika 1, Fumie Shimazu 1, Nobuhisa Fukushima 1, Yoko Kataoka 2, Ken Tanaka enthusiast 3, Masako Nagase 3, Sonomi Nakajima 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2010.

	Action to standardization of systems construction and the instruction in the self-administration induction of the P1-065 G-CSF preparation Keiko Miyakawa, Izumi Shimada, Makoto Hayashi, Akemasa Yamaya, Aspect shrine Koji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2010.

For instruction of the colonoscopic examination pre-treatment medicine which can feel relieved to the P1-066 patients
Kimotsuki Miho 1, 中拂絵里香 1, Pond increase sweetfish beauty 1, Shrine gate Takanori 1, Terumasa Sata 1, Kazuko Tanaka 1, Tail Saori Tsuji 2, As for the one of Nakagawa, it is beauty 2, Yuichi Nakamura 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2010.

	Improvement of the adherence by the instillation instruction intervention to the P1-067 cataract surgery patients Shinya Yamanaka 1, Ikuyo Sakai 2, Eriko Yamada 1, 森章哉 1, Yuko Nakamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2010.

	Making of the brochure about the use of drug of P1-068 children Kasama A village, Tomoko Komatsu, Hideki Koyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2010.

Examination about the number of the administration-related cold water re-hat reports of the nurse by the ward permanent residence system of the P1-069 pharmacist
Koichi Tanabe 1, Machiko Nakamura 1, Aya Handa 1, Kanako Shinohara 2, Fukiko Shiroyama 2, Murata Italy Noriko 3, Shizue Ishida 3, Tomoaki Ikezaki 1, Satoko Takeuchi 1, Hidenori Kitazawa 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2010.

P1-070 "duties change by the ward placement of the pharmacist and effect"
Hiroyuki Nagasawa, True river Sachiko, Kyoko Takahashi, 眞鍋美由紀, Yoshiko Katsuta, New ear Yuko, 渡辺孔明, Masae Yoshizawa, Mami Kazaoka, Taeko Ono, Ayako Sato, Height of island Ichiro, Tomoko Kawasaki, Chie Yuasa, Makoto Hoshi Ichiro
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2010.

	An activity report and the prospects of the resident pharmacist in the P1-071 circulatory organ ward Noriko Tsuzuki, Daichi Shibata, Mitsuru Sugiura, 足立守 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2010.

	1 approach - - of a Distribution of medicine mistake and the drug department in the P1-072 ward 中井千絵, 山村恭子, 溝口知宏, 萩野訓子, 楠本薫, 畑中智子, 杉本由平 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2010.

	P1-073 Distribution drugs misses and Medicament department of efforts in the ward: Part 2 萩野訓子, 山村恭子, 溝口知宏, 中井千絵, 楠本薫, 畑中智子, 杉本由平 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2010.

	Use of the confirmation lecture safe for action ... five minutes to the medical security by the P1-074 pharmacist and evaluation ... Harumi Tanoe 1, Yukiko Horikawa 1, Tadahiro Tanaka 1, Yuki Fujimoto 1, 飛野幸子 1, Koichi Nakao 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2010.

Trial (a tendency and measures) of the drugstore risk management in the P1-075 this hospital
Shinichiro Matsuda, Maze Hisanori, Harumi Teramoto, Reina Matsuda, Yuko Shimizu, Sakie Senoo, 田邨保之, Yuko Nakagawa, Takahiko Uno, Riyo Kanbara, Atsuko Inoue, Yu Okabayashi, Yasuhiro Haruna, 前岡翠, Chika Yamamoto, Chika Takagi, Nine mountain Reiko
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2010.

	Action of the drug duties improvement using the P1-076 risk foresight training law Haruka Murase, Igawa summer fruit, Ejima Aoi, Yuka Oyama village, Chie Oda, Hitomi Ishigami, Masayo Yamashita, Hiroshi Yoshida, Yoji Sugiura, Akio Katsumi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2010.

The P1-077 advanced high-risk drug workshop - fourth year begins; and ...
Ishikawa immensity 1, 後藤志央 1, Shrine Akihiro Ichiro 1, Mimata Sayaka 1, Maruyama Akina 1, Tatsuya Sasaki 1, 末安由拓 1, Kaifu Masayo 1, Akihiro Kai 1, Prince Taniguchi chapter 1, Keiko Kitajima 1, Ken Takakura 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2010.

	Analysis and evaluation about the incident development situation in the P1-078 new face education period Ishiwatari beach 1, Noriko Tsuchiya 1, Haru Sato or 2, Naoyuki Yakura 1, Yuko Hiraki 1, Junko Matsuoka 1, Masakazu Miyachi 1, Well beauty relationship 1, Tetsuro Yumoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2010.

Examination about the way of the offer of the information to the nurse for the purpose of the decrease in P1-079 drug-related error
Kenji Doi 1, Yuki Tokunaga 1, Okada early period 1, Yoko Fujii 1, Masako Ogawa 1, Atsuko Iwama 1, Haruko Shimada 1, Tomoko Kataoka 2, Tadayuki Samura 2, Hideyuki Yoshizaki 2, Kazutaka Matsumoto 3, Hitoshi Harada 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2010.

	Participation in planning as the medical supplies safety management person in charge to the nurse P1-080 new face training Masako Tahara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2010.

Method ... to alert for action ... nurse to the risk management of this hospital pharmacist for the P1-081 electronic chart induction
Harumi Teramoto, Shinichiro Matsuda, Nine mountain Reiko, Reina Matsuda, Yuko Shimizu, Sakie Senoo, 田邨保之, Yuko Nakagawa, Takahiko Uno, Riyo Kanbara, Atsuko Inoue, Yu Okabayashi, Yasuhiro Haruna, 前岡翠, Chika Yamamoto, Chika Takagi, Maze Hisanori
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2010.

	Action of the risk management in the P1-082 generic medicine adoption promotion Misao Arimura, Eri Kanazawa, Seiko Ishigami, Kohei Yamamoto, Helmet slope Tomohiro, Jun Taniguchi, 高田正温, Minato book Yasunori, Takanori Kobayakawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2010.

	Action for the safe use of the P1-083 high risk medicine River Chinese mustard cord, Kaori Kawahara, Kumiko Honma, Rie Ueda, Miyuki Sakurai, Eiji Fukui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2010.

	Making and use of the P1-084 high risk medicine monitor sheet Sachie Kawano 1, Yamashiro Sakae person 1, Period Masayuki 2, Tetsuji Sugata 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2010.

	About the construction of the P1-085 drug information database and the present conditions, a future problem Ryu Kobayashi, Shigeru Sato, Saori Fujiwara, Reina Toda, Yuichi Nakamura, Hatsumi Kikuta, 谷口亮央, Miki Katsuragawa, Jun Matsunami, 目黒亨治, Muki Ryoji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2010.

	The construction of the P1-086 doubt inquiry information sharing system and the fact-finding of the inquiry history and the measures Atsushi Hirata, Yutaka Matsuoka, Takamitsu Ochiai, Saori Nishiura, Sada Tachibana sincerity Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2010.

	Construction of the questions and answers database of P1-087 induction cost zero Jun Wada, Chieko Ozuku, 荒井久暢, 東碧, Yuki Imaizumi, Tomoko Takeda, Michiko Fujioka, 山下彰良, Yoshiko Murayama, Koji Hasegawa, Tatsuya Nakagami, Taeko Murakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2010.

	Construction of the question-response database in the P1-088 regional medicine-response drugstore Mikio Sakakibara 1, 2, Jun Kuribayashi 2, Masahiko Amakawa 2, Michihiko Kido 2, Satoshi Okada 1, 2, Keiji Arai 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2010.

	Efficiency of DI room duties by the computerization of the P1-089 medical supplies document Masato Ishii, Hiroyuki Yamane, Takeshi Shimada, Kae Hanaoka, Valley water Kumiko, Koji Matsushita, Yoshiaki Kita, Atsuko Inoue Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2010.

About the count results of "the questionnaire about the computerization of drug information duties" by P1-090 Hiroshima Hospital Pharmacist Association, the investigation public information committee and a future problem
Takayuki Arakawa, Toshiharu Matsumoto, Masahiro Yasuhara, Masahiro Hiura, This Tawa ear, Tree flat Kenji
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2010.

Examination of the utility of the drug information offer system with the cell-phone using P1-091 matrix type two dimensions cord (QR cord)
栗木沙希恵, Shinya Uchida, Naho Ikegami, Yoshiro Uchida, 三浦基靖, Riyoichi Takenaka, 田中紫茉子, 加藤安宏, Tokuyuki Namiki
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2010.

It is ... for comparison ... appropriate drug information offer systems construction of the drug information database with P1-092 Japan and Europe and America
Noriko Tanabe 1, 2, Natsuko Sugiyama 3, 4, Naoko Ishii 2, 5, Toshikazu Miyagishima 2, 高乗仁 2, Komoda Masayo 2, 4, Hiroshi Terada 2, 4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2010.

	Construction of the data collection system of the drug information in the P1-093 drug information room and the side effect Machiya cheap period, Yuichi Koizumi, 覚前盟, Fujitani Masanori, Mami Nomura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2010.

	Construction of the drug information offer system corresponding to the P1-094 fee-for-service revision Nakanishi will child 1, Yoshihisa Watanabe 1, Satoshi Nagami 2, Well falcon Takashi 2, 福島規志 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2010.

	Reinforcement - of DI information sharing - medical supplies safety information management system inside the hospital using the P1-095 Excel-XML database Yoshiyuki Kosugi 1, 伏見幸浩 2, Masaharu Terasawa 2, Shigeki Akizuki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2010.

	Construction of the brief database of the medical supplies safety information using P1-096 Excel Takashi Hayasaka light 1, Koike Chihiro 2, Masahiro Ishii 3, Sato samisen 4, Eriko Murakami 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2010.

Offer ... of the safe information that medical supplies safety information in the P1-097 Kochi medical center aimed at the improvement of regime - quickness characteristics and the certainty
Step pine Masahiro, Masami Uchida, The Tanaka immensity, Yuki Okazaki, 服部暁昌, Teruo Tanaka
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2010.

	The further improvement of P1-098 drug information offer and cooperation with drug control instruction duties Hajime Nakai, Kazunari Nakamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2010.

	Association between individual reporting and DSU to P1-099 physician 初田泰敏 1, 2, Ishinomaki Yasuhiro 2, Paulownia book Chika 2, Keiji Matsumoto 2, Hatadani Yoshimi 2, Silver Machiko 1, Toshiaki Tanaka 1, Fossa field wisdom 1, Masahiko Taniguchi 2, Masashi Ogawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2010.

	Analysis of the adverse event case of the antiplatelet drug using P1-100 FDA size scale adverse event spontaneous report (AERS) Koichi Hosomi, Charcoal floor Keita, Hideaki Miyamoto, Mitsutaka Takada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2010.

	It is ... through P1-101 medical supplies safety reporting and attached document revision about the interaction of evaluation - clopidogrel and omeprazole Motoko Funato, Keiko Nitta, Akemasa Junko, South Reiko, Kiyoshi Sasayama, Masaaki Mori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2010.

For destruction medicine zero by the P1-102 change of prescription action - in the - injection mixed preparation
Keisuke Kiyomiya 1, Hiroshi Muramatsu 1, Shu Kojima 1, Naomi Nishimatsu 1, Jewel bug Kasumi 1, Saeko Takei 1, Yoshiyuki Matsuki 1, Asami Wakimoto 1, Masaya Yamaguchi 1, Shunichi Kawamura 1, Shinichiro Okamoto 1, 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2010.

Action for the present conditions and the medical supplies purchase costs reduction of the quantity of preparation disposal anticancer drug in the P1-103 this hospital
Yuichiro Kayano, 根來寛, Valley Daisuke, Ukuru Watanabe is flat, Jin Tsukamoto, Ryoichi Yano, Toshiaki Nakamura, Mikio Masada
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2010.

Investigation about the use situation of donepezil based on the medication history information in the P1-104 health insurance pharmacy
Shunya Matoba 1, Mitsuko Onda 1, Seven Kaiyo child 2, Rie Tanaka 1, Kenichi Tsubota 1, Hiroaki Mukai 1, Hidehiko Sakurai 3, Kosai Hayase 3, Arakawa line straight 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2010.

	Investigation about the factor associated with compliance and that of patients with P1-105 donepezil remedy Hiroaki Mukai 1, Mitsuko Onda 1, Seven Kaiyo child 2, Rie Tanaka 1, Kenichi Tsubota 1, Shunya Matoba 1, Hidehiko Sakurai 3, Kosai Hayase 3, Arakawa line straight 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2010.

Investigation about the intervention effect of the pharmacist based on the use of drug evaluation on donepezil in the P1-106 outpatient
Kenichi Tsubota 1, Mitsuko Onda 1, Seven Kaiyo child 2, Rie Tanaka 1, Shunya Matoba 1, 向井祐亮 1, Hidehiko Sakurai 3, Kosai Hayase 3, Arakawa line straight 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2010.

	P1-107 surgery, opioid use investigation in the gynecology Misa Sato, Takashi Watanabe, Akio Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2010.

	Need ... of the consideration for present conditions - tooth caries of the P1-108 syrup sweetener Fold Ikuno 1, 浦裕之 1, 2, Mizuho Takahashi 1, Kiyomi Sadamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2010.

Antimicrobial agent consumption investigation of the municipal hospital-affiliated institution using P1-109 ATC/DDD
Mikako Nakano 1, Akiko Yamagata 2, Rumi Ishida 3, Pine Yoshimitsu child 4, Junichi Suwa 5, Yukiko Omura 6, Koichi Kawase 7, Small Saussurea Root Satoko 8, Takahashi sincerity 9, Yasuhiro Sasaki 10, Mariko Negishi 11, 鈴木礼乃 12, Yumiko Umezaki 3, Kumi Funatsu 11
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2010.

	Use situation investigation of medical institution-limited cosmetics in the P1-110 Fukuoka University Hospital Tadahiro Ikeuchi 1, Adachi るい 1, Yoshihiro Kawahara 1, Shoichi Kinoshita 1, Koji Washiyama 1, Jiro Takada 2, Kojiro Nikami 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2010.

	Prescription fact-finding (2000-2009: the second report) of the P1-111 migraine headache therapeutic drug Sachiko Imai 1, 2, 鈴木浩彰 2, Mari Nishizawa 1, Kenji Fujita 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2010.

	Use fact-finding for proper use of P1-112 aprepitant Grass sincerity Harumi 1, Satoko Fujiwara 2, Yukihiro Kawakami 2, It is still 2 Matsunaga, Sendo graduate apprentice 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2010.

	Administration fact-finding for the risperidone proper use for P1-113 delirium Tsukiji jasmin child 1, Mayuko Kawaguchi 1, 仲佐啓詳 1, Hiroshi Nakamura justice 1, Amount of Ariyoshi example 1, 伊豫雅臣 2, Koichi Kitada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2010.

	P1-114 Survey of Sitagliptin in Hokusetsu General Hospital 千葉知子, 加冶佐聖子, 松尾彬宏, 南宅梨沙, 辛永美, 榎南祥太, 東野友美, 佐藤千恵, 吉田智子, 柳川智子, 和田恭子, 高橋宏幸, 百海有二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2010.

	Use situation investigation about the procedure of SMBG and the insulin self-administration to P1-115 insulin self-administration patients Ken Kitamura is elegant, Hiroshi Kita University, Great Hisao Takeno, Noriko Ikeda, 横尾賢乗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2010.

	Physician-led making clinical path improvement suggestion from P1-116 case data analysis Kumi Nakamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2010.

	Effect ... by the presence or absence of fact-finding - lipid microsphere combination of the P1-117 TPN enforcement situation Takashi Yamazaki 1, Ayumu Nozaki 1, 茂木孝裕 1, 土手賢史 1, Ito greens wave 1, Yuka Kobayashi 1, Toshiko Aramiya 1, Hirokazu Nakanishi 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2010.

	Examination of the use situation and the resistant bacteria change of injectable antibiotics in the P1-118 Saga Hospital Masashi Hashimoto, Higashijima good luck way, Tashiro early period, Yagi Hideaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2010.

	Effect investigation by the antimicrobial agent cost-cutting measure enforcement of the P1-119 Fukuoka Red Cross Hospital Tatsuya Oishi, Yu Koga group, Tomohiko Takeno, Chie Gotanda, 川野昭, Noriko Nishimura, Rieko Fujinaga, Yoshida Hiroaki, Hiroyuki Otake Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2010.

	A comparison and examination of the consumption of the injectable tazobactam sodium piperacillin sodium between the P1-120 2 institution Tadanori Suzuki 1, Chie Takahashi 1, Kuniyoshi Sato 1, Chie Okazaki 2, Kazuyo Shimojima 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2010.

	Trial to a prescription investigation and proper use of P1-121 levofloxacin Hatamoto Keita, Hisafumi Morita, Yasuko Ichikawa, Yasushi Fujii, Kenichiro Fujii Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2010.

	It is hard to stop bleeding of the P1-122 cardiovascular surgery surgery and reports use of the genetically-modified active form blood clotting factor VII in the case Tomoyuki Gomi 1, Kenichi Horiuchi 1, Kazumi Yoda 1, Takahiro Takemura 2, Kazuaki Shiratori 2, 濱元拓 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2010.

	About the use situation and registration system induction of the albumin preparation in the P1-123 this hospital Mari Mizuki 1, Eiko Ueda 2, Tomoko Nishikawa 3, Itsuki Chiyoko 3, Saeko Sakamoto 3, Sakai well 1,000 Emi 4, Masami Takahashi 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2010.

	Fact-finding about the prescription of the P1-124 oral antihistamine Kayoko Maezawa 1, Asako Terashima 1, 秋田博伸 2, Moat Seiji 3, Junko Kitsu 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2010.

	It is J-HOME Morning study the present conditions of the diuretic use in the hypertensive practice of P1-125 Japan Ikeda back et al. 1, Taku Ohara 2, Kazuki Ishikura 3, Ai Yoshida koto 4, Yuka Kobayashi 1, Takayoshi Okubo 3, 5, Hiroshi Sato 1, Jun Imai 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2010.

	About an association between salt intake and remedy drug and BMI in P1-126 patients with hypertension Seiji Machida, Toshiaki Tomita, Masaru Fukushima friend, Kazuhisa Masuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2010.

	Trend of the statin prescription in the P1-127 ischemic stroke prevention of recurrence Tomiyasu 1, Mayuu, 90,000 field reason Takae 1, Yuki Fujimoto 1, Harumi Tanoe 1, Yuichiro Inatomi 2, Toshiro Yonehara 2, 飛野幸子 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2010.

Work of the pharmacist in the opioid use of preparation situation investigation and proper use in the P1-128 University of Tokushima Hospital
西迫寛隆, Yoshiko Yoneta, 上村卓広, Tetsuya Mizoguchi, Shinji Abe, Kazuhiko Teraoka, Hisatsugi U.S. Toshihide, Kazuyoshi Kawazoe, Kazuo Mizuguchi
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2010.

	"A prescription, the use actual situation of the nonsteroidal antiphlogistic analgetic (NSAIDS) patch" that we saw from P1-129 pharmacist Young Susumu Hayashi 1, Akiko Miki 2, Hiroki Sato 2, Sayo Matsuoka 2, Moat foster child 2, 3, Yasufumi Sawada 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2010.

	Use experience of the Fra fin hydrochloride becoming the fact-finding for the itch of the P1-130 patient on dialysis Eri Wakita, Shigeru Yamada tree, Hiromi Sakai, Hiroshi Hozumi, Mika Shinoda, Kana Kato, Nomura connection, Yuichiro Wada, 吉田雅彩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2010.

	Effect ... of examination - non-steroid-related antiphlogistic analgetic combination about the dose change of methotrexate in patients with P1-131 articular rheumatism Norio Masumoto 1, 2, Takako Yuko 1, 大槻裕朗 1, Yoshihisa Takao 1, Kazutaka Harada 3, Seigo Iwakawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2010.

	Examination of the drug costs reduction by the screening of the P1-132 prescription 鵜山泰詳 1, Yoshiko Yotsumoto 1, Fujii sheath or 1, Miyanooku Kei Tsu celebration 1, Ikuko Fukuoka 1, Yoko Nakamura 1, Kensuke Matsushita 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2010.

	It is ... based on approach - medical supplies purchase quantity for the P1-133 prescription of drug adequacy Yukio Kondo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2010.

	Review of the adoption drug which came from P1-134 business efficiency and economy North field Tomohide, Naomi Sogabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2010.

	The P1-135 "effect of running it on late departure medicine change in the DPC Hospital" Taku Yamauchi, Yoshiko Onuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2010.

	Economic effect (investigation in the orthopedics ward) that the bringing medicine check by the P1-136 pharmacist results in Hideyuki Kakiuchi, Yoshihiro Nakata, Daisuke Tsuchimoto, Shigeki Hirano, Yamada Toru Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2010.

Change of drug costs by the "smallest price list use with the quantity of extraction" of the P1-137 anticancer drug, the preparation efficiency
Hidekazu Fujita, Hamamoto right child, Yuko Hino, Noriko Nishimura, Rika Tanaka, Yuri Aoki child, Naoko Noguchi, Hiroshi Yamamoto, Koji Takai, Yoshinobu Kitao
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2010.

	Comparison between clinical evaluations and economy - erythropoietin ... of the P1-138 darbepoetin 堀哲史, 岩崎純子, 水岡大策, 布川修次, 伊東利紗, 佐野良平, 土下喜正, 伊藤公博, 藤村保夫, 楠本正明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2010.

	Effect of the calcium lactate which gives it to effect of treatment of the P1-139 levothyroxine Hiroyuki Miyazaki, Yoshinori Okubo, Takahiko Nakao Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2010.

	Examination of the drug interaction of cyclosporin A in the P1-140 hematopoietic stem cell transplantation 増田理央 1, Kan Yukio 1, Junko Ishizaki 1, Ryo Matsushita 1, 崔吉道 2, Kenichi Miyamoto 2, Arai country three 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2010.

	Examination of the downward titration method of warfarin doses in the P1-141 amiodarone induction patients Megumi Kurita 1, Keiko Ono 2, Tetsuro Ono 3, Jun Umemura 4, Satoshi Kishino 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2010.

	Examination of the patient factors about the rise in INR value at P1-142 warfarin and bucolome combination Momoko Tomioka 1, 植沢芳広 2, Mitsuhiro Saito 3, Tomio Matsumoto 3, Mori Kiminori 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2010.

	Examination of the medical supplies proper use from P1-143 warfarin bucolome combination case follow-up Emi Momiyama, Yoshie Nishiyama, Thin wave Tomoko, Hiromi Nagai, Kanako Sakashita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2010.

	Investigation about the anticoagulant action augmentation by the combination of P1-144 anticancer drug and warfarin Hiromi Nagai, Emi Momiyama, Yoshie Nishiyama, Thin wave Tomoko, Kanako Sakashita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2010.

	Study on interaction of warfarin and the proton pump inhibitor in the P1-145 common practice Kenta Sugiura 1, Keiko Ono 1, Tetsuro Ono 2, Jun Umemura 2, Satoshi Kishino 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2010.

	1 case - prescription fact-finding and future problem ... that it influenced anticoagulant effect of the warfarin to have switched from P1-146 hyperalimentation to tube feeding Chieko Suda 1, Yuko Inoue 1, Michio Tomita 1, Toshiyuki Matsuda 1, Daisuke Arai 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2010.

	It is ... through the poor case of examination - phenytoin control about the interaction of P1-147 warfarin potassium and the phenytoin 齋川善行, Masayuki Kaneta, Shuzo Fujita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2010.

	One case that a blood level of voriconazole was thought to show high level by P1-148 drug interactions Yukako Yanagihara 1, Megumi Yamauchi 1, Kiyotaka Iwai 1, Bank of a river Yuki man 2, Hiromasa Yamauchi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2010.

One case that serum phenytoin levels increased by capecitabine administration in patients with epilepsy during P1-149 cancer chemotherapy enforcement
Pond Masayuki Nishi 1, 林口剛泰 1, Masatoshi Sano 1, Mutsumi Ueda light 1, 樽野陽亮 2, 大鳥徹 3, Kenji Matsuyama 3, Eitaro Nakatsuka 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2010.

	Prediction of the drug interaction by the CYP2C9 instruction of P1-150 rifampicin Masaki Ueno 1, Yoshiyuki Ono 1, Gutter slope Akihiro 2, Taketo Yamamoto 1, Hiroshi Suzuki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2010.

	For "the cancer chemotherapy" that is effective in action - security avoiding the drug interaction of the P1-151 anticancer drug - Hiroko Shibata, Yohei Miyawaki, Naoko Shibata, Junko Tsujimoto, Manabu Kako, Hitoshi Okugawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2010.

	One case of prolidase deficiency that showed erythroderma by P1-152 stellate ganglion block Yamamoto high example 1, Atsushi Fukumura 2, Yoji Mitsui 1, Munekatsu Hotta 1, Tomoya Asaga 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2010.

	One case that was regarded as chemical pneumonia of the P1-153 paclitaxel induction Keiko Adachi 1, Kazuya Fujita 1, Yukako Hatanaka 1, Toshiaki Matsuki 1, Sho Nakata will 2, 郷間厳 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2010.

	One patient who raised myelosuppression during P1-154 sorafenib remedy Masashi Honma 1, Yukihiro Hamada 1, 大野凛太郎 2, Takeshi Hirayama 1, 2, Kazunori Furuta 3, Masahiko Watanabe 3, Masaichi Kuroyama 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2010.

	It is examined the case with suspected severe form drug eruption in P1-155 super elderly people Koike reason Expo 1, Tomoyasu Furukawa 2, Yagi Motohiro 2, 齊藤幹央 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2010.

	P1-155☆ Examination of hypersensitivity in X-rays contrast media 齊藤幹央1, 阿部学1, 影山美穂1, 朝倉俊成1, 影向範昭1, 古川智康2, 八木元広2, 宇野勝次3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2010.

	One patient who presented with tardive stent thrombosis by going to hospital interruption after P1-156 drug elution stent placement Kazuyuki Ito 1, Mika Wakayama 1, Keita Urasaki 1, Takamitsu Akita 1, Kamikubo Yosuke 2, Naoya Tsuboi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2010.

	An example of the nephrotic syndrome that developed de novo hepatitis B by an immunosuppressive action of P1-157 cyclosporine Star Hiroshi Noji 1, Aiko Hirano 1, Shinichi Miyazaki 2, Tsutomu Takeuchi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2010.

	One patient who presented with severe dyslipidemia by P1-158 lansoprazole Yumiko Yada, 新美詠彦, Reiko Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2010.

	An example of toxic epidermal necrolysis (TEN) that had the report in the P1-159 information on adverse drug reactions center Makoto Nakazaki person 1, Mariko Kawana 1, Yutaka Kobori ankle 1, Junko Nagai 1, ウォーン pole 1, Kunihiko Araki 2, Tadanori Sasaki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2010.

	Action second report to information on adverse drug reactions collection of in the P1-160 information on adverse drug reactions center and evasion Mariko Kawana, Makoto Nakazaki person, Yutaka Kobori ankle, Junko Nagai, ウォーン pole, Tadanori Sasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2010.

The hypermagnesemia that appeared during treatment of P1-161 cancer pain
Flat dance, 澤谷佳美, Hidekazu Kizaki, Shinji Honma, Miki Akizuki, Kimoto good luck is rare, Miyuki Okada, This Western philosopher, The long waterfall truth, Watanabe Kyoko, Masayo Takagi, Michiyo Terasawa, Kayo Saito, 川瀬泰裕, Kenichi Ooe, Yasuhiko Hirota
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2010.

Study about side effect incidence and the risk factor with the ST mixture administration to patients with collagenosis during P1-162 high dose steroid administration
Akiko Hayashi 1, Kazushi Masuda 1, 2, Michiko Imazeki 1, Masato Okubo 1, Satoshi Ikeda 3, 仲佐啓詳 1, Hiroshi Nakamura justice 1, Amount of Ariyoshi example 1, Yasushi Nakajima 3, Katsu Takabayashi day oneself 3, Koichi Kitada 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2010.

Rearward observational study about frequency and the risk factor of the thrombocytopenia by the use of P1-163 linezolid
中蔵伊知郎1, 2, 山下大輔1, 2, 高麗睦子1, 堀部明美1, 2, 森英人1, 和田恭一1, 岡田博1, 小原延章1, 嘉田晃子3, 朝倉正紀3, 佐田誠2, 4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2010.

	Examination about expression of infusion reaction by P1-164 Rituximab and the association with the dosing rate 鈴木亜維, Miki Katsuragawa, Hiroyuki Komatsu, Tokutome chapter, Tomoko Abe, Ryu Kobayashi, 目黒亨治, Muki Ryoji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2010.

	Examination of the side effect (edema) factor of the P1-165 blood clotting inhibitor (fondaparinux sodium, enoxaparin sodium) Maki Shimizu 1, Satomi Kobayashi 1, 田島濔子 1, 眞鍋公二 2, Yoshihiro Ogasawara 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2010.

	Risk factor analysis from the fever at the P1-166 IFNβ-1a initial administration 越智香保1, 原田実1, 岡田弘康1, 大江田知子2, 澤田秀幸2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2010.

	Evaluation of celecoxib for the urinary frequency of P1-167 patients with nonsmall cell lung cancer Mariko Araki 1, Mari Hirabayashi 2, Yagi Satoshi 2, 小林靖奈 1, Toshitaka Takenouchi 2, Junichiro Murayama 1, 3, 山元俊憲 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2010.

	Examination of the cooling time for the nail disorder by P1-168 DOC Hiroyuki Shimizu 1, Eiko Yoneta 1, Kensuke Hirooka 1, Yumi Yamaguchi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2010.

	Examination about the side effect of P1-169 pemetrexed Shinohara Keisuke, Yutaka Ichikawa is flat Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2010.

	Examination about the liver damage onset of erlotinib for P1-170 progress non-small cell lung cancer Celebration Chikako 1, Ikuko Yano 1, Ryo Miyahara 2, Hiroshi Date solstice 2, Toshiya Katsura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2010.

Utility - of gemcitabine postoperative adjuvant chemotherapy - every other week administration in the P1-171 pancreatic cancer
平田大氣 1, Akihiko Tsuchida 2, Yongchuan Yuichi 2, 松土尊映 2, 許文聡 2, Takahisa Ikeda 2, Yoshiaki Suzuki 2, Kazuhiko Kasuya 2, Tatsuya Aoki 2, Kanako Azuma 3, Tomoko Takenaka 3, Masami Onishi 3, Takashi Kawaguchi 1, Hiroki Takeuchi 1, 畝崎榮 1, Takao Akashi 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2010.

	Investigation of the interstitial pneumonia by Gemcitabine in patients with P1-172 pancreatic cancer Yuji Ishio, 谷口亮央, Flat land tax, Tokutome chapter, Mihoko Sasaki, Fujiko Kamata, Sato male tree, Miki Katsuragawa, Jun Matsunami, Ryu Kobayashi, 目黒亨治, Muki Ryoji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2010.

	Making of the side effect check sheet based on the side effect investigation of CCRT (concurrent chemoradiotherapy) in P1-173 cervical cancer Yoko Sone 1, Yoko Hayashi 2, Shingo Takatori 1, Sendo Toshiaki 2, 川崎博已 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2010.

	About induction and a utility of the bringing medicine administrative work in the P1-174 this hospital Cheap tail Tetsuro, Three fence Tomoko, Tomoko Ohashi, Akemasa Imamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2010.

	Utility - of the on admission initial interview of fact-finding - pharmacist of the doubt inquiry at the P1-175 bringing medicine differentiation Misako Uchida 1, Teruhiko Hoshino 2, Rumiko Sugiyama 1, Kazunori Shiozu 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2010.

	Examination about the utility of the bringing medicine confirmation by the hospital day interview in the P1-176 orthopedics ward Kimiko Furukawa, Pupil-maru Emi, Yoshiteru Honda, Hideyuki Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2010.

	Contribution of the ward pharmacist for the bringing medicine management in the P1-177 this hospital Keita Urasaki 1, Jun Hisada straight 1, Kazuyuki Ito 1, Takamitsu Akita 1, Tatsuya Hibi 2, 弥政晋輔 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2010.

	Relation of bringing medicine management and the pharmacist in the P1-178 this hospital Wakana Kawada, Hatsuko Iwai, Chisato Matsumae, Kiyoe Kimura, Takefumi Hayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2010.

	Role of the pharmacist in the P1-179 convalescent rehabilitation ward Kazuya Shirai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2010.

	About the revision of the bringing medicine differentiation book in the P1-180 Kumamoto central Hospital and the effect 栗崎貴啓, 東矢恵, Satoko Nakamura, Rika Sakamoto, 續政哉, Yasushi Hirata Jiro, Yoshiharu Wada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2010.

	Evaluation of P1-181 on admission bringing medicine differentiation duties Natsuko Ano, Michiko Onozawa, Shinnichiro Yamamoto, Mitsumasa Kaneta Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2010.

	Evaluation of the bringing medicine complete management by the pharmacist in the hospital targeted for P1-182 DPC Minako Tsukada, One river Etsuko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2010.

	The error measures of P1-183 bringing medicine differentiation duties and the utility Kuniaki Moriki, Naoko Shimizu, Chisato Iwai, Tatsuya Kaneta, Kenji Otsubo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2010.

	Use of the bringing medicine to think about from an aspect of the P1-184 medical supplies safety management Yumi Niinuma, We see it with Yano, Yukiko Kotaki, Sato preference, Junko Kurimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2010.

	Action to the risk aversion through the bringing medicine control center in the P1-185 this hospital Miyake hemp sentence 1, Kaoru Takemura 1, Hiroyuki Kawahara 1, Junpei Mizuta 1, Country original Junichi 1, Chisato Nishioka 2, Yasuda Wakana 2, Noboru Okamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2010.

Use of the P1-186 medical supplies check vote that cancellation is desirable preoperatively
Yumi Ito 1, Tomoyuki Nonogaki 1, Masayuki Takeuchi 1, Yosuke Shiraishi 1, Iku Kawamura person 1, Masafumi Onishi 1, Hiroshi Ito 2, Yoshihiro Fujiwara 2, Hiroko Saito 1, Takaaki Hasegawa 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2010.

	Action - testing, preoperative bringing medicine confirmation - of the P1-187 pharmacist outpatient department Rie Shibue 1, Kyoko Iwata 1, Yasuko Yamamoto 1, Terukazu Nakajima 1, Kumaoka Maiko 1, Title prefecture reason officer 1, Hiroki Tajima 1, Tadao Inoue 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2010.

	Than on admission bringing medicine utility ... pre-Abo id report by the P1-188 pharmacist of a check ... Hiroko Arai, 岸本大裕, Suguru Kasahara Castle, Jun Hamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2010.

	Appropriate prescription of drug support ... in prescription suggestion ... elderly people by the P1-189 pharmacist at admission Tetsuya Miyakawa 1, Koji Muto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2010.

	It is a change of the prescription situation and the blood pressure at change from P1-190 bringing medicine to an in-hospital alternative agent Midori Onoda 1, Teruhiko Hoshino 1, 2, Rie Tayama 1, Kazunori Shiozu 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2010.

Examination ... of this hospital adoption medicine by the present conditions - bringing medicine for bringing medicine differentiation analysis in the P1-191 this hospital
Susumu Kaneshige, Miyuki Sakamoto, Descent from a mountain Machiko, Hidechika Uozumi, Namimatsu Hiroko, Shimomura connection, Yuko Hara, Noriko Karashima
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2010.

A bringing medicine investigation and prescription intervention of the renal function degeneracy patients in the P1-192 on admission
Yuri Nagai 1, Kaoru Takemura 1, 1000, Aga Kyoko 1, Miyake hemp sentence 1, Satsuki Abe 1, Hiroyuki Kawahara 1, Country original Junichi 1, Yasuda Wakana 2, Chisato Nishioka 2, Noboru Okamura 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2010.

	Correspondence to patients with renal dysfunction in the P1-193 bringing medicine administrative work Hiroki Inoue, Yukari Nakase, Tetsu Fukatsu, Akira Takahashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2010.

	About disagreement of prescription information and the medication situation at the P1-194 bringing medicine confirmation Hiromi Tamura, Yumiko Uchida, Hiroyuki Fujii, Shinobu Hasebe, Tadaaki Ito, Masahiro Hayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2010.

	Discussion of the antimicrobial agent brought in P1-195 on admission Toru Nagai, Hiroshi Hara person Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2010.

Questionary survey about the safe use of the P1-196 generic medicine
為村聡彦 1, 2, Toshiaki Akatsu 1, 3, Kenji Kogo 1, 4, Yoshihiro Kondo 1, 5, Field stake Masako 1, 6, Teiko Nakahira 1, 7, Jujube Noriaki 1, 8, Takashi Minagawa 1, 9, 矢部勝茂 1, 10, Rie Naito 1, 11, Yoshio Kosaka 1, 12, Kimiko Matsuda 1, 13, Hideyuki Shimizu 1, 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2010.

	Fact-finding about the generic medicine in medical facilities in P1-197 Kagoshima Tadashi Kanazawa intellect 1, 2, Kazuaki Matsumoto 2, 3, Fujiko 2 between the fortune, 4, Hiromi Tokunaga 2, 5, Seiichi Kawahara 2, 6, Kotobuki Shinichiro 1, 2, Katsushi Yamada 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2010.

	Questionnaire report second report about action ... generic medicine of the P1-198 - Mizusawa clinical pharmacy meeting for the study Takeshi Onodera 1, Kenji Minamikawa 1, Kumi Ishikawa 2, Yukiko Senda 3, Makoto Matsuura 4, Kiyoaki Miura 5, Toshihiro Miura 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2010.

	Enlightenment activity to the nation for the P1-199 generic medicine spread is enough; or the examination about the full degree of - public information Miyoko Fujimori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2010.

	It is as a result of company questionnaire that we conducted for P1-200 generic medicine adoption Kiyoko Ogino, Kana Koyama, Yasuhiro Aikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2010.

	Action for the change to generic medicine by the P1-201 Hospital leadership Takanobu Hashimoto, Yoichi Hiraoka, Tatsuo Nakagawa, Kazumi Kito, Akito Nagai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2010.

	Investigation about the change situation to the generic medicine in the P1-202 out of the hospital prescription Yoshihiro Kakiuchi 1, Atsushi Yamashita 1, Hiromi Atsumi 1, Hiroki Nemoto 1, 薛寿栄 1, Natsumi Nakagawa 1, Masako Kume 1, Rii Takei 1, Aya Yoshida 1, Kae Toyama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2010.

The present conditions about the change to the generic medicine in the out of the hospital prescription of the eastern part of P1-203 Saiseikai Yokohama-shi Hospital
Keiko Atsumi, Yamashita excellent texture, Mayumi Fujii, Kenji Saito, Yu Shimomura Kei, 眞野匠智, Ochiai thread of logic, Megumi Ota, Kazuko Aoki, Imperial garden Mikiko, Jun Takimoto, Yuzo Eguchi, Hiroshi Sugano, 赤瀬朋秀
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2010.

Attitude survey to the physician about the feedback method of the change information to the generic medicine in the P1-204 out of the hospital drugstore
Kozo Tsuchiya, Kaori Yamazaki, Takaaki Suzuki, Makoto Kimura spring, 仲佐啓詳, Hiroshi Nakamura justice, The amount of Ariyoshi example, Koichi Kitada
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2010.

About the correspondence at action for the P1-205 generic medicine change and change and the enforcement of the in-hospital questionnaire
Toshihiro Matsumoto, 高崎紘臣, Ryoko Yoshihara, Nishida beauty society child, Kumi Kawano, Hirotaka Suzuta, Kenji Matsumoto, Hiroshi Sakai virtue
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2010.

	Investigation to face each other to pass through reshuffling from a P1-206 forerunner pharmaceutical products anchor Ron lock to generic medicine amiodarone tablets "sand" 平川雅章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2010.

	Investigation about the use of 5-HT3 antagonist injection generic drug in the P1-207 this hospital 日置三紀 1, Yuka Kobayashi 1, Ayako Nakamura 1, Ayumu Nozaki 1, Hiroki Iwane 1, Toshiko Aramiya 1, Hirokazu Nakanishi 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2010.

	Comparison of the side effect frequency for starting medical supplies of the generic medicine in P1-208 cisplatin Yutaka Kawahara, Yusuke Noguchi, Yoko Tokuyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2010.

	Use experience of generic medicine warfarin K infinitesimal grain 0.2% "YD" (R) in our P1-209 center Mariko Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2010.

	Three cases that generic medicine was effective in P1-210 autoimmune disease treatment Mami Yoshioka 1, Ayako Miyake 2, Shigeyuki Ohata 2, Yukihide Shibata 1, Hosoyamada truth 3, Suguru Saito paternal blood 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2010.

	Examination of the asthmatic exacerbation risk with the P1-211 generic medicine Koji Nakao, Sei Tanabe committee child, 藤井広久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2010.

	Person in charge of the pharmacist to the operating room in the cottage-hospital out of P1-212 Hideki Sato, Keisuke Otsu, Young book Azusa, Umehara Kengo, Yoshiko Wada, First mountain Tae Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2010.

	Development 2 of the set medicine inspection system of the operating room in the cottage-hospital out of P1-213 Yuka Saito 1, Yuka Watanabe 1, Shuichi Shimura 1, Noriaki Fujii 1, 齋藤進 1, Yasuko Sato 2, Takashi Matsukawa 3, 因泥栄一郎 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2010.

	Development of the P1-214 operating room set medicine system of administration Hiroki Ito 1, Masayo Otsuka 1, 西村文宏 1, 因泥栄一郎 2, Shoji Takeyama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2010.

	Contribution and refinement of the pharmacist to the operation region medical supplies management in the hospital attached to P1-215 Kanazawa University Katsuhiko Nagase 1, Ryota Kurosawa 1, Daizo Maeda 1, 崔吉道 1, Masako Sakao 2, Hironori Ito 3, Kenichi Miyamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2010.

	Duties development of the pharmacist in the P1-216 operating room 藤田將嗣, Satoshi Yamamoto, Mutsumi Kobayashi, Chizuru Shirokami, Shiho Hirahara, Norifumi Nakajima, 面田恵, 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2010.

The pharmacist duties in the operating room of the P1-217 this hospital and the evaluation
小林彦登 1, Sakai Naoko 1, Shinobu Matsumoto 1, Takashi Ito kernel 1, Futoshi Saito 1, Kotobuki, Keiko Higuchi 1, Month Sachiko Nogi 1, Soichi Shibata 1, Sato いね 2, Masanori Kashiwagi 3, Atsuta Koichiro 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2010.

	Drug control duties in the P1-218 intensive care unit Yosuke Kanazawa, 田村健悦, South Kazushi, Takako Miura, Origin of Hiraga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2010.

	Trial in this hospital for the P1-219 drug management Hiroshi Katsumata, Kan Yutaka Otaka, History of Sei Koshiba, Takafumi Ichida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2010.

	Construction of the drug system of administration in conjunction with P1-220 electronic chart system Kenichi Anjiki, Kazuo Takeshita, Naomi Kaneko, The Yumi Hara beauty, Tomohiro Sonoyama, Katsuki Yokote, Tabe princess Sachimi, Ei Hirano product, Sumiko Goto, 石野外志勝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2010.

Construction of the product system of administration derived from the specific organism which linked P1-221 electronic chart
Toshiyuki Ozaki, Kenichi Anjiki, Yorimitsu runs, Emiko Fukuda, The Yumi Hara beauty, Tomohiro Sonoyama, Katsuki Yokote, 卜藏俊仁, Ei Hirano product, Sumiko Goto, 石野外志勝
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2010.

	Examination of the exposure dose with the P1-222 PET drug handling 内田朋毅 1, Look at the piece; Toshihiko 1, 2, Susumu Onodera will 1, Takashi Yoshino Expo 1, Haruko Endo 1, Infield Fussa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2010.

Relation of the present conditions and the pharmacist of the 11C- methionine composition for the PET in the P1-223 this hospital
Hiroki Arakawa 1, Yohei Sakurai 1, 東禎二 1, Takeshi Yasuda 1, Yasuhisa Tsuchida 2, 成瀬広恭 2, Yoshinori Kato 2, Motoyuki Suzuki 2, 伊藤信嗣 2, Kawakado Yasuhiro 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2010.

	Examination of flow deferred depression effect and the side effect of P1-224 hospital preparation 5% scopolamine ointment Kenichiro Shimoda 1, Teruhiko Hoshino 1, 2, Rumiko Sugiyama 1, Morizaki Chongwen 1, Kazunori Shiozu 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2010.

	Effective case of the 3%Ara-A eye ointment for the P1-225 acyclovir eye ointment-resistant corneal herpes 牧秀美 1, Takahiro Hirata 1, Hisao Ikeda 1, Michihide Seguchi 2, Katsuyoshi Hatanaka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2010.

Clinical evaluations about efficacy, the safety of the in-hospital special preparation mesalazine suppository in patients with P1-226 ulcerative colitis
Hirokazu Takatsuka 1, Kazushi Masuda 1, 2, Jin Miyamoto 1, Tatsuya Suzuki 1, Kenichi Arai 1, 仲佐啓詳 1, Hiroshi Nakamura justice 1, Amount of Ariyoshi example 1, 中川倫夫 3, Toru Sato 3, Tatsuro Katsuno 3, 横須賀收 3, Koichi Kitada 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2010.

	Examination of the efficacy of the surface anesthesia preparation for the new oral cavity which assumed P1-227 polyvinyl acetate a basis Takashi Ando kernel 1, 2, Lower tail Yoshiaki 3, Sei Nakazato possible 3, Hisahiro Yoshida 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2010.

The efficacy of the pilocarpine sodium alginate component liquid drug for the patients with xerostomia with the medicine for the P1-228 psychiatry and safe examination
Hiroyuki Hosono 1, 1, Chisato, Yamada, Akira Wada 2, Shinichi Niwa 1, Saito hundreds of branches beauty 1, Fumio Itagaki 1, Machiko Watanabe 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2010.

Examination about skin permeability in the lidocaine preparation of P1-229 four kinds (hospital preparation) and the analgesic effect
Watanabe many Maki 1, It is still world 2 Yamaoka, Keiji Maruyama 1, Shigekazu Watanabe 1, Yu Kato tree 2, Saito hundreds of branches beauty 1, Shinichi Hirabayashi 2, 土屋雅勇 1, Keiko Yamaoka 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2010.

	Blood micafungin levels assay using the P1-230 plasma direct injection-response HPLC column 浦西洋彰 1, Yukari Ikeda 2, Otsuka ten thousand Yuko 1, 中村弘揮 2, Mitsuhiro Nakamura 1, Teruo Tsuchiya 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2010.

	Establishment of the plasma concentration assay of P1-231 long-acting local anesthetic ropivacaine and levobupivacaine Yosuke Shiraishi 1, Masafumi Onishi 1, Tomoyuki Nonogaki 1, Atsushi Hashimoto 2, Yoshihiro Fujiwara 2, Hiroko Saito 1, Takaaki Hasegawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2010.

	Comparison of ACMIA method in the blood P1-232 sirolimus levels measurement, MEIA method and LC/MS/MS Yotaro Matsumoto, Masaya Fujiyoshi, Tomoko Uenishi, Mayumi Sato, Forest size, Miki Shimada, 眞野成康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2010.

	Comparison of fluorescence polarization immunoassay (FPIA method) and the chemiluminescence immunoassay (the CLIA method) in the P1-233 children specimen Ryohei Takahashi 1, Koichi Imai 1, 2, 新井康俊 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2010.

	The establishment of the HPLC-UV method assaying serum free form drug concentration of the P1-234 teicoplanin and application to TDM Yukako Yasui 1, Hayato Konishi 2, Yutaka Yoshikawa 2, Hiroyuki Yasui 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2010.

	Blood level evaluation of methotrexate with the P1-235 measuring assembly change and the tacrolimus 山口佳津騎, 福岡憲泰, Sumio Kimura, Kazuko Higuchi, Shigeko Tsuji, Valley Kumiko, Yoshie Isobe, Kenta Sumiyoshi, Shinji Kosaka, 芳地一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2010.

	Establishment of the appropriate conservation method in consideration of the stability in the blood sample of the P1-236 meropenem Relation corner Yukie, 西端麻莉, Marina Yamauchi, Kana Matsumoto, Kunihiko Morita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2010.

	Construction of the TDM management use system in connection with P1-237 order ring Ko Hiraide stone, Takako Imazeki, Yasushi Yokoyama, Emi Furui, Takeshi Kato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2010.

Utility of the longitudinal contribution of the pharmacist in infection treatment through the P1-238 TDM analysis
Mitsuru Otsuka 1, Yasuyuki Nishikawa 1, 2, Kazumasa Ueda 1, Yoshitaka Kato 1, Mikiko Tsujimura 1, 岡橋孝侍 1, Komori Tamao 1, 野田能成 1, 小西偉雄 1, Tadashi Mikami 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2010.

	Trial of the pharmacokinetic tool making for the purpose of the dose evaluation in the P1-239 high risk medicine Daisuke Ishigaki 1, Choichiro Miyazaki 2, Hideko Yamauchi 2, Rie Miyazaki 2, Rie Ikeda 1, Mitsuhiro Wada 1, Kenichiro Nakajima 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2010.

	Action for the P1-240 antimicrobial agent proper use promotion Minato Saint Ichiro, Yasuko Hayashi, Tomohiro Hayashi, Hirohiko Mishima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2010.

	The need of the TDM enforcement of the anticonvulsant in P1-241 elderly people Yoshimi Yoshikawa, Hidenori child, Kanako Torikai, Now hilum Sakiko, Ritsuko Sakoda, Ryuji Hagiwara, Akira Takada fruit Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2010.

	Investigation about P1-242 theophylline prescription and the blood level measurement Yuko Watanabe 1, 2, Kayoko Maezawa 2, Asako Terashima 2, Junko Kitsu 2, Hajime Kagaya 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2010.

	Digoxin population pharmacokinetics analysis in elderly people for P1-243 medical treatment individualization Ei Yukawa two 1, Miho Yukawa 2, Fumihiro Suematsu 3, Takako Takiguchi 1, Hiroto Ikeda 2, Aki Hatsumi 2, 峯本正夫 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2010.

	Pharmacokinetic analysis of the new tacrolimus sustained-release product in the P1-244 living renal transplantation Nami Yokoya 1, 2, Kokufu Takatoshi 3, Nobuyuki Sugioka 4, 奈邉健 1, Masahiko Okamoto 2, 吉村了勇 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2010.

	P1-244☆ Efforts to TDM standard administration plan of VCM 阪野和重, 三木康弘, 中西俊介, 山内悠起子, 奥本真巳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2010.

	Effect on blood enoxacin density of P1-245 enoxacin chelate baby at metal-containing antacid combination by the pivoxil esterification 今仲洸1, 大鳥徹1, 沖吉慶子1, 岡本佳世1, 瀬川雅彦1, 西脇敬二2, 川瀬篤史3, 岩城正宏3, 松山賢治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2010.

	Utility of the vancomycin component cement beads for the P1-246 renal function degeneracy MRSA patients Yukihiro Kawakami 1, Koji Asaumi 2, Toshifumi Ozaki 3, Sendo Toshiaki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2010.

One patient who performed blood level analysis of Carboplatin in patients with uterine cancer under the P1-247 haemodialysis enforcement
Kazufumi Iwata 1, 2, 合澤啓二 1, Boundary Saori 1, Takako Baba 1, Akiko Akiyoshi 1, Eiko Fukunaga 1, 濱田哲暢 2, 3, Hideyuki Saito 2, 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2010.

Examination about the preparation properties of the P1-248 high dose acetaminophen suppository and the efficacy
Koji Tazoe 1, Takeura Hiroyuki 1, 2, Hiroko Noda 1, Yoichi Ishizuka 1, Mitsuru Irikura 1, Toru Irie beauty 1, Minoru Yoshida 3, Akiko Sadanaga 2, 永田浩泰 2, It is Sachiko 2 in a camp, Eiko Fukunaga 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2010.

	5-FU pharmacokinetics after the TS-1 capsule administration from the nasotracheal tube by the P1-249 simple suspension method Shigeru Tomiyama chapter 1, Muneaki Hidaka 2, 花田法久 3, Chizuko Nakamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2010.

	Examination about the gastrointestinal absorption promotion of the acyclovir with the P1-250 chitosan Ayumi Masuda, Yuko Goto, 合葉哲也, Yuji Kurosaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2010.

	Pharmacokinetics change of immunosuppressive drug mycophenolic acid in the P1-251 growth process Junko Ishizaki 1, 2, Tomoko Tsuda 1, Kan Yukio 1, 2, Arai country three 1, 2, 崔吉道 1, 3, Kenichi Miyamoto 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2010.

Comparison about the elution behavior between the dosage form in the P1-252 Efavirenz preparation
矢倉裕輝 1, Akiko Akasaki 2, Keiko Kaneko 2, Mayu Shibata 2, Reiko Teraoka 2, Shuji Kitagawa 2, Hiroyuki Kushida 1, 吉野宗宏 1, 山内一恭 1, Yoshihisa Honda 1, Katsuya Komori 1, Asako Kamihira 3, Takuma Shirasaka 3, Takeshi Kuwahara 4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2010.

Comparison ... of the plasma ivermectin level of P1-253 Stromectol lock change at examination 2 - simple suspension method of the factor to affect the effectiveness and the tablet administration
山本陽介, 河原匡秀, 宮嶋篤志, 大谷真理子, 小茂田昌代, 廣田孝司
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2010.

	Expression of cytochrome P450 change in the P1-254 adiponectin transgenic mouse Kiyomi Saito 1, Kei Inoue length 1, Eri Sugiyama flower 1, Mutsumi Inada 2, Hitoshi Sato 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2010.

	Relative ... Exxon 19 (deletion) and Exxon 21 (L858R) ... of EGFR mutation in the gene and the Gefitinib therapy in P1-255 patients with nonsmall cell lung cancer Yasuhiro Maeda 1, Shinya Suzuki 2, Tomoko Ogawa 2, Yoshihiro Aoyagi 2, Kojiro Takashima 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2010.

Investigation about weight loss and the cancellation in the CPT-11 administration before and after the P1-256 UGT1A1 genetic polymorphism measurement induction
Tokutome chapter, 谷口亮央, Flat land tax, Yuji Ishio, Miki Katsuragawa, Jun Matsunami, Ryu Kobayashi, 目黒亨治, Muki Ryoji
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2010.

	Association of a blood level and the side effect of irinotecan (CPT-11) in the P1-257 outpatient department chemotherapy Mizuho Kitamura 1, Koichi Hirose 1, Chihiro Takatsu 1, Tsuyoshi Yamashita Shiro 1, Eiji Maruo 1, Junichi Hasegawa 2, 面田恵 1, 前田頼伸 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2010.

	The development of the quick assay of P1-258 CYP2C9 and the CYP2C19 genetic polymorphism and clinical application to patients with childhood epilepsy Yoshiaki Yamamoto, Shigeko Nishimura, Nobuyuki Mishima, 幾見泰洋, Yukitoshi Takahashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2010.

	P1-259 CYP2C19 slow-up and the case that blood tacrolimus levels rose 5 times by changes from itraconazole to voriconazole in CYP3A5 defective Makoto Fujita charges will 1, Tomonori Nakamura 1, 2, Yuko Okada 2, Blue Tooru Mori 1, Takuya Araki 2, Yasushi Yamamoto Jiro 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2010.

Role of patients needs and the pharmacist judging from the consultation record of patients with P1-260 cancer
Tetsuya Yoshida 1, 中尾將彦 1, Naoki Yamazaki 1, Yasutaka Goto 1, Masashi Takeuchi 1, Miwako Yamanishi 2, Junko Ide 2, Koichi Taira 3, Shinya Tokunaga 3, 駄賀晴子 3, Koji Takeda 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2010.

	About the making of the tool of the reporting to the medical institution in P1-261 chemotherapy patients Daigo Suzuki 1, Atsushi Suzuki term 1, Akira Ogawa intellect 1, Goji Maeda 1, Hiroshi Sakata 1, Miho Furuta 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2010.

	Action of this hospital that we deal with P1-262 antineoplastic prescription management addition induction Toshiko Okura, Minako Yoshida, Hideki Okamoto, Kunio Takahashi, Shoji Takagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2010.

	Examination of RDI (relative dose intensity) in the P1-263 outpatient department chemotherapy 中村卓巨 1, Yuji Hayakawa 1, Daisuke Kito 2, Motonori Ito 1, Koichi Okamoto 2, Toshiharu Nomura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2010.

It is ... for burden on patients who received examination - R-CHOP therapy reduction about the mixed administration with P1-264 rituximab and other antineoplastic
Tomiko Tachikawa 1, Takumi Yamaguchi 2, Well hilum Keiko 1, Takashi Egawa 3, 末丸克矢 1, 薬師神芳洋 4, Hiroshi Araki positive 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2010.

	About a pollution status of cyclophosphamide in the P1-265 outpatient department chemotherapy room and the platinum Atsuo Otsuka, Tetsuya Sakamoto, Shuzo Nakamura, Chiaki Koshikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2010.

	Cancellation, examination of a change, the additional reason in the P1-266 this hospital outpatient department chemotherapy on that day 小笠原信敬, Akira Masuda, Sae Takahashi child, Yuji Koyanagi, Koji Okada, Katsuhiko Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2010.

	The action that aimed at the investigation about the TS-1 interruption reason of the P1-267 gastric cancer postoperative adjuvant chemotherapy and the treatment by side effect grade reduction continuation Yutaka Hayashi 1, Nabeta Izumi 2, Midori Kimura 2, 河原崎貴伯 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2010.

	Study on blood pressure fluctuation before and after the anticancer drug administration in the P1-268 outpatient department cancer chemotherapy 町支優和, Motoaki Ishikawa, Masaki Sato, Takahiro Ishida, Masumi Nakagami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2010.

	Examination about the elevated blood pressure at the bevacizumab administration in our P1-269 center Naoya Okumura, Kubokawa Naomi, Kazuhiro Fukami, It is passed through old Masaru Den, Takeshi Noro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2010.

Examination about the tolerability of the Cisplatin administration using short hydration in patients with P1-270 lung cancer
Hideko Isozaki 1, Tomoaki Sato 1, Satoko Fujiwara 1, Satoshi Uejima 1, Kinoura Katsuyuki 2, Masahiro Tabata 2, Nagi Takigawa husband 2, Tanimoto light sound 2, It is still 1 Matsunaga, Sendo Toshiaki 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2010.

	Safety assessment judging from renal function in the Cisplatin component regimen enforcement in the P1-271 outpatient department Okada sum intellect, Eri Abe, 吉村知哲, Daisuke Ito, Shino Adachi, Tomoko Matsuoka, 宇佐美英績, Michio Kimura, Toshiya Nakao, Tadashi Yasuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2010.

	Intervention of the pharmacist to the formulation study by the renal function evaluation in the P1-272 cisplatin outpatient department chemotherapy Hiromi Fujisawa, Takeshi Nakamura will, Ayana Nakamura, 竹内芙実, Mitsue Shindo, 室親明, Takeshi Kimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2010.

	Examination - of the chemotherapy -bevacizumab + s de Gramont therapy in P1-273 progress, recurrent colorectal cancer Minako Higuchi, Koichi Matsuo, Yoshimi Sasaki, Sanae Iwatsubo, Yoriko Wada, Sachi Imaizumi, Hiroaki Nishino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2010.

	An anaphylactic symptom with the mFOLFOX6 therapy enforcement in the P1-274 outpatient department chemotherapy and the measures Toshimitsu Nakayama, Masatoshi Hayasaka, Michiko Kishi, Tatsuya Hayama, Mayumi Takezawa, Zenichi Yoshida, 丹正勝久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2010.

	Action -XELOX therapy support to P1-275 colorectal cancer chemotherapy Lower morning law of nature 1, Chisa Emura up 1, Miki Takara 1, Tokuko Sasahara 1, Shuichi Iwami 1, 1 that is Zao, Yuko Kubo 1, Yutaka Ogata 2, Mieko Tsuruta 3, Michio Sada 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2010.

	Example that Rikkunshito was effective for anorexia with the P1-276 colorectal cancer chemotherapy 篠原義剛 1, Junji Iwashige 2, Hidehiro Kamachi 1, Tei Hara Expo 1, Kojiro Takahashi 1, Hiroaki Morimoto 2, Katsuragi Takefumi 2, Junichi Tsukada 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2010.

Action for the present conditions and proper use of the P1-277 cancer chemotherapy regimen management
Satoshi Yamada sand Kei 1, Masahiko Kobayashi 1, Keiko Hayashi 1, 山際岳朗 1, Hideyuki Motohashi 1, Celebration Chikako 1, Naoto Gondo 1, Kazuhiro Yanagihara 2, Masakazu Toi 3, Toshiya Katsura 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2010.

	Role ... of the pharmacist in promotion - liver cancer sectional meeting of the drug proper use in the cancer sectional meeting according to the P1-278 organ Hiroko Yamaji, Hiroyuki Watanabe, Pond end Hiroaki, Nobuaki Egashira, Ryozo Oishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2010.

"The sorafenib induction critical path" that P1-279 pharmacist played a key role and made
Yasuko Watanabe 1, Existence Reiko Sawa 1, Gain book Shuji 1, Lake Aso Kazuyo 1, Tomoyuki Goto 2, Taste field lawn arrow child 3, Hiromi Fujiwara 3, Dohon Mayumi 4, Yuichi Nakajima 4, Kazunobu Takayanagi 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2010.

	Relation of the pharmacist in the safe use of the P1-280 anticancer drug Hidekazu Sato, Takeshi Sasao, Masumi Mori, Yoshiharu Kato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2010.

	The example analysis that became the stopping dosage after the anticancer drug preparation instructions reputation in the P1-281 electronic chart Hiroshi Goto kernel, 彌冨恵, Ichiro Ota, Hirofumi Koike, 西川能治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2010.

Relation to drug control instruction of the carboplatin paclitaxel bevacizumab combination therapy in P1-282 patients with nonsmall cell lung cancer
Dozu Maiko 1, Yuka Kishimoto 1, Manabu Sakurai 1, Shuji Murakami 2, Tetsuro Kondo 2, 斎藤春洋 2, 尾下文浩 2, Kozo Yamada 2, Akemi Takada 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2010.

	NET EXCEPTION Err: Could not connect to host 岩切詩子1, 2, 林田哲也3, 日高里奈4, 窪田敏夫2, 小林大介2, 林睦子1, 河野徳明1, 末永啓二1, 島添隆雄2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2010.

	Relation as the pharmacist to the chemotherapy in the P1-284 children region Yuka Tanaka 1, Nishizawa jasmin 2, Yokoyama skillful writing 2, Mari Takagi 2, Emi Kadoi 2, Great Xisha cord law of nature 2, Kuni Shinoda University 2, Takao light 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2010.

	Relation of the pharmacist for the treatment of the P1-285 malignant glioma Kenji Miyazawa 1, Hayato Sugimura 1, Makoto Hayashi 1, Akemasa Yamaya 1, Original seal Yoshio 2, Shuichi Akaike 2, 2, Kiyonobu, Ikeda, Aspect shrine Koji 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2010.

	1 case that a pharmacist was able to participate in for P1-286 cancer therapy positively 猿谷淳, Nami Matsui, Maeda Miyuki, Yuka Nakano, 向一美, Ground field Mikiko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2010.

	It is ... about a making - blood regimen of the made-to-order reporting book of the P1-287 cancer chemotherapy about internal medicine Hisashi Miyamori, Miwako Mukai, Mari Fujita, Akemi Takashima, Yumiko Inaba, Tomoyuki Okawa, Hideko Hashimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2010.

	2 cases that was given PAD therapy to patients with P1-288 untreated myeloma Tatsuya Otsubo 1, Kazumasa Ueda 1, Yoshitaka Kato 1, 野田能成 1, Takashi Tanaka 2, Eri Kawata 2, Teru Akoogi chapter 2, Yutaka Kobayashi 2, 小西偉雄 1, Tadashi Mikami 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2010.

	Examination about the risk factor of the hiccup induced at the dexamethasone administration in patients with P1-289 multiple myeloma Tetsushi Kanematsu 1, 宇佐美英績 2, Mitsuru Takai 1, Hitoshi Yoshida 3, Takahiko Ito 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2010.

	Contribution and side effect investigation to selective cisplatin intraarterial injection treatment for P1-290 head and neck squamous cell carcinoma Kyoko Tadokoro, Tomohiro Miyake, Keiki Mori, Manabu Tanimura, Hiroshi Yoshida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2010.

About the experience of the pre-Abo id 3 case in action - outpatient department chemotherapy to the vascular pain reduction by the injection method change of the P1-291 anticancer drug -
Masahiro Yasuda 1, Hiromi Ishihara 2, 坪井謙之介 3, Yumi Kuzutani 3, Osamu Umeda 1, Makoto Sahashi 1, Katsutoshi Goto 1, Teramachi eyes 3, Teruo Tsuchiya 3, Kazushi Yoneta 1, 4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2010.

	The vascular pain at the P1-292 pirarubicin hydrochloride administration is significantly high by the instillation method Takashi Goto 1, Kazuki Tanimoto 2, Furumi Kazuhiro 1, Masahiro Nakano 3, Makoto Ishibashi 1, Seiichi Okamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2010.

	Evaluation - by making of the anticancer drug extravasation label in the P1-293 Suzuka center general hospital and operational - CS analysis Daisaku Kuki 1, 森章哉 1, Shinya Yamanaka 1, Yuka Maekawa 1, Yukiko Kawamura 1, Yumiko Hasegawa 2, Takuya Iwamoto 3, Yuko Nakamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2010.

Effect of the transfusion increase in quantity on vascular pain at the P1-294 oxaliplatin intravenous feeding
Yumiko Goto 1, 2, Iku Kawamura person 1, Masayuki Ejiri 1, 2, Shoko Kinoshita 2, 3, Hiromi Ota 2, 3, Kazumi Yokoi 2, 3, Keiko Ota 2, 3, Hiroko Saito 1, Takaaki Hasegawa 1, Kazuyoshi Suzumura 4, Masahiko Miyachi 4, Field wave Toshiaki 4, Eiji Mihara 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2010.

	Examination of the vascular pain measures regimen in the P1-295 XELOX therapy Mika Tashiro, Hiroko Tai, Kazunori Shimomura, Keiko Yamamoto, Shinichi Kawaguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2010.

	The vascular associated algetic expression situation with the P1-296 XELOX therapy and the measures Atsushi Suzuki term 1, Daigo Suzuki 1, Akira Ogawa intellect 1, Goji Maeda 1, Miho Furuta 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2010.

	Evaluation of the simple transfusion warming law for the vascular pain-like symptom at the oxaliplatin administration in the P1-297 XELOX therapy Atsushi Tomita sum 1, Masahide Matsuzaki 2, Michiko Tatematsu 1, Mitsuyo Nishio 3, 室圭 4, Masao Maeda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2010.

	Single dexamethasone in P1-298 carboplatin combination chemotherapy patients; and is compared the antinausea effect of repeated doses Kozoe kernel, Shishino Yuki, Well hilum Keiko, 末丸克矢, Hiroshi Araki positive Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2010.

	... using evaluation - MASCC Antiemesis Tool(MAT) of antiemetics aprepitant in P1-299 practice medical care, the lung cancer cisplatin combination therapy Kazuo Komatsubara, Matsuhisa Noriaki, Hisae Eguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2010.

Examination about the efficacy of aprepitant for the digestive symptom (nausea, vomiting) with the P1-300 cisplatin (CDDP) administration
Gilt bronze Yoko 1, Tomonori Hirashima 2, Court Security Office Mika 1, Masashi Kobayashi 2, Norio Okamoto 2, Hidekazu Suzuki 2, Yuka Matsuura 2, Shangdong Masumi 1, Yuya Fukuchi 1, Usui Naoko 1, Keiko Fujita 1, Nobuhisa Fukushima 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2010.

Inspection of the efficacy of aprepitant for nausea, vomiting at TS-1, the cisplatin combination therapy for patients with P1-301 gastric cancer
Keiko Komori 1, Tomoi Rieko 1, Takahiro Sugimoto 1, Hiroyuki Nakano 1, Chie Mochizuki 1, 丁元鎭 1, 桝喜惠 1, Nana Aono 2, 吉波哲大 2, Your Akazawa 2 to be constipated, Yukiko Yamamoto 2, Daisuke Sakai 2, 杉本直俊 2, 屋木敏也 2, Fumio Imamura 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2010.

	A use situation investigation of P1-302 aprepitant and examination about the efficacy Keisuke Seto, Yoshihiro Naito, Masahiko Takasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2010.

	Evaluation of the antinausea therapy including aprepitant in patients receiving P1-303 altitude emetic risk anticancer drug 中尾將彦 1, Tetsuya Yoshida 1, Yoko Honda 2, Naoki Yamazaki 1, Yasutaka Goto 1, Noboru Okamura 2, Masashi Takeuchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2010.

	Evaluation of aprepitant in the prevention of nausea, vomiting in the FEC100 therapy of patients with P1-304 breast cancer 芦埜和幸 1, Hijiwara life 2, Taku Asanuma 2, Takeshi Shibazaki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2010.

	About the adverse event that occurred at use of aprepitant in the chemotherapy of the P1-305 emetic risk moderate degree Kazunori Aoyama, Masahiro Ogami, Miyako Shibata, Atsumi Yanaka, Katsuki Kurosawa, Masahiko Shimada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2010.

	Efficacy of aprepitant in the P1-306 EC therapy Masahiro Ogami 1, Kazunori Aoyama 1, Shoichi Mitsuhashi 2, Masahiko Shimada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2010.

Making of P1-307 "Numazu Municipal Hospital antinausea therapy guidelines 2010"
Masako Kondo 1, Akira Nagayama 1, Noriko Kawakami 1, Mitsuaki Suzuki 1, Toru Mano 1, Noge Ichiro 1, 福長徹 2, Masayuki Kimura 2, Tadashi Iioka religion 3, Masami Shinozaki 4, Kosugi sincerity fine weather 5, 金井督之 6, Norikazu Urabe 7, Ryuji Ishikawa 8
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2010.

	Change of the side effect of antiemetics change symptom of the P1-308 gemcitabine monotherapy Mayumi Kaise 1, Shinki Yoshino 1, Yukiko Himeno 2, Hiroshi Hasegawa 2, Mt. end Expo man 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2010.

	Grasp ... of an evaluation and the problems after action (the second report) - antiemetics criteria for use of food additives application for the proper use of P1-309 cancer chemotherapy antiemetics Shinki Yoshino, Mayumi Kaise, Haruki Nagai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2010.

	Fact-finding of the antinausea therapy in the P1-310 nedaplatin component regimen and inspection of the emetic risk 兒玉幸修 1, 2, Norihide Higuchi 1, Egashira Kanoko 1, 2, Mikiro Nakajima 2, Tadahiro Nakamura 1, wisteria Hideto 1, Takashi Kitahara 1, Hitoshi Sasaki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2010.

	Examination of antinausea drug criteria for use of food additives, the modi operandi with the P1-311 aprepitant beginning to use 薬師寺信匡, Ko Tokuda period, Koji Moriya, Kazunobu Takayanagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2010.

	Examination of the efficacy of aprepitant in the P1-312 breast cancer chemotherapy It is still person 1 Tagashira, Matsuhisa Noriaki 1, 原文堅 2, Shozo Osumi 2, Hisae Eguchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2010.

Study about the effect on clinical outcome of the antinausea therapy for nausea and vomiting induced by the cancer chemotherapy in the P1-313 digestive cancer patients and quality of life
Tomoya Komori 1, Chihiro Kawano 1, 2, Tobita evening period 1, 2, Takeshi Hirayama 1, 2, Wasaburo Koizumi 3, Masaichi Kuroyama 1, 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2010.

Examination - of the medical economics of aprepitant in action - altitude emetogenicity anticancer drug administration of the P1-314 Aichi on koro Gee meeting for the study
Masayuki Ejiri 1, 2, Tatsuya Hisada 2, Itakura affinity 2, Mountain Seki wisdom 2, Motoaki Ishikawa 2, Yumiko Oshima 2, 牛膓沙織 2, Yumiko Sato 2, 町支優和 2, Akio Katsumi 2, 3, Takaaki Hasegawa 1, Hiroko Saito 1, 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2010.

	Evaluation of the aprepitant proper use in the P1-315 this hospital Masayuki Okada, Manami Matsuura, Yuka Sugimoto, Hideko Iwamoto, Ryoichi Baba, Shinichiro Mizumachi, Saki Jinnai picture, Risa Nagata, 成末 Masami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2010.

	Examination about the efficacy of aprepitant in the two-drug regimen containing P1-316 cisplatin Naoko Takada, Minato light will, Hideki Nishida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2010.

	Comparison of the antinausea effect before and after the use of NK1 receptor blocker in patients who received P1-317 CIC therapy (CDDP divided doses) Yoshiko Wada 1, Kengo Umehara 1, Keisuke Otsu 1, Young book Azusa 1, 初山多惠 1, Hideki Sato 1, Tooru Hayakawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2010.

	It is ... from the onset of nausea and vomiting situation in ... aprepitant three days administration to think about proper use of P1-318 new antiemetics Yuko Kudo, Kazuyuki Ito, Atsushi Shirai, Kenichi Suzuki, Toshiaki Kato, Michihiro Shino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2010.

	It is ... using nausea investigation ... "nausea diary" of patients who received P1-319 gynecology chemotherapy Ryoko Inuzuka, Yasushi Yamamoto University, Yukio Toyama, Tatsuya Muto, Hiroko Saito, Takaaki Hasegawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2010.

	Action to in-hospital proper use based on P1-320 "antiemetics proper use guidelines" Keiichiro Matsuda, Nobukawa Masao, Saito order, Hiroyuki Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2010.

	About nausea, vomiting measures at the cancer chemotherapy in the P1-321 Fukui Prefectural hospital Mitsue Uno, 坂井伸成, 中村尚未, 佐澤佳彦, Takashi Hiraga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2010.

	Examination of the utility of olanzapine for nausea, vomiting in P1-322 cancer chemotherapy patients Maiko Arai, Takuya Furukawa, Yutaka Kubota, Kazuhiko Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2010.

	Cisplatin - doxorubicin combination therapy - in patients with 2 case - osteosarcomas which a digestive symptom improved by P1-323 aprepitant administration Yoko Hayashi, Tomoaki Sato, Matsunaga still, Sendo Toshiaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2010.

	Evaluation of the gastric cancer chemotherapy given triple-drug therapy of P1-324 aprepitant, palonosetron and dexamethasone 西八重乃, Yuko Fujisaki, Asami Tokutome, Hideki Sugawara, 下堂薗権洋, Tatsuya Yamaguchi, Yasuo Takeda, Katsushi Yamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2010.

	About examination - effect and the side effect of the utility of P1-325 aprepitant - Yukiyo Funakoshi, Miho Yamazaki, Masataka Fukuzawa, Yuko Kubo, Matsuura relationship, Katsuaki Takeda, Tadaaki Ogawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2010.

One patient who responded to aprepitant for delayed-action nausea, vomiting in the MEA therapy for the P1-326 persistent trophoblastic disease
Hiroyuki Isogai 1, Kaori Hirose 1, It is Yukiko 1 in a piece, Taku Miyakawa 1, Toru Koshiishi 1, Sachiko Harada 1, Kiyoshi Okuyama 1, 野平知良 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2010.

	Examination of the antinausea therapy at use of extensive emetogenic anticancer drug in the P1-327 lung cancer chemotherapy 1, Kawabata success 1, Pear Ayumi 1, 廣畑和弘 1, Inside many springs 1, Toshihiko Yamaguchi 2, Soichiro Yokota 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2010.

	Effect on hiccup frequency by the dexamethasone aprepitant combination in the P1-328 cisplatin component regimen Kenji Mori, Sugawara sheath, Sachiko Sahara, Norio Takimoto, 足立守 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2010.

	The present conditions of the use of antiemetics in the chemotherapy of the P1-329 head and neck cancer 藤戸靖久, Sachiko Oda, Ota fence Satoe, Yutaka Ichikawa oneself, 井上慎護, Rie Bando, Miyako Kihara, Hideko Iwasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2010.

	Fact-finding about the antinausea therapy for P1-330 HEC and MEC Yumi Yabuta, Satoshi Yokoyama, Yuko Toyota, Kengo Utsubashi, 只佐正嗣, Akihiko Isogai, Keiko Nakajima, Chieko Ogawa, Yoshihiro still very much, Keiko Yoshida, Hiroko Ota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2010.

	Fact-finding of nausea, vomiting in the P1-331 FEC therapy Makoto Hosomi 1, Aimi Goto 1, Masami Nishihara 1, Mitsuhiko Iwamoto 2, 瀧内比呂也 3, Hiroshi Tamai 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2010.

	Use situation investigation of aprepitant in the P1-332 this hospital Ayako Nakamura 1, Yuka Kobayashi 1, Takashi Yamazaki 1, 日置三紀 1, Ayumu Nozaki 1, Toshiko Aramiya 1, Hirokazu Nakanishi 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2010.

	P1-333 The use situation and usefulness of Aprepitant in the FOLFOX, FOLFIRI ± Bevacizumab therapy 岡澤美貴子, 折井孝男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2010.

	Comparison in approximately the antinausea therapy change in the P1-334 gastric cancer S-1/CDDP therapy Mayumi Ono 1, 外石昇 2, 古澤利紗 2, Akio Murakami 2, 石川稚佳子 1, Kentaro Yamaguchi 3, Takao Katsube 3, Kenji Ogawa 3, Kazunori Watanabe 2, Masahiko Obayashi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2010.

	Antiemetic inspection by the adjustment of steroid doses at the P1-335 chemotherapy enforcement 永野俊玲, Hisae Shinichiro, Yusuke Sato, Toshiharu Asakura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2010.

	Examination about the effect on patients with diabetes of the P1-336 aprepitant dexamethasone combination Kuni Imazu intellect, Hiroyuki Furuta, Masaru Sugawara, Kyoko Nakata, Hu field Masahiko, Masanori Takaoka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2010.

	Improvement effect ... by tardive nausea and vomiting measures - prescription unification of the P1-337 breast cancer chemotherapy Tsutomu Watanabe, Junichi Takano, 1, Morita, Megumi Aizawa, Yuka Ito, Emiko Yokoyama, Keiso Masuhara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2010.

	Evaluation of the antinausea therapy for P1-338 cisplatin-induced nausea, vomiting Eri Kurosaki 1, Yoichi Tanaka 1, 2, Kiyoshi Shibuya 1, 2, Takako Komiyama 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2010.

	An antinausea effect of aprepitant in patients who received P1-339 esophageal cancer FP therapy and effect on treatment Mieko Kishi, Toshiyuki Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2010.

	Effect on drug consumption and patients quality of life by the promotion of the P1-340 antiemetics proper use Yutaka Kubota, Takuya Furukawa, Kazuhiko Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2010.

	Association with a neutrophil count and the oral mucositis severity in the P1-341 esophageal cancer chemoradiotherapy Masahide Sugiyama, Fumi Aoki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2010.

	About association with the blood toxicity and the serum albumin concentration of the P1-342 hydrochloric acid amrubicin 大久保博史1, 高瀬久光2, 内山将伸2, 清水裕彰1, 林稔展1, 冨澤達1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2010.

	Examination of the febrile neutropenia risk factor in the P1-343 hematologic cancer Daisuke Kato 1, Hisakichi Nozawa 1, Masako Sato 2, Nomura order 3, Ishizawa sentence 2, Yagi Tomomi 1, Takeshi Katsuyama 1, Yukio Kishikawa 1, Jin Nakamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2010.

	Side effect expression intensity with P1-344 erlotinib and association of the survival period Hitomi Kawaguchi 1, 2, 寺田智祐 1, 3, Matsubara grammar 2, Toshiya Katsura 1, Kenichi Inui 1, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2010.

	Analysis of the blood sugar level fluctuation that the steroid medicine as antiemetics at the P1-345 cancer chemotherapy gives Sanae Iwatsubo, Koichi Matsuo, Minako Higuchi, Yoshimi Sasaki, Yoriko Wada, Sachi Imaizumi, Hiroaki Nishino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2010.

The examination about the decrease effect of the neurotoxicity frequency with the oral azole-based antifungal agent temporary withdrawal at the P1-346 vinca alkaloid medicine administration sees the rear and analyzes a mark
Yoichi Osato 1, Early part Hiroko 1, 宮松洋信 1, Yumiko Saito 1, Rina Kani child 1, Maki Natsume 1, 横山智央 2, Oyashiki Kazuma 3, Takao Akashi 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2010.

Can P1-347 albumin become the proper use criteria of the platinum-based anticancer drug?
Shunichi Aida 1, Naotake Takase 1, Gutter book Mayuko 1, Takashi Kato children 2, Yoshio Ijiri 2, Kazuhiko Tanaka 2, Hidenori Takahara 3, Tadashi Yokoyama 3, Shigeru Ono tree 3, Nobuyuki Muroi 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2010.

	Examination about the background factor of the granisetron treated patients who developed P1-348 constipation Ability volost Hirohisa 1, 2, 植沢芳広 2, Original Hideki Sawa 1, Mori Kiminori 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2010.

	Examination about the coagulation ability change at P1-349 internal use fluorouracil system anticancer drug and warfarin combination Naoko Tosa, 森穣二, Ikuyo Toyota, Ryuma Sato, Ikegami English sentence Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2010.

	Examination of the kidney protection of the Mg for the P1-350 cisplatin nephrotoxicity Tatsuya Hayama, Masatoshi Hayasaka, Zenichi Yoshida, 丹正勝久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2010.

	Examination about the G-CSF preparation administration for the myelosuppression which S-1 at the P1-351 renal function degeneracy caused 牛膓沙織, Tatsuya Hisada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2010.

	Examination of the side effect frequency in consideration of the renal function in the P1-352 capecitabine remedy patients Mina Iwai, Michio Kimura, 吉村知哲, Tadashi Yasuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2010.

	Effect on renal function by the difference in hydration at the P1-353 cisplatin administration 伊藤剛貴, Seki Daisuke, Yoshiba Mayumi, Furihata cannot come, Shinya Miura, Toru Hibi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2010.

	Relations of a moisture loading dose and renal dysfunction in the P1-354 low dose cisplatin administration Hisashi Takahashi tree 1, Satoru Tamura 2, Manabu Shoji 3, Kozo Suzuki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2010.

	Action to rescue medicine management manual induction in the P1-355 this hospital Junko Nakanishi 1, 2, Yumi Kozai 1, 篠永浩 1, Tsunekazu Harada 1, Tsutomu Kachi 1, Eiji Mukai 1, Ritsuko Shirakawa 2, 3, Aiko Sato 2, 3, Hiroko Noda 2, 3, Atsushi Hosokawa 2, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2010.

	The use situation and problems of the rescue dose for the P1-356 fentanyl patch Yusuke Hara 1, Makiko Takabayashi 1, Yoshiko Takahashi 1, 板井進悟 1, Keisuke Yamada 2, Akiko Marutani 3, 崔吉道 4, Kenichi Miyamoto 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2010.

	Evaluation for the rescue dose of the narcotic analgesic in the P1-357 this hospital Kayoko Yamaguchi, Naoko Takakuwa, 高橋喜統, Small Masaru Hori, Koji Nishio Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2010.

	The opioid rotation enforcement situation in patients with P1-358 cancer pain and the evaluation Harue Okada, Hiroki Tamaki, Norio Doi, Nobuhiro Nishimura, 直良浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2010.

	Relations of the rate of use and the clinical response of the P1-359 opioids rotation 織田梨恵 1, 2, Mikio Chiba 1, 2, 森井博朗 1, 2, Seiko Hattori 2, 遠藤善裕 2, 寺田智祐 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2010.

	Examination about the opioids-induced sedative resistance under P1-360 cancer pain Field road Akihiro 1, Hama table solstice 2, Kunihiko Kagawa 3, Yoshio Kitamura 1, 田伏克惇 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2010.

	Using fact-finding -Rome III about the constipation with the P1-361 opioid analgesic - Mai Nishihara, Yuichi Koizumi, Machiya cheap period, Fujitani Masanori, 禰占奈美江, Negoro early Noriko, Mami Nomura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2010.

	1 case that olanzapine worked for for nausea of the morphine sulfate timed-release tablet that P1-362 prochlorperazine was invalid Kenichi in the new line, Hideyuki Yanagibashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2010.

	The fact-finding of antiemetics used at the medical drug induction in the P1-363 outpatient and future problem Mariko Otsuka, Tomoko Nishimura, Maki Miyazaki, Ayako Ajioka, Koji Fukuda, Miki Imai, Keiko Sakurai, Hiroko Iijima, Osamu Tomishima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2010.

	One patient who showed subcutaneous bleeding in the P1-364 fentanyl MT patch pasting site Takuya Furukawa 1, Yutaka Kubota 1, Motoko Minemura 1, Tokuko Shimizu 2, Kazuhiko Saito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2010.

	An administration route change conversion method of the ketamine hydrochloride in the P1-365 Shizuoka Prefectural Shizuoka cancer center and the evaluation Tomomi Kataoka 1, Tetsu Sato 1, Michihiro Shino 1, 相河明規 2, Iwao Osaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2010.

	One patient who was treated effectively with ketamine administration from gastric fistula for P1-366 cancer pain control Pre-night Miho 1, 2, Onaga Shinichiro 1, Tamotsu Hika 1, Seiichiro Niisato 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2010.

	Examination for the use of gabapentin adequacy as the sedative adjuvant in P1-367 cancer pain Masahiko Irie 1, Yasuhiko Ichida 2, Genei Shinya 2, Yoshihiro Aoyagi 2, Akinori Yanaka 1, Ichiji Endo 3, Shuji Shimada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2010.

	Use experience of bone metastases pain relaxant meta stolon (R) note (Sr-89) in the P1-368 this hospital Minoru Kurihara man Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2010.

	2 cases that used Mohs ointment for P1-369 advanced breast carcinoma, and obtained improvement of the quality of life Kazuhiro Muramoto 1, 2, Eri Yoshikawa 1, 2, History of Tadashi Hatakeyama 1, Yuko Kawakami 2, Ritsuko Honma 2, Noriko Nagase 2, Tsujimoto A 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2010.

	One case of the metastatic skin tumor that the Mohs gauze method which improved an application method of P1-370 Mohs' paste was useful Toshihiro Nakanishi 1, Masaru Kawai 1, Takeuchi 2, Aruki, Ken Ina next 3, Seiji Nagao 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2010.

Examination and effect of treatment - of the pharmaceutics in the clinic of study on P1-371 hospital preparation -1 - Mohs ointment
Yukiyo Hayakawa 1, Kenjiro Inaba 1, Madoka Kita 1, Haruhiko Someya 1, Makiko Fujii 2, 渡邊善照 2, Jun Arita 3, Yoshio Sakai 3, Mochizuki success 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2010.

	The analysis of the doubt introduction about P1-372 anticancer drug preparation and pre-Abo id report 谷之木佑歌, Hiroyuki Yamaguchi, Ito wide commander, Yasushi Sekiya, Rie Ono, Tomomi Iwakiri, Manabu Okumura, Kazuhiko Arimori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2010.

Examination of the doubt inquiry contents in the anticancer drug sterility preparation using P1-373 electronic chart
Side Yukari, 片山歳也, Asako Ito, Asuka Watanabe, Eri Ito, Momoko Hattori, Aspect pine Shinya, Araki A, Yuki Mizutani, Saori Kojima, 野々部崇哉, Mitsuru Fujioka
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2010.

	Relation - as investigation - outpatient department chemotherapy and the team approach in medical care about the doubt inquiry in the anticancer drug sterility preparation in the P1-374 drug department Higashijima good luck way, Junko Ide, Masashi Hashimoto, Yagi Hideaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2010.

	Safety management and evaluation by the use of the P1-375 cancer chemotherapy individual regimen and the preparation memo Naoki Yoshikawa, Yuko Kobayashi, Nobumitsu Iizuka, Motohiko Seyama, Toshio Kosuge Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2010.

Making and evaluation of the in-hospital anticancer drug preparation manual for P1-376 pharmacist and other types of job
Hiromi Hayashi 1, Nawa Hideki 2, Takeo Okada 2, Eiji Kawakami 2, Fine weather field Yusuke 2, Shiho Sugimoto 3, Toshihiro Koyama 1, Kazuaki Shinomiya 1, It is still 2 Matsunaga, Yoshihisa Kitamura 1, Sendo Toshiaki 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2010.

	Development of the simple and easy anticancer drug preparation support system to install in the P1-377 existing safety cabinet Aida Toshie, 山村康比古, Takako Watanabe, 右川浩, Kaori Ito, Yasuda life, Junko Hiroi, Kanichi Kawasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2010.

	A construction and evaluation of the P1-378 anticancer drug sterility preparation support system 大下直宏, Hiroki Kano, Seiko Koike, Natsumi Endo, Mizuho Goto Yasuko, Akira Ueda, 結城祥充, Hiroshi Kuronuma, Shinji Iwai, Katsumi Ito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2010.

	Stability of the dilute solution of paclitaxel in the TIP therapy for P1-379 progress-related germ cell tumors Hideaki Niwata 1, 2, Fumio Itagaki 1, 2, Hiroyuki Hosono 1, 2, Machiko Watanabe 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2010.

	Examination (3) of the quantity of preparation extraction of the P1-380 docetaxel preparation 双樹恵, 岩瀬利康, Yoshio Ito, Tadashi Nagase, Kumiko Okitsu, Mieko Morita, Junko Miyakawa, 長岡匠, Miyuki Suehiro, Minoru Mori Tomoko, Tomoaki Toyama, Chiaki Koshikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2010.

	Examination about the decomposition method of P1-381 albumin-binding paclitaxel (oil xanthan gum (R)) 中山季昭 1, Motohiko Sano 2, Toru Kishino 2, Fumio Iwasaki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2010.

	Comparison of the starting drug and late departure drug with the P1-382 DPC induction 清水裕彰, Minoru Hayashi exhibition, Hiroshi Okubo, Tomisawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2010.

	P1-383 The investigation against the possibility of glass pieces mixed into the Infusor pump 橋本直弥, 望月英明, 竹元友佳子, 若杉裕子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2010.

	Examination of the P1-384 5FU in fuser pump method of dispensing Black liman Takako 1, Tomofumi Okamura 1, Hiroshi Yamazaki 1, 小川丈彦 1, Naoyuki Miyano 1, Shigeharu Oie 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2010.

	Effect of the capacity control type transfusion pump to give to intravenous feeding speed at the P1-385 anticancer drug administration Takeshi Nakamura will 1, Hiromi Fujisawa 1, Masahiro Nakayama 1, Tsuyoshi Azuma 1, Tsuneo Hamaguchi 2, Takeshi Kimura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2010.

Examination of the precision of the portable chronofuser in the P1-386 colorectal cancer chemotherapy
Tomoko Suzuki 1, Kotaro Kawamoto 2, Ayako Kato 1, Tatsuro Fujii 1, Seina Noda child 1, Kadomura Shota 1, Mina Takeuchi 1, Yuko Fukuda 1, It is still 1 Asano, Takashi Aoki 2, Tatsuya Ito 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2010.

	P1-387 Study of the usefulness of "ChemoCLAVE System" (Part 2): About leakage quantitative test using potassium permanganate solution 波多野博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2010.

Approach for the elimination of radiation exposure recognition and knowledge, the maneuver of the pharmacist in the P1-388 anticancer agent germfree preparation
小暮友毅1, 河添仁2, 井門敬子2, 村上通康3, 浅川隆重4, 井上智喜5, 末丸克矢2, 荒木博陽2, 江口久恵1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2010.

	From present conditions - questionary survey of the prevention of anticancer drug exposure in the P1-389 three folds throughout the prefecture Hospital - Tomohiro Miyake 1, 2, Mitsuru Fujioka 2, 3, Masahide Mori 2, 4, Yasushi Kataoka 2, 5, Shinko Okuda 2, 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2010.

Examination -2 about the permeability of the antitumor agents in medical gloves to put on at P1-390 injection mixture preparation
Fold Toyohito 1, 2, Ryoji Yanagihara 1, Katsuhiko Nara 1, Toshihide Abe 1, Takashi Tomabechi 1, Katsuyoshi Nakajima 1, Takao Aoyama 2, Hiroshi Suzuki 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2010.

It is 2 about the anticancer drug pollution in the prevention of exposure objective saline packing administration set at the P1-391 anticancer drug bypass administration
Tomori Nishina 1, New branch Maiko 1, Yuka Kobayashi 2, Hiroki Iwane 2, Yukiko Yoshikawa 3, Kazuki Nagasawa 3, Shinichi Sugiura 4, Hirokazu Nakanishi 1, 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2010.

Safe examination for the radiation exposure of the person of preparation in the 111In of P1-392 ibritumomab tiuxetan (Zevalin (R)) and 90Y-labeled preparation
Yasushi Yoshikawa period, Kinuyo Matsuda, Taeko Suzuki, Noro Mizuki, Shinji Kojima, Artificial pond Mika, Megumi Sugitani, Nagayoshi eyes, West Luo Teruo, Kazuhiro Sase
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2010.

	Utility of the operation to recap for the prevention of P1-393 anticancer drug exposure Takeo Okada, Nawa Hideki, Eiji Kawakami, Fine weather field Yusuke, Atsushi Ogawa, Yoichi Kawasaki, Kazuhisa Yao, Sendo Toshiaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2010.

	Examination of the residual anticancer drug resolution in the safety cabinet using P1-394 photocatalyst Junya Sato 1, 2, Kenzo Kudo 1, 2, Takimoto success 3, Three Masayuki Hayashi 4, Pheasant nose Ichiro 5, Katsuo Takahashi 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2010.

	Utility of the closed system system in a series of work from an anticancer drug preparation in the cottage-hospital out of P1-395 to the disposal Izumi Ouchi, Katsuaki Arai, Kaoru Nakamura, Noriko Shimizu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2010.

Closed quantitative examination in the P1-396 closed system drug mixture appliance
宮松洋信 1, Yoichi Osato 1, Tanaka 1,000 greens beauty 1, Sachiyo Sudo 1, Fumiko Maruyama 1, Iga Chinatsu 1, Early part Hiroko 1, Momoko Tomioka 1, Komi Yoshiyuki 1, Akira Miyazato bud 1, Toshihiko Hirano 2, Takao Akashi 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2010.

	It fluctuates at preparation usability, preparation time with the P1-397 anticancer drug closed system preparation system induction and investigates it Takashi Motoki, 菊池謙宏, Yasuhiro Tanaka, Kiyoto Watanabe, 千田泰健, Hiroyuki Shinagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2010.

	Examination of the performance of the P1-398 PhaSeal(R) system new model protector "protector so RAS" Kazuo Sugita, Akane Hagino, Wataru Suzuki, Tsuyoshi Aoyama, Toshihiro Hama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2010.

	Operation situation investigation after the P1-399 closed system drug mixed system induction Toshiko Hoshika 1, Takuya Yano 1, 福岡竜逸 1, Ochi success child 1, Takako Fujita 2, Mika Aoki 2, Kato three Eiko 2, 松原常起 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2010.

	Action for the prevention of anticancer drug exposure to P1-400 this hospital Taguchi poetry rare child 1, 菅原馨悟 1, Kei Sasaki 1, Jin Yoshida 2, Shigeki Koda 3, Hisao Kanazawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2010.

	Setting ... of reconfirmation and the evidence level of reevaluation - literature of the P1-401 cancer chemotherapy regimen City storehouse Daisuke 1, 2, Hisashi Shimizu example 3, 牧野好倫 4, Akiko Sakashita 5, Hiroshi Yamamoto 4, Minoru Sakata 1, Junichiro Murayama 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2010.

	The induction of the evidence level in the P1-402 regimen examination and the evaluation Kazuto Sato 1, Toshiyuki Hirai 1, Yasushi Akiyama 1, Seki Toshikazu 1, Kamiga Masahiro 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2010.

	Evaluation for the contribution of the pharmacist in the P1-403 cancer chemotherapy regimen registration 金素安, Naoki Kinjo, 閔貴善, Chie Okazaki, Kazuyo Shimojima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2010.

	Problems of the P1-404 cancer chemotherapy regimen order ring system induction Junko Arima 1, Yuka Arima 1, Yoshihiko Shibayama 1, 2, 下堂薗権洋 1, Yasuo Takeda 1, Yoshifumi Kawano 3, Katsushi Yamada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2010.

	About information sharing by the collection of P1-405 pocket edition chemotherapy regimens making Koga good luck greens 1, Ayumi Nakao 1, Rie Ueda 1, Miyuki Sakurai 1, Hideko Nakagoshi 2, Shino Hisashi Hara 3, Eiji Fukui 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2010.

	An action and evaluation of the pharmacist for the safety management of the P1-406 cancer chemotherapy Tomokazu Fujii 1, 2, Kenichi Nomura 1, 澤柳直樹 1, Haruhiko Nakamura 1, 岩瀬定利 1, Hisashi Kamiya line 1, Tetsuo Adachi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2010.

	Problems of the regimen use in the checking prescription duties (2) - this hospital in the P1-407 cancer chemotherapy and discussion ... A in the hill, Kazuhisa Tsu Minoru, Tomohiro Otsuki, Toshi Tanaka, Masuo Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2010.

	P1-408 Cancer chemotherapy optimized to the towards efforts Part 5 It can be seen from the enforcement frequency survey of adaptation regimen 中村勝之1, 2, 野田師正1, 2, 加藤淳二2, 3, 中田浩雅1, 宮本篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2010.

	Action of the chemotherapy regimen reporting through the P1-409 prescription Yumi Tsuchiya, Junko Shimomura, Masahiro Tsuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2010.

	P1-410 Safe comparison of the pre-print injection prescription and electronic chart system in the anticancer agent order 平野真健, 岸川春樹, 下河邉安妃子, 曽我弘道, 小田原由香, 増田和久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2010.

The making of the check sheet to perform the correct, effective checking prescription of the P1-411 temozolomide capsule and the evaluation
Kiyotaka Omori 1, Akiko Kochi 1, Tomoko Shimazu 1, 杉本司 1, Yusuke Noguchi 1, Keiji Matsumoto 1, Yoko Tokuyama 1, Hiroyuki Takakura 2, Wicket Minoru Oka 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2010.

	For the establishment of the safety management system of the anticancer drug that P1-412 is new induction - of - identification management drug adoption registration system Satoru Kato next, 金正煥, Seiichi Ito, Takamitsu Akita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2010.

	It is systems construction to becoming it regimen order internal use, the injection in the P1-413 anticancer drug prescription at the same time Mt. Ishii husband, Tsuyoshi Suzuki, Namba existence intellect, Consider among outsiders; a husband, 宇野司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2010.

	About the protocol registration system induction in the oral P1-414 anticancer drug 正置耕一, Mutsumi Yoshioka exhibition, Kondo ten thousand Yumi, Tomoji Ishizu, Sachiko Kaji, Noriko Morimoto, Yoshimi Ogawa, 渡雅克 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2010.

	Use on the electronic chart without induction and the regimen system of the cancer chemotherapy regimen in the cottage-hospital out of P1-415 Kasumi Suzuki, Maiko Nakao, Yoshiko Ikeda, Mai Nishikawa, Tomoko Sakamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2010.

	Approach aiming at improvement of the quality of the P1-416 cancer chemotherapy prescription checking 星野真之, 星野寿恵, 梅野友子, 小池恭士, 郷原哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2010.

	Examination (1) about the drug scattering to the gown at the P1-417 anticancer drug preparation Maiko Kondo, Risa Kuwahara, Naomi Nakajima, Shibata Kei greens child, 椿井朋, Makoto Nakao Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2010.

	A change of the injection antimicrobial agent consumption by induction of P1-418 DPC and the electronic chart induction and effect on susceptibility for Pseudomonas aeruginosa Kiyoko Tanimura, Seiji Onda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2010.

	P1-419 antimicrobial agent consumption and chemosensitive correlation 樗木智聡 1, Yuichi Izumi 1, Satoshi Kamoshita 1, Long Yuji Mine 2, Koji Fukuda 3, Mitsuru Kikuchi 4, 篠原由憲 1, Osamu Tomishima 3, Masashi Shimomura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2010.

Examination about the detection situation of the ESBLs-producing bacteria in the P1-420 East Hiroshima 8 institution and the factor
Masako Yasuhara 1, Takeji Yokota 2, Kumiko Doi 3, Kumiko Urabe 4, Keiko Hara 5, Tetsuo Tomita 3, Tetsuko Ito 6, 武郷徹 7, Daisuke Hira 1, 橋本佳浩 1, Sawa Akihiro 8
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2010.

The consumption of the antimicrobial agent in the P1-421 this hospital, the count of the dosage regimen and investigation of the chemosensitive rate
Toshiaki Onuki, Yoshihiko Matsuki, Yumi Matsumoto, Asami Yasuda, Tatsuya Suzuki, Akiko Shinoda, Hiroko Asai, Takahashi Yuka, Noriko Mishima, Arinobu Yumi, Noriko Iwasa, Kemuyama Yukiko
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2010.

Adoption of the antimicrobial agent using the P1-422 test for drug sensitivity
Morihiko Terashi 1, 野間口寛 1, Reiko Kirino 1, Tomohiro Kakimoto 1, Takeshi Takahashi 1, Middle Yuka Kihara 1, Toyosumi Ayako 1, West Kyoko Tsuji 1, New top Kanako 1, Hiramatsu sheath or 1, Chikara Kuroki 2, Eiki light 2, Kaoru Yamazaki person 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2010.

The antimicrobial agent consumption in the P1-423 Kanagawa throughout the prefecture 6 institution and chemosensitive examination
Shuichi Matsui 1, Shusaku Noguchi 2, Hinako Kosaka 1, Makoto Usuda 3, Ayako Suzuki 4, Ayumu Sato 5, Toru Morita 5, Yayoi Iwasaki 6, Junko Makino 6, Hiroshi Hara person 3, Hiroshi Tanaka period 7, Shun Igarashi 8
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2010.

	A change of the injection antimicrobial agent consumption by the P1-424 generic medicine induction and effect on in-hospital isolate Masayuki Maeda 1, Miura Liao child 1, Chika Kawahara 2, Kentaro Uejima 1, Tadao Inoue 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2010.

The effect that the intervention of the P1-425 infection control team gave to antimicrobial agent consumption and Pseudomonas aeruginosa susceptibility
村田龍宣, Honda Azusa, Xiacheng Sayo, Shinnya Horie, History of Sanmatsu field, Yasushi Meguro, Kyoko Kumagai, Keiichi Ono, Mitsuhiro Yoshimura, Shinji Honda, Masaru Ono, 平田敦宏, Imagawa grammar
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2010.

A consumption investigation and Pseudomonas aeruginosa resistance ratio of the injectable antimicrobial agent using ATC/DDD system in the P1-426 Tokai district
望月敬浩, Takumi Umemura, 片山歳也, Yuichi Muraki, Waterfall Hisashi, Takao Omagari, Yuka Yamagishi, 三鴨廣繁, Ken Mori
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2010.

	The effect that induction of P1-427 Antibiogram gives to infection treatment Yukako Tomota 1, Akiko Kaneko 1, Inubushi thickness husband 1, Haruka Fujise 1, Hiroshi Soeda 1, 2, Katsumi Chiba 2, 3, 中村造 2, Kumi Sato 2, Yumiko Kusama 2, Takao Akashi 1, Tetsuya Matsumoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2010.

	Relative comparison between antiPseudomonas aeruginosa medicine consumption (AUD) and drug resistance between the P1-428 ward Akiko Watanabe 1, Kunio Kato 2, Ayako Sudo 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2010.

	Action to P1-429 carbapenem system antimicrobial agent proper use Manami Kurita 1, Aya Maeda 1, Ai Nakajima 1, Toshiyuki Kadoi 1, Atsuhiko Sakamoto 2, Toshitaka Muto 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2010.

	Examination about a dose, the number of dose of the P1-430 carbapenem system antimicrobial agent (meropenem) Aspect shrine Koji 1, Kenji Miyazawa 1, Makoto Hayashi 1, Akemasa Yamaya 1, North Toshiyuki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2010.

Associated evaluation of the use density of the carbapenem-based antimicrobial agent in P1-431 children, the neonatal ward and the resistant Pseudomonas aeruginosa detection
Yasuhiro Saeki 1, 2, Kazuhito Imai 2, 3, Obtain Sugawara; Risa 2, Atsuko Moriya 2, 4, 安藤常浩 2, 4, Masanobu Odaka 1, 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2010.

	Fact-finding of problems for the proper use of the P1-432 carbapenem system antimicrobial agent Kimiko Nakayama 1, Tsuyako Fujie 1, Kazuyo Sawaguchi 1, Keiichi Uemura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2010.

	Utility of an adequacy evaluation and the antimicrobial agent surveillance of the carbapenem-based antibiotic therapy using P1-433 PK-PD parameter Yoshikazu Kobayashi 1, Seiya Kamino 2, 土屋整也 3, Koji Ikuta 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2010.

About the utility of the permission system asking a specialist in infection for consulting with use of P1-434 carbapenem system antimicrobial agent application in the first time
Kazuhiro Hirano 1, 2, 祖川倫太郎 1, Kawano sentence 1, 中野行孝 1, Zenzo Nagasawa 2, Yukiko Mihara 2, Asami Fukuoka 2, Yosuke Aoki 2, Fujito Expo 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2010.

	Use situation investigation for the purpose of the antifungal agent proper use based on P1-435 guidelines Aiso Hiroshi, Minako Mori, Haruka Iida, Seiichi Kobayashi, Emiko Iguchi, Takahashi Hiromitsu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2010.

	Effect of the macrolide small quantity chronic administration on respiratory infection of the P1-436 neuromuscular disease intractable disease prolonged hospitalization patients 佐野晃宏 1, Natsuko Ishida 1, Kazumasa Murakami 1, Kazuya Takahashi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2010.

After P1-437 surgery about use situation - postoperative infection prevention antimicrobial agent of the antimicrobial agent in the ICU admission patients -
Hiroshi Kawaguchi 1, Junko Abe 1, Takeshi Nishikawa 1, Katsuya Nagayama 1, Mountain village kernel 2, Fossa side Yasumitsu 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2010.

	Use fact-finding of the antifungal agent in P1-438 blood disorder Hitoshi Yoshida, Satoshi Aoyagi summer, Masato Matsuura, Akie Kobayashi, Isono Junichi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2010.

	Action by the many types of job that P1-439 antimicrobial agent consumption decreased Hidekazu Takamatsu 1, 宇都仁惠 2, Akemi Nonaka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2010.

Action of this hospital ICT about the proper use of the P1-440 antiMRSA medicine
Kuto chapter wide 1, 宮良高維 1, Shingo Hirakawa 2, Tomohide Matsushima 1, Hirofumi Toda 1, Yasuko Komiya 1, Motoi Nishio 3, Venus intellect world 3, U.S. book Keisuke 3, Kanako Miyachi 2, Masako Ieda 2, Yumiko Inoe 2, Morihiro Nomura 2, Kazu Tanaka beauty 1, Rika Yoshida 1, 山口逸弘 1, Yuzuru Yamazoe 2, Hiroyuki Morishima 3, Kenzo Moriyama 2, Yoshinori Takeyama 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2010.

	Enforcement of the core ICT round using the P1-441 infection Web system Saori Hashiguchi, Fujiwara fine weather summer, Asami Mori, Miyako Kanazawa, Tomiko Wakiyama, Koji Hashiguchi, Tsuyoshi Machida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2010.

	About P1-442 MRSA surveillance Hideyuki Yanagibashi, Kenichi in the new line Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2010.

	Intervention for P1-443 blood cultures-positive patients 石田茂伸 1, Kayo Maeda 1, Yuka Nakai 1, 楠本茂雅 2, Toshio Oshima 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2010.

	Examination of the effect by the pharmacist participation in planning to P1-444 infection treatment Yuko Takada 1, Tomoko Matsuoka 1, Tadashi Yasuda 1, Hiroko Asano 2, Ishigo Shiomi 2, Atsushi Iriyama 2, Shindo length 3, Yoshinori Fujimoto 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2010.

	Use of injectable antimicrobial agent all patients utility by the P1-445 ICT pharmacist of a check Takashi Niwa 1, 2, Akio Suzuki 1, Satoshi Omori 1, Mitsuru Yasuda 2, 太田浩敏 2, Ayumi Fukao 2, Katsuhiko Matsuura 1, Satoshi Murakami male 2, Yoshinori Ito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2010.

	Present conditions report of the ICT induction in the P1-446 Kusatsu General Hospital Gen Nakajima line, Kazushi Nishide, Hideko Iwasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2010.

	Evaluation of the action for the P1-447 antimicrobial agent proper use Maiko Hashimoto 1, Katsuhiro Nagai 1, Yoshihiko Katsuyama 1, Eriko Kasuga 2, Shinichiro Kanai 2, Yasuyuki Momose 1, 1, Sakae, Omori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2010.

	Examination of the system aiming at the present conditions and rate of use improvement of the TDM enforcement of the P1-448 antiMRSA medicine Mariko Negishi 1, Mari Hosaka 1, Hiroshi Matsuzawa 1, Funatsu Kumi 1, Nigorigawa Hiroko 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2010.

	The use of P1-449 linezolid actual situation and pharmacist function 上田賢太郎, 塩地聖一, 水野恵司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2010.

Introduce the check list by the ICT pharmacist at the beginning of effectiveness of the linezolid in the approach of the P1-450 proper use and safe evaluation - use; and ...
一ノ瀬直樹1, 2, 天野雅子1, 3, 横沢隆行1, 4, 土橋直子1, 5, 米沢牧子1, 2, 南山絹江1, 5, 芝崎健志1, 2, 青木茂行1, 3, 小林隆1, 6, 木津純子7
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2010.

	Examination of the use of P1-451 linezolid situation and the proper use 北村正樹, 奥津利晃, 染谷雅弘, 川久保孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2010.

The in-hospital round enforcement by the ICT team aiming at prevention of role - drug resistance of the pharmacist in the P1-452 infection control, antimicrobial agent proper use promotion and the effect
Takehiro Yamada 1, Tsuyoshi Miyamoto celebration 1, Hiroko Yamashita 2, Reiko Oyamada 2, Nobuhisa Ishiguro 2, Takeshi Iseki 1, 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2010.

	Practice of the antimicrobial agent proper use based on P1-453 PK/PD theory and the effect Takeshi Kimura 1, 2, Worth Chongwen 1, 2, Naoko Takahashi 1, 3, Saikai life 2, Former river Rie 2, Masako Tsukada 2, Kimura Shuya 2, Hidemi Sasaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2010.

Intervention effect of the pharmacist to de-escalation for the proper use of the carbapenem-based antimicrobial agent in P1-454 serious case infection treatment
Aono Hironao 1, Yagi Tatsuya 1, 2, Shiyo Yamada wide 1, 2, Yamakawa flower Akemi 1, Takafumi Naito 1, Junichi Kawakami 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2010.

Promotion of the antimicrobial agent proper use based on P1-455 infection measures committee, ICT, drug committee and PK/PD theory by the cooperation of drug control instruction duties
Mai Okazaki 1, Sachiko Saito 1, Saori Isa 1, 澤畠孝幸 1, Slightly dried fish Yuka 1, Masashi Onozaki 1, Yoshifumi Aoyama 1, Takeshi Nawa 2, Atsushi Shinagawa 2, 後藤達宏 2, Yasunori Watanabe 2, Shinji Hirai 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2010.

	Action for the antimicrobial agent proper use based on the P1-456 PK-PD theory Daisuke Kameshima, Daichi Shibata, Mitsuru Sugiura, 足立守 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2010.

	Effect on renal function with the direction for use dose change of P1-457 Levofloxacin 丹代恭太, Susumu Kudo, 蒲澤一行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2010.

	Association between use pulse-taking and trend of the drug resistant bacterium of the oral P1-458 antimicrobial agent Masako Tsukada, Former river Rie, Takeshi Kimura, Worth Chongwen, Saikai life, Yoshiko Egashira, Kimura Shuya, Hidemi Sasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2010.

	Trend of the use of P1-459 antimicrobial agent situation and levofloxacin-resistant Escherichia coli 滝波昇悟, Auditor Hideo, Akemasa Imamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2010.

About the present conditions of the HIV treatment in the P1-460 Himeji medical center about - HAART therapy -
Shigeki Takematsu 1, 2, Yoriyuki Kawato 1, 2, Masamichi Shuji 1, 2, Katsuaki Kobayashi 1, 2, Kiyoko Fujii 1, 3, Yumiko Morita 1, 3, Tokiko Saegusa 1, 3, Atsushi Tsuda 1, 4, Mimori Yasuyuki 1, 5, Tomoko Katsuta 1, 5, Yoshiro Mochizuki 1, 5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2010.

From present conditions and this of Clostridium difficile association diarrhea / enterocolitis (CDAD) treated patients in the P1-461 Nagaoka Red Cross Hospital
Kenichi Kobayashi, Masanori Abe, Hiroshi Nakazawa, Star Shuichiro, Kumiko Nagai, Akemi Kawakami, Kumiko Shioiri, Kuniko Takahashi, Takeaki Nishibori
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2010.

	Examination about the effect of the antituberculous combined medication in the VCM internal use treatment for the P1-462 C.difficile-related diarrhea Keiko Fujita, Hiroyuki Iwata, Rie Tamura, Court Security Office Mika, Gilt bronze Yoko, Teruhisa Ishikawa, Nobuhisa Fukushima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2010.

	Evaluation of the P1-463 teicoplanin high dose loading dose Mari Hirabayashi 1, 2, Kazumi Taguchi 2, Mikako Namiki 1, 2, Hiroshi Tanaka period 1, 2, Kazuhisa Ugajin 2, Your forest sect 2, Toshitaka Takenouchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2010.

	Comparison ... of efficacy of the antiMRSA medicine in patients with P1-464 blood cultures-positive febrile neutropenia and safe - TEIC and VCM Hiroko Yamauchi, 野村久祥, West Keiji, 永井茂, Takao Shinohara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2010.

Examination about the treatment with antifungal agent to patients with central venous catheter-associated blood flow infection with P1-465 Candida
Lower Ida Akina 1, 2, Makoto Kimura 1, 2, Satoshi Yamano group 1, 3, Taguchi chrysanthemum Hisako 1, 4, Tadashi Yoshida dragon 1, 5, Kaori Shibata 2, Chiharu Kagawa 2, Takashi Sawazaki 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2010.

	One case that VRCZ internal use succeeded for switch therapy after the L-AMB administration for candidemia of the P1-466 ventriculoperitoneal shunt deuteropathy Keisuke Takada, Samura A, 1, Kotobuki, Sekine Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2010.

	The situation of patients with HIV infection and the patient compliance instruction in the P1-467 Aomori Prefectural center Hospital Ayaka Narita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2010.

Action for the hand hygiene of the P1-468 pharmacist and the procedure acquisition of the personal protector
Katsutoshi Takada 1, 2, 3, Atsushi Hasegawa 1, 2, 4, Mutsumi Kawamura 1, 2, 5, Chizuru Komine 1, 2, 6, Eri Kamiya 1, 2, 7, Hitoshi Chiba 8, 仲佐啓詳 1, 4, 9, Tadanori Sasaki 1, 2, 10, Hideyuki Shimizu 1, 11
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2010.

	Examination of the nutritional management using the hyperalimentation kit preparation in the P1-469 perioperative period Akiko Yoshiike, Eiji Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2010.

	Examination of the necessary amount of energy in the TPN of P1-470 elderly people Asami Yasuda, Yumi Matsumoto, Toshiaki Onuki, Tatsuya Suzuki, Akiko Shinoda, Hiroko Asai, Takahashi Yuka, Noriko Mishima, Arinobu Yumi, Noriko Iwasa, Kemuyama Yukiko, Yoshihiko Matsuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2010.

	Attitude survey about the electrolyte administration in the P1-471 TPN preparation Akihiro Hayashi 1, Island ノ江千里 2, 岡橋朋世 2, Toshihiko Mizuta 3, Fujito Expo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2010.

	The present conditions and measures of the electrolyte abnormality with suspected the P1-472 chemical Satoko Kimura 1, 勝浦譽介 2, Ayako Kogo 3, Yasuko Kiuchi 4, Fusako Yoshino 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2010.

	The risk of the hypophosphatemia in the hyperalimentation for patients with P1-473 renal failure Satoshi Kosaka 1, Akiko Ueda 1, Kiyoshi Okuyama 1, Noriko Yoshikawa 2, Masaharu Yoshida 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2010.

	Two cases of the copper deficiency that occurred during P1-474 enteral feeding therapy enforcement Kunihito Kochi 1, Mountain Yuji Sawa 1, Wakako Honma 1, Takashi Fukui person 2, Hirohiko Nakamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2010.

	Examination about the long-term nutritional management using P1-475 half solidity nourishing food recovery Newt lied (R) Yo Sato incense 1, Yutaka Inoue 1, Ikuo Kanemoto 1, 佐藤眞治 2, Harunobu Iwase 3, Kazuo Nakamura 3, Reiko Iwase 4, Masaaki Oshita 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2010.

	Basic study on gastric emptying by the half solidification of the P1-476 enteral nutrient 戸田州俊, Yuriko Nimura, 西岡宙太, Nobuko Umemura, Hiroyuki Sato, Risa Kanie, 豊田行康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2010.

The effect that a change gives to psychiatric symptoms, medication adherence and treatment satisfaction on risperidone sustained release injection from an oral agent of the P1-477 antipsychotics
Kayoko Mizutani 1, 佐々木淳輝 1, Azusa Kato sand 1, Italy Ami Saji 1, 有満征伸 1, Ippei Takeuchi 1, Hiroyuki Kamei 1, Tsutomu Yoshida 1, Tadashi Nagamatsu 1, Koji Ezaki 1, Iwata relation straight 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2010.

	The use situation of the P1-478 risperidone sustained release injection Yuko Abe 1, Kenzo Miyazaki 1, Koba Sani beauty 1, Asako Endo 1, 趙岳人 2, Koichi Oda 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2010.

From the follow-up of 18 continuously administered in efficacy and safe - Oizumi Hospital of the P1-479 risperidone sustained release injection -
Yasuko Matsuda 1, Mika Usuda 1, Miki Otsuki 1, Kyoko Nagai 1, Kazuko Nakajima 1, Chieko Miyawaki 1, Rumiko Chatani 1, Sawada method British 1, 2, Saito hundreds of branches beauty 3, Ko Watanabe Ichiro 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2010.

	Use of P1-480 new antipsychosis, medicine sustained release injection preparation investigation Takako Toi 1, Hitomi Horikawa 1, Tomoki Ichikawa 1, Kimiko Kitahara 2, Masato Suzuki 2, Naoki Iimura 2, Ritsuko Nishizaki 2, Koichi Ito 3, Ryoji Matsubara 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2010.

	P1-481 Comparison with the long-term administration test results and hospital prescription status of Risperdal Consta 木藤弘子, 国見美紀, 安高由起, 立松美代子, 山川琴江, 力丸友里, 石田保美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2010.

	P1-482 About actual use of Risperdal Consta injection in prefectural Dazaifu hospital 中川伴子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2010.

Remedy-related comparison - by the taste evaluation (1) - human sensory evaluation of the P1-483 risperidone internal use liquid
Isurugi Ikuko 1, Mitsuru Takahashi village 2, Kazumi Hayashi 3, Chihiro Hayashi 4, Tooru Mori 2, Etsuko Arai 5, Masahiko Shida 6, Miki Sato 1, Koji Saito 7
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2010.

Correlative evaluation - of taste evaluation (2) - human sensory evaluation and the taste sensor study of the P1-484 risperidone internal use liquid
Mitsuru Takahashi village 1, Isurugi Ikuko 2, Yosuke Ohashi 3, Hiroshi Nishibe 4, 曽我師賢 2, 彦阪剛 5, Hitomi Horikawa 6, Well bird Keiichi 7, Koji Saito 8
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2010.

A side effect and investigation about the cause that are hard to be manifested in the medical treatment of the P1-485 schizophrenia patient
Azusa Kato sand 1, Italy Ami Saji 1, Kayoko Mizutani 1, 佐々木淳輝 1, 有満征伸 1, Ippei Takeuchi 1, Hiroyuki Kamei 1, Tsutomu Yoshida 1, Tadashi Nagamatsu 1, Koji Ezaki 1, Junji Uno 2, Kiyoshi Fujita 2, Goji Kitajima 3, Hiroshi Naito 3, Iwata relation straight 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2010.

	The thing which we saw than the side effect investigation to P1-486 schizophrenia patient Yasuhiko Hashimoto 1, 2, Satoshi Terawaki 2, Valley water Tomomi 2, Kazuhiko Saito 2, Tensho era Masami 3, Eri Masaki 2, Miki Takahashi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2010.

	P1-487 The prescription situation of the sleeping drug of patients with schizophrenia in Wakahisa Hospital 中山智美1, 萩尾美代1, 生嶋つる江1, 田口美恵子1, 長友美保子1, 上妻万智子2, 神村英利3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2010.

	Prescription investigation about the medical treatment of P1-488 schizophrenia Megumi Shibuya 1, Kohei Kitagawa 2, 3, Yoshihisa Kitamura 2, It is still 1 Matsunaga, 3, Sendo Toshiaki 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2010.

	It is ... for the insulin therapy that is effective by attitude survey - security of the nurse about the P1-489 insulin therapy Rika Tomita 1, 2, Kumiko Ohara 1, Michiko Kishimoto 1, Kanako Ukita 1, Hitomi Nomura 1, Yukimi Kinugasa 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2010.

	The use trend of the P1-490 diabetes therapeutic drug and effect on effect of treatment Kazuhiko Okamura 1, Tomomi Naito 1, Aya Fujimoto 1, Masaaki Ikemoto 1, Ayako Ishida 1, 佐々木雄啓 1, Sanuki Hideko 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2010.

	Use investigation of the P1-491 DPP-IV inhibitor (sitagliptin acid salt hydrate) 野口景子, 葛葉守, 久嶋真紀子, 中野玲子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2010.

	An evaluation and patients background factor of the hypoglycemic action of the P1-492 DPP-4 inhibitor sitagliptin 武市佳己, 井門敬子, 末丸克矢, 荒木博陽 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2010.

	P1-493 Evaluation of the usefulness of sitagliptin in patients with type 2 diabetes 原直己 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2010.

	Change of dose of glimepiride with the use of the P1-494 sitagliptin and HbA1c 近藤洋一1, 宮津美紀1, 宮原留美1, 亀島大輔1, 滝本典夫1, 杉浦剛司1, 杉浦充1, 足立守1, 林良成2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2010.

	Examination about change and the side effect of HbA1c of P1-495 incretin association preparation Step Masaaki Hayashi 1, Anzai 1,000 folds child 1, Valley long Minako 1, Shogo Nakamura 1, 杉本更絵子 1, Yukihiro Hayakawa 1, Hiroshi Yasuda Ichiro 2, Kazue Takahashi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2010.

	Importance of the instruction method that performed assessment of a lifestyle and the adherence for P1-496 diabetes education inpatients Mera spirit Ichiro, Kamura Motoki, Naoya Ueno, Kioroshi Shiori, Natsuko Hashimoto, Hiroshi Yoshimatsu chapter, Fukushima connection Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2010.

	Analysis of sex differences of the effect to give to carbohydrate metabolism of the statin in patients with P1-497 type II diabetes mellitus and the factor Chigusa Kikuchi 1, Mari Kato 1, Moat Hideo 1, Takashi Kato 2, Imaeda Kenro 2, Naoji Okayama 2, 松永民秀 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2010.

	Elucidation of sthenia of the oxidative stress in the femoral artery of the P1-498 type I diabetes mellitus model rat and the mechanism Moat Hideo 1, Chigusa Kikuchi 1, 永味千枝 1, Masayoshi Takeuchi 2, 松永民秀 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2010.

	Effect by the change on Glimepiride from glibenclamide in the P1-499 this hospital Matsuda law of nature beauty 1, Kyoko Kataoka 2, Tomoko Hirayama 2, Satoshi Kataoka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2010.

	P1-500 Basic study of the glycogenesis metabolism improvement effect of the nateglinide 佐藤寛之1, 二村由里子1, 梅村展子1, 戸田州俊1, 水谷佳成1, 三輪一智1, 北原吉朗2, 三浦恭子2, 豊田行康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2010.

	The proper use investigation for patients with renal failure of the P1-501 metformin hydrochloride and analysis of the risk factor of the onset of hypoglycemia Tomimatsu Noriko, Norihide Higuchi, Tadahiro Nakamura, wisteria Hideto, Takashi Kitahara, Hitoshi Sasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2010.

Application ... to patients with early renal disease of participation in medical treatment - Kremezin (R) for the patients with diabetic nephropathy for the purpose of the P1-502 dialysis induction delay
Kosuke Suzuki 1, Akihiro Nakamura 2, Masayuki Obayashi 1, 小林靖奈 1, Junichiro Murayama 3, 山元俊憲 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2010.

	Standardization of a pregnant woman, the nursing mother instruction using a P1-503 Kikukawa City general hospital and the brochure in the Ogasa Pharmacist Association health insurance pharmacy Kumi Matsushita 1, Tomio Yamazaki 2, Yuichi Aono 2, Toshiaki Kitagawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2010.

	Action to "nursing and the making of the medicine" explanation booklet that made an opinion of the P1-504 nursing mother reflected Yoshiko Fukazawa, Yoshida lily, Akira Goto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2010.

Action for the making of the P1-505 "in-hospital use guideline about the drug administration to a pregnant woman, nursing mother"
Tatsuo Nakagawa 1, Yoichi Hiraoka 1, Kazumi Kito 1, Akito Nagai 1, Takanobu Hashimoto 1, Mikio Yamazaki 2, 牛越賢治郎 2, Osamu Okitsu 2, Tsuneo Mimura 2, Kazuo Inoue 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2010.

A construction and use of the confirmation procedure about the nursing advisability of the P1-506 drug use postpartum woman
Sachiko Takagi 1, Tatematsu space 2, Yumi Taniguchi 2, Now Yoshiko Takada 1, 2 which is related to Nagata, Masako Kamio 2, Kenji Tokui 1, Tanaka 3, Taihei, Osamu Kurauchi 4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2010.

	Investigation - in source of information - hospital pharmacist about P1-507 pregnancy and the medicine Ayumi Kayano 1, Yamahana Noriko 2, Mizuho Takahashi 1, Kiyomi Sadamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2010.

	Comparison of the drug administration rating system to P1-508 nursing mother Teiko Toyoguchi, Kanako Takano, Asako Honda, Jun Hosoya, Tadashi Shiraishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2010.

Comparison - of the drug evaluation of the seventh edition and the eighth edition in examination -Lactation of the drug evaluation at nursing in P1-509 Drugs in Pregnancy and Lactation (Gerald G. Briggs. et al.)
Young book Taro 1, Saori Kimura 1, Yuko Okada 1, Seiichi Maruyama 2, Satoshi Toyama 2, Hiroshi Sato 2, Hiroki Masuda 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2010.

Comparison - of the drug evaluation of the seventh edition and the eighth edition in examination -Pregnancy category of the drug evaluation at pregnancy in P1-510 Drugs in Pregnancy and Lactation (Gerald G. Briggs. et al.)
Saori Kimura 1, Young book Taro 1, Yuko Okada 1, Seiichi Maruyama 2, Satoshi Toyama 2, Hiroshi Sato 2, Hiroki Masuda 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2010.

	Effect on blood glucose level of neonates with the ritodrine hydrochloride administration to P1-511 mother Yumi Suzuki, Yukiko Shibata, Takahiro Kumagai, Yoshie Nomura, Takuya Goto, Makoto Nakajima, Kimio Wakabayashi, 加藤浩充, Shuichi Matsumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2010.

	Examination about the atropine premedication at the P1-512 cesarean section Yoshie Nomura, Yukiko Shibata, Yumi Suzuki, Takuya Goto, Makoto Nakajima, Kimio Wakabayashi, 加藤浩充, Takahiro Kumagai, Shuichi Matsumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2010.

	Examination of the number of quantity of to give it to an effect of the P1-513 moisturizer application and application Mariko Otani 1, 大谷道輝 2, Akane Nozawa 2, Mika Matsumoto 2, Boulevard wide 2, Kiichi Yamamura 2, Komoda Masayo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2010.

	About clinical application of the unpolished rice enzyme preparation for the P1-514 chronicity constipation Makoto Nakao 1, Takuya Ogawara 2, Tomoko Nakao 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2010.

	About the antibiotics susceptibility of the P1-515 sporulation-related butyric acid bacteria preparation Takafumi Kaneko, Tomohiro Nakayama, Naoki Tomiyama, 一川暢宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2010.

	About the in vitro antibacterial activity of the P1-516 burning shell and the clinical application (1) Risa Kuwahara, Maiko Kondo, Naomi Nakajima, Shibata Kei greens child, 椿井朋, Makoto Nakao Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2010.

	It is the quantitative analysis of the antioxidant action of the chitosan in the healthy subject application to the preventive health care of the P1-517 health food Makoto Anraku 1, Daisuke Kadowaki 2, Lower stone Kazuki 3, Odagiri A tree 2, 4, Toru Maruyama 2, Hisao Tomita 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2010.

	Correlation with cyclosporin A and the blood lipid levels in patients with P1-518 intractable ulcerative colitis Mika Yamazaki 1, Member of Satoshi Doi 2, Masaka Wataru 2, Yasuo Suzuki 3, Mitsutoshi Sato 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2010.

Pharmaceutical management of patients with advanced Parkinson's disease that used COMT inhibitor by P1-519 blood L-dopa and the L-dopa metabolite monitoring together
Mayu Kogure true 1, Member of Satoshi Doi 2, Junko Hagino 3, Takatsugu Sakakibara 4, Masaka Wataru 2, Mitsutoshi Sato 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2010.

	An effect of the antiHIV therapy including P1-520 Raltegravir and examination about the fat metabolism Shinichi Hikasa 1, Satoshi Hikasa 2, 澤田暁宏 2, Tazuko Tokugawa 2, Takeshi Kimura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2010.

	Enterokinesis usability test of patients with Parkinson's disease that we applied P1-521 13C breath test to 1, Seiwa, Hirai, Member of Satoshi Doi 1, Ishii Toshihiro 1, Masaka Wataru 1, Mitsutoshi Sato 2, Hatta Hiroyuki 3, Takatsugu Sakakibara 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2010.

Report of the use case of tocilizumab in the castle man disease (PC type) patients which P1-522 district core Hospital experienced
Foot fence Ryosuke, Kana Kobayashi, Naoko Noda, Yoshiko Tsuda, Haruko Hiraguchi, The Makoto Yamamoto world, Masaya Miyatani, Yasushi Katsui, Tatsumichi Naomi, Kondo meets
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2010.

	One case that P1-523 vancomycin shifted to in pleural effusion abundantly Kowata male solstice 1, 今浦将治 1, Kotaro Kobayashi 2, Hiroyuki Takahashi 2, 赤瀬朋秀 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2010.

	The case that a sodium benzoate note was effective for P1-524 hyperammonemia Hiroko Yamauchi 1, Masayo Shimomura 1, Rie Kihara 1, 井手飛香 1, Reina Ogata 2, Hiroshi Yamashita virtue 2, Toshiyuki Kadoi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2010.

Action for the smoking cessation foreign setup of the pharmacist-led type in the P1-525 this hospital and the establishment of the smoking cessation instruction method
Noriko Ishida 1, 2, Tatsuya Ono 1, 2, Michiko Yoshino 1, Emiko Yamamoto 1, Ushidani Yumi 1, It is still I 2 Tokuyama, Hideyuki Nishida 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2010.

	The situation of the use of drug depending on the true clinic in the P1-526 premature infant region Akiko Kobayashi, Koji Moriya, Ko Tokuda period, Kazunobu Takayanagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2010.

	About the change situation of the antiHIV medicine regimen in the P1-527 this hospital Chikako Shimokawa 1, Akiko Yasuda 1, Table Shiho 1, Katsuichiro Kamei 1, Mieko Yamada 2, 3, Mikio Ueda 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2010.

	Questionnaire results after the HFA-BDP nasal summons method instruction for asthma to be complicated with P1-528 nose lesion 表忍 1, Shimanuki sum lawn 1, Noriko Miyawaki 1, Tsuyoshi Matsumoto 1, Cheap place wide high 2, Makoto Hashimoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2010.

For the cooperation reinforcement of a hospital, the drugstore in the P1-529 area
Shigeki Kanemaru 1, 西川能治 2, Hirofumi Koike 2, Kozo Takizawa 3, Yuki Fukuda 4, Kuniko Yamanaka 5, Terumi Miyazato 6, Oda arms and fields of battle 7, Mieko Shimizu 7, Kayo Horikawa 7, Tadashi Wakasugi 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2010.

	Skill up ... of improvement and the pharmacist of the quality of medicine medicine cooperation - pharmacotherapy through the P1-530 combination conference 中尾圭裕 1, Takuya Suenaga 1, Hashida sweetfish beauty 2, Kazuo Watanabe 2, Yutaka Ueyama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2010.

	Attitude survey of the use actual situation and the hospital personnel in Masuda-shi of the P1-531 "medicine notebook" 西迫多重1, 猪股育夫1, 吉田勝好2, 郷原学2, 大庭信行3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2010.

	Relation to an action and regional medicine of the medicine medicine cooperation in the P1-532 this hospital Yoshihiro Watanabe, Ikuo Yoshihara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2010.

P1-533 Kyushu University Hospital cancer chemotherapeutic drug medicine cooperation seminar holding and the evaluation
Hiroyuki Watanabe 1, Uchida まやこ 1, Pond end Hiroaki 1, Mishima one up 1, King Suetsugu table 1, Ayumi Kodama 1, Obayashi かよ 1, Hiroko Yamaji 1, Asami Yamaguchi 1, Asami Saito 1, Rumi Ishikawa Kei 1, Masanori Sueyasu 1, Nobuaki Egashira 1, Kazuhiro Mizumoto 2, Ryozo Oishi 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2010.

Making ... of the document "reporting book between institutions" (mild version) which supports approach ... regional alliances of the P1-534 Aichi hospital pharmacist society on koro Gee meeting for the study
小島昌代1, 2, 鈴木善貴2, 小野田千晴2, 浅野幸子2, 竹原祐子2, 山本倫久2, 池田哲雄2, 岩田智樹2, 青山佳晃1, 斎藤寛子3, 勝見章男4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2010.

	Action of the medicine medicine cooperation in the cancer therapy of the P1-535 Kagawa Prefectural center Hospital Nakagawa spring, Hiromi Abe, Yuka Deguchi law of nature, Junko Nozaki, Akiko Nakajima, 寳田繁基, Masumi Miyakawa, Yasuyo Fukuda, Osamu Konishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2010.

	Medicine medicine cooperation ... of the oral anticancer drug with the action ... treatment information seal to reporting and medicine medicine cooperation by the inflection of the P1-536 medicine notebook Eri Asago, Sachiko Iwai, Toyodome Masae, 山下由季惠, Minako Matsumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2010.

Trial about the quality improvement of the medicine medicine cooperation in the P1-537 cancer chemotherapy
Akiko Taguchi 1, Tomoko Kawai 1, 2, Kuniko Nagakubo 3, Shun Ito elegant 1, 2, Akiko Hayashi 1, Yuichi Hattori 1, Rieko Ikoma 1, Slope Reiko Tanba 1, Kazuhiko Hayashi 4, Toshimi Kimura 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2010.

	Civic attitude survey about the medicine medicine cooperation through the medium of "a medicine notebook" in the P1-538 cancer medical therapy 玉木宏樹, 井上昌樹, 陶山登之, 上村智哉, 西村信弘, 直良浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2010.